{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The autoreload extension is already loaded. To reload it, use:\n",
      "  %reload_ext autoreload\n"
     ]
    }
   ],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "import bert\n",
    "import numpy as np\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "import matplotlib.pyplot as plt\n",
    "import spike_queries\n",
    "import spacy\n",
    "from typing import List\n",
    "from collections import defaultdict\n",
    "import tqdm\n",
    "from termcolor import colored\n",
    "from collections import Counter\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "\n",
    "class color:\n",
    "   PURPLE = '\\033[95m'\n",
    "   CYAN = '\\033[96m'\n",
    "   DARKCYAN = '\\033[36m'\n",
    "   BLUE = '\\033[94m'\n",
    "   GREEN = '\\033[92m'\n",
    "   YELLOW = '\\033[93m'\n",
    "   RED = '\\033[91m'\n",
    "   BOLD = '\\033[1m'\n",
    "   UNDERLINE = '\\033[4m'\n",
    "   END = '\\033[0m'\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_results(fname):\n",
    "    \n",
    "    with open(fname, \"r\", encoding = \"utf-8\") as f:\n",
    "        sents = f.readlines()\n",
    "    \n",
    "    sents = [s.strip().split(\"\\t\")[-1] for s in sents]\n",
    "    original, results = sents[0], sents[1:]\n",
    "    return original, results\n",
    "\n",
    "\n",
    "def get_spike_results_arguments_representations(model, spike_results, layers):\n",
    "    \n",
    "    sents = spike_results[\"sentence_text\"].tolist()\n",
    "    arg1_idx_start = spike_results[\"arg1_first_index\"].to_numpy().astype(int)\n",
    "    arg2_idx_start = spike_results[\"arg2_first_index\"].to_numpy().astype(int)\n",
    "    arg1_idx_end = spike_results[\"arg1_last_index\"].to_numpy().astype(int)\n",
    "    arg2_idx_end = spike_results[\"arg2_last_index\"].to_numpy().astype(int)\n",
    "    \n",
    "    arg1_rep = []\n",
    "    arg2_rep = []\n",
    "    \n",
    "    for s, arg1_start, arg2_start, arg1_end, arg2_end in zip(sents, arg1_idx_start, arg2_idx_start, arg1_idx_end, arg2_idx_end):\n",
    "        #idx_to_mask = [arg1_start, arg2_start, arg1_end, arg2_end]\n",
    "        H, _, _, orig2tok = model.encode(s, layers = layers)\n",
    "\n",
    "        h1, h2 = H[orig2tok[arg1_start]:orig2tok[arg1_end] + 1], H[orig2tok[arg2_start]:orig2tok[arg2_end] + 1]\n",
    "        \n",
    "        h1 = np.mean(h1, axis = 0)\n",
    "        h2 = np.mean(h2, axis = 0)\n",
    "        \n",
    "        arg1_rep.append(h1)\n",
    "        arg2_rep.append(h2)\n",
    "        \n",
    "    arg1_mean = np.mean(arg1_rep, axis = 0)\n",
    "    arg2_mean = np.mean(arg2_rep, axis = 0)\n",
    "        \n",
    "    return arg1_mean, arg2_mean\n",
    "    \n",
    "\n",
    "\n",
    "def main(filename, layers = [-1], num = 500):\n",
    "    \n",
    "    \n",
    "    query, results1 = load_results(filename)\n",
    "    results1 = results1[:num]\n",
    "    \n",
    "    spike_results = spike_queries.perform_query(query, dataset_name = \"covid19\", num_results = 100, query_type = \"syntactic\")\n",
    "    spike_results = spike_results[spike_results['sentence_text'].notnull()]\n",
    "    arg1_rep, arg2_rep = get_spike_results_arguments_representations(model, spike_results, layers)\n",
    "        \n",
    "    first, first_ind1, first_ind2 = spike_results[\"sentence_text\"].tolist()[-1], int(spike_results[\"arg1_first_index\"].tolist()[-1]), int(spike_results[\"arg2_first_index\"].tolist()[-1])\n",
    "    \n",
    "    alignments = []\n",
    "    \n",
    "    for s in results1:\n",
    "                    \n",
    "        H, tokenized_text, tok_to_orig_map, orig2tok = model.encode(s, layers = layers)\n",
    "        sims_arg1 = cosine_similarity([arg1_rep], H[1:-2])[0]\n",
    "        sims_arg2 = cosine_similarity([arg2_rep], H[1:-2])[0]\n",
    "        arg1_ind = np.argmax(sims_arg1) + 1\n",
    "        \n",
    "        sims_arg2[np.argmax(sims_arg1)] = -1\n",
    "        arg2_ind = np.argmax(sims_arg2) + 1\n",
    "        #print(arg1_ind, arg2_ind)\n",
    "        if arg1_ind not in tok_to_orig_map or arg2_ind not in tok_to_orig_map:\n",
    "            #print(\"ERROR\")\n",
    "            continue\n",
    "        alignments.append((s, tok_to_orig_map[arg1_ind], tok_to_orig_map[arg2_ind]))\n",
    "            \n",
    "    return query, spike_results, alignments"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "loading configuration file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/config.json from cache at /home/shauli/.cache/torch/transformers/199e28e62d2210c23d63625bd9eecc20cf72a156b29e2a540d4933af4f50bda1.4b6b9f5d813f7395e7ea533039e02deb1723d8fd9d8ba655391a01a69ad6223d\n",
      "Model config BertConfig {\n",
      "  \"attention_probs_dropout_prob\": 0.1,\n",
      "  \"hidden_act\": \"gelu\",\n",
      "  \"hidden_dropout_prob\": 0.1,\n",
      "  \"hidden_size\": 768,\n",
      "  \"initializer_range\": 0.02,\n",
      "  \"intermediate_size\": 3072,\n",
      "  \"layer_norm_eps\": 1e-12,\n",
      "  \"max_position_embeddings\": 512,\n",
      "  \"model_type\": \"bert\",\n",
      "  \"num_attention_heads\": 12,\n",
      "  \"num_hidden_layers\": 12,\n",
      "  \"output_hidden_states\": true,\n",
      "  \"pad_token_id\": 0,\n",
      "  \"type_vocab_size\": 2,\n",
      "  \"vocab_size\": 31090\n",
      "}\n",
      "\n",
      "loading configuration file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/config.json from cache at /home/shauli/.cache/torch/transformers/199e28e62d2210c23d63625bd9eecc20cf72a156b29e2a540d4933af4f50bda1.4b6b9f5d813f7395e7ea533039e02deb1723d8fd9d8ba655391a01a69ad6223d\n",
      "Model config BertConfig {\n",
      "  \"attention_probs_dropout_prob\": 0.1,\n",
      "  \"hidden_act\": \"gelu\",\n",
      "  \"hidden_dropout_prob\": 0.1,\n",
      "  \"hidden_size\": 768,\n",
      "  \"initializer_range\": 0.02,\n",
      "  \"intermediate_size\": 3072,\n",
      "  \"layer_norm_eps\": 1e-12,\n",
      "  \"max_position_embeddings\": 512,\n",
      "  \"model_type\": \"bert\",\n",
      "  \"num_attention_heads\": 12,\n",
      "  \"num_hidden_layers\": 12,\n",
      "  \"pad_token_id\": 0,\n",
      "  \"type_vocab_size\": 2,\n",
      "  \"vocab_size\": 31090\n",
      "}\n",
      "\n",
      "Model name 'allenai/scibert_scivocab_uncased' not found in model shortcut name list (bert-base-uncased, bert-large-uncased, bert-base-cased, bert-large-cased, bert-base-multilingual-uncased, bert-base-multilingual-cased, bert-base-chinese, bert-base-german-cased, bert-large-uncased-whole-word-masking, bert-large-cased-whole-word-masking, bert-large-uncased-whole-word-masking-finetuned-squad, bert-large-cased-whole-word-masking-finetuned-squad, bert-base-cased-finetuned-mrpc, bert-base-german-dbmdz-cased, bert-base-german-dbmdz-uncased, bert-base-finnish-cased-v1, bert-base-finnish-uncased-v1, bert-base-dutch-cased). Assuming 'allenai/scibert_scivocab_uncased' is a path, a model identifier, or url to a directory containing tokenizer files.\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/vocab.txt from cache at /home/shauli/.cache/torch/transformers/e3debd8fbdf40874753724814ee0520f612b577b26c8755bca485103b47cd3bc.60287becc5ab96d85a4bf377eb90feaf3b9c80d3b23e84311dccd3588f56d4fb\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/added_tokens.json from cache at None\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/special_tokens_map.json from cache at None\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/tokenizer_config.json from cache at None\n",
      "loading weights file https://cdn.huggingface.co/allenai/scibert_scivocab_uncased/pytorch_model.bin from cache at /home/shauli/.cache/torch/transformers/54e18c298451d3195ba8359e7a3fa2bc04c70c730c5b6744928278e67940eacb.7587182ea55c40bf7fd0961c1176c31fa22558da2bf20c199874fa5a8ecb4613\n"
     ]
    }
   ],
   "source": [
    "model = bert.BertEncoder(\"cuda\", \"scibert\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Parse"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "def parse_results(sentences: List[str]):\n",
    "    \n",
    "    #nlp = spacy.load(\"en_core_sci_sm\")\n",
    "    nlp = spacy.load(\"en_core_sci_lg\")\n",
    "    \n",
    "    docs = [spacy.tokens.Doc(vocab=nlp.vocab, words = sentence.split(\" \")) for sentence in sentences]\n",
    "    for name, proc in nlp.pipeline:\n",
    "        for i,doc in enumerate(docs):\n",
    "            docs[i] = proc(doc)\n",
    "    return docs\n",
    "\n",
    "\n",
    "\n",
    "def get_ancestors(tok):\n",
    "    \n",
    "    parents = [tok]\n",
    "    \n",
    "    while tok.head != tok:\n",
    "    \n",
    "        parents.append(tok.head)\n",
    "        tok = tok.head\n",
    "        \n",
    "    \n",
    "    return parents\n",
    "    \n",
    "def get_path_between_tokens(tok1, tok2, doc):\n",
    "    \n",
    "    path1 = get_ancestors(tok1)\n",
    "    path2 = get_ancestors(tok2)\n",
    "    #print(path1, path2)\n",
    "    \n",
    "    lowest_ancestor = None\n",
    "    for tok in path1:\n",
    "        if tok in path2:\n",
    "            lowest_ancestor = tok\n",
    "            break\n",
    "\n",
    "    path1 =  path1[:path1.index(lowest_ancestor)+1]\n",
    "    path2 =  path2[:path2.index(lowest_ancestor)+1]\n",
    "    \n",
    "    linear_path_before = [tok1 if tok1.i < tok2.i else tok2]\n",
    "    linear_path_after = [tok1 if tok1.i > tok2.i else tok2]\n",
    "    linear_path_between =  [t for t in doc if t.i < max(tok1.i, tok2.i) and t.i > min(tok1.i, tok2.i)]\n",
    "    \n",
    "    min_i, max_i = min(tok1.i, lowest_ancestor.i, tok2.i), max(tok1.i, lowest_ancestor.i, tok2.i)\n",
    "    \n",
    "    linear_path = [t.text for t in doc if t.i >= min_i and t.i <= max_i]\n",
    "    linear_path[linear_path.index(tok1.text)] = colored(tok1.text, \"red\")\n",
    "    linear_path[linear_path.index(tok2.text)] = colored(tok2.text, \"blue\")    \n",
    "    linear_path_str = \" \".join(linear_path)\n",
    "    \n",
    "    path = {\"ancestor\": lowest_ancestor, \"path1\": path1, \"path2\": path2, \"tok1\": tok1, \"tok2\": tok2, \"linear_path\": linear_path,\n",
    "           \"linear_path_str\": linear_path_str}\n",
    "    return path"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "#from spacy import displacy\n",
    "#displacy.render(doc, style='dep', jupyter=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "def regularize(path1: List[str], path2: List[str]):\n",
    "\n",
    "    #print(\"path1\", path1)\n",
    "    #print(\"path2\", path2)\n",
    "    \n",
    "    \n",
    "    path1[-1] = color.BOLD + path1[-1] + color.END\n",
    "    path2[0] = colored(path2[0], \"blue\")\n",
    "    path1[0] = colored(path1[0], \"red\")\n",
    "        \n",
    "    path = path1 + path2[::-1][1:]\n",
    "\n",
    "    return path\n",
    "        \n",
    "\n",
    "def get_paths(docs, alignments, path_type = \"lemmas-deps\"):\n",
    "\n",
    "    paths_lemmas = []\n",
    "    paths_deps = []\n",
    "    paths_lemmas_deps = []\n",
    "    paths_pos = []\n",
    "    i = 0\n",
    "    linear_paths = []\n",
    "    \n",
    "    for doc, (sent, idx1, idx2) in zip(docs, alignments):\n",
    "        \n",
    "        tok1, tok2 = doc[idx1], doc[idx2]\n",
    "        \n",
    "        try:\n",
    "            path_dict = get_path_between_tokens(tok1, tok2, doc)\n",
    "        except: continue #TODO: check the \"None\" error.\n",
    "            \n",
    "        linear_paths.append(path_dict[\"linear_path_str\"])\n",
    "    \n",
    "        tok1_2ances = path_dict[\"path1\"]\n",
    "        tok2_2ances = path_dict[\"path2\"]\n",
    "        \n",
    "        \n",
    "        lemmas1 = [tok.lemma_ for tok in tok1_2ances]\n",
    "        lemmas2 = [tok.lemma_ for tok in tok2_2ances]\n",
    "        deps1 = [tok.dep_ for tok in tok1_2ances]\n",
    "        deps2 = [tok.dep_ for tok in tok2_2ances]\n",
    "        #pos1 = [tok.tag_ for tok in tok1_2ances]\n",
    "        #pos2 = [tok.tag_ for tok in tok2_2ances]\n",
    "        \n",
    "        lemmas = regularize(lemmas1, lemmas2)\n",
    "        deps = regularize(deps1, deps2)\n",
    "        #pos = regularize(pos1, pos2)\n",
    "        \n",
    "        zipped = \"-\".join([lemma+\".\"+dep for lemma, dep in zip(lemmas, deps)])\n",
    "        paths_lemmas_deps.append(zipped)\n",
    "        paths_lemmas.append(\"-\".join(lemmas))\n",
    "        paths_deps.append(\"-\".join(deps))\n",
    "        #paths_pos.append(\"-\".join(paths_pos))\n",
    "        \n",
    "        i += 1\n",
    "    \n",
    "    paths = None\n",
    "    \n",
    "    if path_type == \"lemmas-deps\":\n",
    "        \n",
    "        paths =  paths_lemmas_deps\n",
    "\n",
    "    elif path_type == \"lemmas\":\n",
    "        \n",
    "        paths = paths_lemmas\n",
    "    \n",
    "    elif path_type == \"deps\":\n",
    "        \n",
    "        paths = paths_deps\n",
    "    \n",
    "    elif path_type == \"pos\":\n",
    "        \n",
    "        paths = paths_pos\n",
    "    \n",
    "    else:\n",
    "        \n",
    "        raise Exception(\"Unknown type\")\n",
    "    \n",
    "    return paths, linear_paths"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def sort_by_freq(paths, linear_paths):\n",
    "    \n",
    "    together = zip(paths, linear_paths)\n",
    "    counts = []\n",
    "    \n",
    "    for p, p_lin in zip(paths, linear_paths):\n",
    "        \n",
    "        counts.append(paths.count(p))\n",
    "\n",
    "    paths_linpaths_counts = zip(paths, linear_paths, counts)    \n",
    "    paths_linpaths_counts = sorted(paths_linpaths_counts, key = lambda pair: -pair[-1])\n",
    "    \n",
    "    paths, linear_paths, counts = list(zip(*paths_linpaths_counts))\n",
    "    return paths, linear_paths, counts\n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Collect Paths"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "def collect(num_results, path_type):\n",
    "    \n",
    "    fnames = [\"results{}.txt\".format(i) for i in range(1,10)]\n",
    "    k = 0\n",
    "    \n",
    "    for fname in fnames:\n",
    "        query, spike_results, alignments = main(fname, layers = [-1], num = num_results)    \n",
    "        sents = [s for s,ind1,ind2 in alignments]\n",
    "        docs = parse_results(sents)\n",
    "    \n",
    "        paths, linear_paths = get_paths(docs, alignments, path_type)\n",
    "        paths, linear_paths, counts = sort_by_freq(paths, linear_paths)\n",
    "    \n",
    "        #df = pd.DataFrame({\"paths\": paths, \"linear_paths\": linear_paths})\n",
    "    \n",
    "        print(color.BOLD + \"QUERY {}:\\n\\t\".format(k) + query + color.END )\n",
    "        print(color.BOLD + \"\\nMOST FREQUENT PATTERNS:\\n\" + color.END)\n",
    "        for i in range(100):\n",
    "        \n",
    "            print(\"PATH: \"+ paths[i] + \"\\tLINEAR: \" + linear_paths[i] +\"\\tCOUNT: \" + str(counts[i]))\n",
    "        \n",
    "        print(\"\\n\\n\")\n",
    "        print(\"=================================================================\")\n",
    "        print(\"=================================================================\")    \n",
    "        \n",
    "        k += 1"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Pattern: dep labels + lemmas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 0:\n",
      "\t<>arg1:virus $infection $causes a <>arg2:condition .\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m cause a debilitating \u001b[34mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes respiratory tract \u001b[34mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m of JEV can cause nervous system \u001b[34mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with LIV in humans can cause a neurological \u001b[34mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with SARS-CoV causes lower respiratory tract \u001b[34mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with MAdV-1 causes multisystemic \u001b[34mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can cause severe lung \u001b[34mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can result in severe respiratory \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m results in an acute , self-limiting and icteric \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in humans often results in a severe , life-threatening \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m with encephalitic alphaviruses may result in severe neurologic \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m by LCMV can result in acute central nervous system \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m of cattle with BoHV-1 generally results in inflammatory \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m also characterized\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in humans \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with hMPV \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minflammation\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in humans is characterized by extensive pulmonary \u001b[34minflammation\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcan\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m of humans \u001b[34mcan\u001b[0m result\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcan\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mcan\u001b[0m result\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcan\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mcan\u001b[0m results\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minflammation\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m are characterized by \u001b[34minflammation\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minflammation\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m are characterized by \u001b[34minflammation\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msyndrome\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m , in domestic cats , causes a variable immunodeficiency \u001b[34msyndrome\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mvirus\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mvirus\u001b[0m causes a lower respiratory tract \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mmyocarditis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes \u001b[34mmyocarditis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpedv\u001b[0m.\u001b[31mcompound\u001b[0m-infection.nsubj-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34menteritis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mPEDV\u001b[0m infections cause acute , severe atrophic \u001b[34menteritis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34millness\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes undifferentiated febrile \u001b[34millness\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-spectrum.dobj-symptom.nmod-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with DENV can cause a spectrum of \u001b[34mclinical\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpedv\u001b[0m.\u001b[31mcompound\u001b[0m-infection.nsubj-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34menteritis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mPEDV\u001b[0m infections cause acute , severe atrophic \u001b[34menteritis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34millness\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes \u001b[34millness\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-result.acl-\u001b[34mdamage\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m characterized by severe clinical manifestations of the lower respiratory tract , resulting in diffuse alveolar \u001b[34mdamage\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-result.acl-\u001b[34mdamage\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m characterized by severe clinical manifestations of the lower respiratory tract , resulting in diffuse alveolar \u001b[34mdamage\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbkv\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mestablish\u001b[0m.\u001b[1mROOT\u001b[0m-cause.conj-number.dobj-\u001b[34mdisorder\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mBKV\u001b[0m establishes infection in the kidney and the urinary tract , and its activation causes a number of \u001b[34mdisorders\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbkv\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mestablish\u001b[0m.\u001b[1mROOT\u001b[0m-cause.conj-number.dobj-\u001b[34mdisorder\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mBKV\u001b[0m establishes infection in the kidney and the urinary tract , and its activation causes a number of \u001b[34mdisorders\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msyndrome\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of humans with SARS-CoV typically causes an influenza-like \u001b[34msyndrome\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a systemic \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minduce\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of both susceptible and resistant mouse strains induces an early acute \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-spectrum.dobj-symptom.nmod-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes a broad spectrum of \u001b[34mclinical\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-onset.nsubjpass-\u001b[34menteritis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34menteritis\u001b[0m is associated with \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-onset.nsubjpass-\u001b[34menteritis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34menteritis\u001b[0m is associated with \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m an important systemic parvoviral \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-spectrum.dobj-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes a wide spectrum of \u001b[34mdiseases\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-spectrum.dobj-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes a wide spectrum of \u001b[34mdiseases\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcan\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m by SFTSV \u001b[34mcan\u001b[0m cause\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mdobj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mhowever\u001b[0m.\u001b[34madvmod\u001b[0m\tLINEAR: \u001b[34mHowever\u001b[0m , SARS-CoV-2 causes \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mdobj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mhowever\u001b[0m.\u001b[34madvmod\u001b[0m\tLINEAR: \u001b[34mHowever\u001b[0m , SARS-CoV-2 causes \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-loss.nmod-\u001b[34mfocal\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of the brain with the JHM strain of MHV ( JHMV ) results in \u001b[34mfocal\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-loss.nmod-\u001b[34mfocal\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of the brain with the JHM strain of MHV ( JHMV ) results in \u001b[34mfocal\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34millness\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with CHIKV often results in acute \u001b[34millness\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mmyocarditis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m of mice can cause \u001b[34mmyocarditis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcan\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mcan\u001b[0m cause\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34millness\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of ZV results in a self-limiting mild \u001b[34millness\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mvirus\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mvirus\u001b[0m causes \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minduce\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in dogs generally induces a multisystemic \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-manifestation.dobj-\u001b[34mneurologic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can also cause \u001b[34mneurologic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-manifestation.dobj-\u001b[34mneurologic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can also cause \u001b[34mneurologic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-characterize.conj-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m the major cause of lower respiratory tract infections in infants and \u001b[34mis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-characterize.conj-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m the major cause of lower respiratory tract infections in infants and \u001b[34mis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mvirus\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minduce\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minflammation\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mvirus\u001b[0m , like MHV-3 infection in mice , can induce exaggerated \u001b[34minflammation\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minduce\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m induces acute \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-immunosuppression.dobj-\u001b[34mprogressive\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes \u001b[34mprogressive\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-encephalitis.dobj-disorder.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can cause Japanese encephalitis ( JE ) with \u001b[34msevere\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mproduce\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m with HHV-6 can produce a mononucleosis-like illness and , more rarely , severe \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-illness.nmod-\u001b[34mfebrile\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with MV typically results in an acute \u001b[34mfebrile\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mbrv\u001b[0m.\u001b[31mnsubj\u001b[0m-infection.nsubj-\u001b[1mcomponent\u001b[0m.\u001b[1mROOT\u001b[0m-pathogenesis.nmod-\u001b[34mdisease\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mBRV\u001b[0m is a lytic infection and destruction of infected mucosal epithelial cells is an important component of \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbegin\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-stage.nmod-infection.nmod-characterize.acl:relcl-fever.nmod-\u001b[34mshock\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m begins with flu-like symptoms and progresses rapidly to the final stages of viral hemorrhagic fever infection , which are characterized by fever , hemorrhage , and hypotensive \u001b[34mshock\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpedv\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-cause.conj-atrophy.dobj-villi.nmod-result.acl-\u001b[34mdiarrhea\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPEDV\u001b[0m infects the epithelium of the small intestine , an environment rich in proteases , and causes atrophy of the villi resulting in \u001b[34mdiarrhea\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-associate.conj-\u001b[34mgastroenteritis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m results in respiratory tract complications with varying degree of severity and has been associated with \u001b[34mgastroenteritis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfect\u001b[0m.\u001b[31macl\u001b[0m-human.nsubj-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msyndrome\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfected\u001b[0m with RVFV usually develop an acute febrile myalgic \u001b[34msyndrome\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mprrsv\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mincrease\u001b[0m.\u001b[1mROOT\u001b[0m-result.advcl-\u001b[34mseverity\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPRRSV\u001b[0m increases the susceptibility of the host to a wide range of viral and bacterial respiratory pathogens , resulting in increased \u001b[34mseverity\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m causes severe \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msars-cov\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV\u001b[0m causes interstitial \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mvirus\u001b[0m.\u001b[31mnmod\u001b[0m-spread.nmod-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m characterized by a rapid and extensive spread of the \u001b[31mvirus\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mrepresent\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m mostly represented\tCOUNT: 1\n",
      "PATH: \u001b[31mvirus\u001b[0m.\u001b[31mnmod\u001b[0m-ability.nmod-\u001b[1mresult\u001b[0m.\u001b[1mconj\u001b[0m-\u001b[34mdamage\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: results from overwhelming cytopathic \u001b[34mdamage\u001b[0m due to the ability of Ebola \u001b[31mvirus\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mmers-cov\u001b[0m.\u001b[31mnmod\u001b[0m-infect.acl-human.nsubjpass-\u001b[1mreport\u001b[0m.\u001b[1mROOT\u001b[0m-develop.xcomp-\u001b[34millness\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m have been reported to develop a severe acute respiratory \u001b[34millness\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mJEV\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minvade\u001b[0m.\u001b[1mROOT\u001b[0m-trigger.advcl-response.dobj-\u001b[34minflammatory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mJEV\u001b[0m invades the central nervous system , wherein virus replication triggers a massive \u001b[34minflammatory\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mmcmv\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-cause.conj-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMCMV\u001b[0m causes asymptomatic infection in adult immunocompetent mice , but experimental inoculation of neonates has caused lethal \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mlead\u001b[0m.\u001b[1mROOT\u001b[0m-viremia.nmod-\u001b[34mto\u001b[0m.\u001b[34mcase\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m leads \u001b[34mto\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mfiv\u001b[0m.\u001b[31mnsubj\u001b[0m-pathogen.nsubj-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-degeneration.dobj-function.nmod-lead.acl:relcl-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mFIV\u001b[0m is an important viral pathogen worldwide in the domestic cat ( Felis catus ) , causes a slow progressive degeneration of immune functions that eventually leads to a \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34monset\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes a sudden \u001b[34monset\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-immunosuppression.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in young chickens results in \u001b[34msevere\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mprrsv\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mreplicate\u001b[0m.\u001b[1mROOT\u001b[0m-lead.conj-infection.nmod-\u001b[34mpneumonia\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mPRRSV\u001b[0m replicates mainly in porcine alveolar macrophages ( PAMs ) and dendritic cells ( DCs ) and leads to persistent infection , interstitial \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-characterize.conj-cascade.nmod-event.nmod-lead.acl-inflammation.nmod-\u001b[34mpulmonary\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of SARS-CoV causes severe acute respiratory syndrome ( SARS ) , which is an emerging infectious disease and characterized by a cascade of immunological events leading to \u001b[34mpulmonary\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mmhv\u001b[0m.\u001b[31mcompound\u001b[0m-infection.nsubj-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mencephalitis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMHV\u001b[0m infection causes \u001b[34mencephalitis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31malphavirus\u001b[0m.\u001b[31mcompound\u001b[0m-infection.nsubj-\u001b[1minduce\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34marthritis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31malphavirus\u001b[0m infections , such as those involving CHIKV , Ross River virus ( RRV ) , and Sindbis virus ( SINV ) , induce debilitating \u001b[34marthritis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-atrophy.nmod-intestine.nmod-result.acl:relcl-\u001b[34mdiarrhea\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is characterized by severe villous atrophy in the small intestine that results in watery \u001b[34mdiarrhea\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mvirus\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mable\u001b[0m.\u001b[1madvcl\u001b[0m-cross.xcomp-stimulate.conj-\u001b[34minflammation\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mvirus\u001b[0m is able to cross the blood-brain barrier and stimulate \u001b[34minflammation\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mmnv\u001b[0m.\u001b[31mcompound\u001b[0m-infection.nsubj-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-replication.nmod-associate.acl-\u001b[34mdiarrhea\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mMNV\u001b[0m infection in immunocompromised mice lacking innate immunity factors such as STAT1 or interferon receptors can result in persistent or acute virus replication associated with severe \u001b[34mdiarrhea\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-severe.nmod-\u001b[34mdisease\u001b[0m.\u001b[34mdep\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m results in severe and even fatal lung \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mbiv\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minduce\u001b[0m.\u001b[1mROOT\u001b[0m-splenomegaly.dobj-\u001b[34msyndrome\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mBIV\u001b[0m induces splenomegaly and lymphademopathy \u001b[34msyndromes\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-consequence.nsubjpass-\u001b[1mreport\u001b[0m.\u001b[1mROOT\u001b[0m-result.parataxis-disease.nmod-cns.nmod-\u001b[34msepsis\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m , such as acute flaccid paralysis , myocarditis , and Reye syndrome , have been reported [ 13 , 18 ] ; HPeV3 infection results in severe diseases of the CNS and neonatal \u001b[34msepsis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mjhmv\u001b[0m.\u001b[31mnmod\u001b[0m-strain.nsubj-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mjHMV\u001b[0m cause a subacute or persistent \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mmarv\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34millness\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMARV\u001b[0m causes an acute febrile \u001b[34millness\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mvirus\u001b[0m.\u001b[31mnmod\u001b[0m-mouse.nmod-infection.nsubj-\u001b[1mproduce\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mvirus\u001b[0m produces clinical \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mterm\u001b[0m.\u001b[1mROOT\u001b[0m-cause.parataxis-\u001b[34menteritis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m , also termed epizootic catarrhal \u001b[34menteritis\u001b[0m or ECE , causes mucoid enteritis\tCOUNT: 1\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 1:\n",
      "\tinfected arg1:patients $usually $develop <>arg2:[entity]respiratory illness.\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with PEDV \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m clinically characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m \u001b[34mare\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msign\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mClinical\u001b[0m signs of CPV-2 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msign\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mClinical\u001b[0m signs in human \u001b[31minfections\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msign\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of respiratory \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msign\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of BDV \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msign\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of FPV \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m who have pneumonic plague typically develop fulminant \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m rapidly develop \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with severe cases usually develop \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with BCC develop a life-threatening , sometimes necrotizing , \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mpresent\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msymptom\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m infected with SARS-CoV often present with \u001b[34msymptoms\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mrabbit\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34msepsis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mrabbits\u001b[0m usually develop \u001b[34msepsis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mrabbit\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34msepsis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mrabbits\u001b[0m usually develop \u001b[34msepsis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mrabbit\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34msepsis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mrabbits\u001b[0m usually develop \u001b[34msepsis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mfever\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m develop rapid onset \u001b[34mfever\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mpresent\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msymptom\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with severe MERS often present with pneumonic \u001b[34msymptoms\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mfever\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m develop \u001b[34mfever\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m in neonatal kids \u001b[34mis\u001b[0m characterized\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mpresent\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msymptom\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m generally present with mild upper respiratory infection \u001b[34msymptoms\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mfever\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m usually develop \u001b[34mfever\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1minfection\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msymptom\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m symptoms of MERS-CoV \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msymptom\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m initially causes non-specific \u001b[34msymptoms\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31manimal\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdie\u001b[0m.\u001b[1mROOT\u001b[0m\tLINEAR: \u001b[31manimals\u001b[0m usually \u001b[34mdie\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-lead.conj-\u001b[34mfever\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m , immature schistosomula pass through the lung and can lead to \u001b[34mfever\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mclinical\u001b[0m.\u001b[31mamod\u001b[0m-manifestation.nsubj-\u001b[1mevolve\u001b[0m.\u001b[1mROOT\u001b[0m-picture.nmod-\u001b[34mseptic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mclinical\u001b[0m manifestations of inhalational anthrax generally evolve to a fulminant \u001b[34mseptic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mclinical\u001b[0m.\u001b[31mamod\u001b[0m-manifestation.nsubj-\u001b[1mevolve\u001b[0m.\u001b[1mROOT\u001b[0m-picture.nmod-\u001b[34mseptic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mclinical\u001b[0m manifestations of inhalational anthrax generally evolve to a fulminant \u001b[34mseptic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfant\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msymptom\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mInfants\u001b[0m with myocarditis usually have \u001b[34msymptoms\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfant\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msymptom\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mInfants\u001b[0m with myocarditis usually have \u001b[34msymptoms\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31manimal\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdie\u001b[0m.\u001b[1mROOT\u001b[0m\tLINEAR: \u001b[31manimals\u001b[0m usually \u001b[34mdie\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhost\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdiarrhea\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mhosts\u001b[0m usually develop self-limiting \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhost\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdiarrhea\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mhosts\u001b[0m usually develop self-limiting \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msign\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of \u001b[31msepsis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msign\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of \u001b[31msepsis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-infection.nsubj-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msyndrome\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mhumans\u001b[0m typically causes an influenza-like \u001b[34msyndrome\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mdisease\u001b[0m.\u001b[1mdobj\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mdisease\u001b[0m.\u001b[1mdobj\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-infection.nsubj-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msyndrome\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mhumans\u001b[0m with SARS-CoV typically causes an influenza-like \u001b[34msyndrome\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with symptomatic EPEC \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msymptom\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34msymptoms\u001b[0m of rapidly-lethal \u001b[31minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1minfection\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1moccur\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdyspnea\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , \u001b[34mdyspnea\u001b[0m and hypoxemia usually occur\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with symptomatic EPEC \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1msevere\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m \u001b[31mis\u001b[0m usually more severe\tCOUNT: 2\n",
      "PATH: \u001b[31mmouse\u001b[0m.\u001b[31mconj\u001b[0m-suckle.nmod-growth.nmod-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m is characterized by retarded growth , ruffled fur , soft feces or diarrhea , rectal prolapse , and moderate mortality in older suckling or recently weaned \u001b[31mmice\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmouse\u001b[0m.\u001b[31mconj\u001b[0m-suckle.nmod-growth.nmod-\u001b[1mcharacterize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m is characterized by retarded growth , ruffled fur , soft feces or diarrhea , rectal prolapse , and moderate mortality in older suckling or recently weaned \u001b[31mmice\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mconj\u001b[0m-\u001b[1mclinic\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-\u001b[34mdisease\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: clinic , COVID-19 \u001b[31mpatients\u001b[0m most commonly present with fever , cough and dyspnea , and from there the \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mconj\u001b[0m-\u001b[1mclinic\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-\u001b[34mdisease\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: clinic , COVID-19 \u001b[31mpatients\u001b[0m most commonly present with fever , cough and dyspnea , and from there the \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msymptom\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m usually causes mild \u001b[34msymptoms\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-lead.conj-\u001b[34mfever\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m , immature schistosomula pass through the lung , and can lead to \u001b[34mfever\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1msevere\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m \u001b[31mis\u001b[0m usually more severe\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mbe\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mattr\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m usually a self-limited \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mbe\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mattr\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m usually a self-limited \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m infected with COVID-19 typically present with fever , cough , dyspnea , and myalgia , and the infection may cause severe \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m infected with COVID-19 typically present with fever , cough , dyspnea , and myalgia , and the infection may cause severe \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdiarrhea\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m usually result in \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mmanifest\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m caused by the virus manifests in most cases as a lower respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mmanifest\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m caused by the virus manifests in most cases as a lower respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msymptom\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m symptoms of norovirus \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msymptom\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34msymptoms\u001b[0m of calicivirus \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1moccur\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdyspnea\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , \u001b[34mdyspnea\u001b[0m occurs\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msymptom\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34mSymptoms\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdiarrhea\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m results in profuse greenish , mucoid \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msymptom\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34mSymptoms\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcat\u001b[0m.\u001b[31mconj\u001b[0m-young.nsubj-have.aux-\u001b[1mprofuse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdiarrhea\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mcats\u001b[0m with cryptosporidiosis will have profuse , watery \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcat\u001b[0m.\u001b[31mconj\u001b[0m-young.nsubj-have.aux-\u001b[1mprofuse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdiarrhea\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mcats\u001b[0m with cryptosporidiosis will have profuse , watery \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpeople\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mmanifest\u001b[0m.\u001b[1mROOT\u001b[0m-feature.dobj-\u001b[34mpneumonia\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpeople\u001b[0m commonly manifest features of \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mexhibit\u001b[0m.\u001b[1mROOT\u001b[0m-encephalopathy.dobj-\u001b[34mencephalitis\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m suffering from severe DENV infection often exhibit encephalopathy and \u001b[34mencephalitis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcat\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mshow\u001b[0m.\u001b[1mROOT\u001b[0m-sign.dobj-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mCats\u001b[0m with FIP show nonspecific \u001b[34mclinical\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcat\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m\tLINEAR: \u001b[31mCats\u001b[0m with signs from FIV often \u001b[34mhave\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34menteric\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mEnteric\u001b[0m FCoV \u001b[31minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-illness.dobj-\u001b[34mrespiratory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with MERS develop severe acute \u001b[34mrespiratory\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-stage.nsubj-\u001b[1minclude\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbleeding\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m usually include diffuse \u001b[34mbleeding\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1masymptomatic\u001b[0m.\u001b[1mROOT\u001b[0m-occur.advcl-sign.nsubj-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is usually asymptomatic , although nonspecific \u001b[34mclinical\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mpresent\u001b[0m.\u001b[1mROOT\u001b[0m-headache.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m can present with \u001b[34msevere\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdeteriorate\u001b[0m.\u001b[1mROOT\u001b[0m-present.conj-\u001b[34msymptom\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m infected with EVD rapidly deteriorate and commonly present with gastrointestinal \u001b[34msymptoms\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mrabbit\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-course.dobj-\u001b[34mdisease\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mrabbits\u001b[0m usually develop a chronic \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcat\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-manifest.conj-\u001b[34mdisease\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[31mCats\u001b[0m are primarily infected subclinically , but gastrointestinal \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1mmarmoset\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mmarmosets\u001b[0m with measles \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-onset.dobj-\u001b[34msudden\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mhumans\u001b[0m , VEEV infection causes a \u001b[34msudden\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msyndrome\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mHumans\u001b[0m infected with RVFV usually develop an acute febrile myalgic \u001b[34msyndrome\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnmod\u001b[0m-subset.nsubj-progress.conj-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m is associated with fever and liver damage , but a subset of \u001b[31mpatients\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mpresent\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: presents in \u001b[31mhumans\u001b[0m as a lower respiratory \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msymptom\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with bubonic plague usually develop \u001b[34msymptoms\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msymptomatic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSymptomatic\u001b[0m CHIKV \u001b[31minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-worsen.conj-symptom.nsubj-\u001b[34mrespiratory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m caused by SARS-CoV typically has an insidious onset , and \u001b[34mrespiratory\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mthose\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msuffer\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-inflammation.nmod-\u001b[34mlung\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mThose\u001b[0m infected with SARS suffer fever , cough , muscle aches , and shortness of breath and often progress to severe \u001b[34mlung\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mnmod\u001b[0m-infection.nsubj-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34millness\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mhumans\u001b[0m usually causes a self-limiting , acute and febrile \u001b[34millness\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhuman\u001b[0m.\u001b[31mamod\u001b[0m-\u001b[1mleptospirosis\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[31mHuman\u001b[0m \u001b[34mleptospirosis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpig\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mpresent\u001b[0m.\u001b[1mROOT\u001b[0m-symptom.dobj-as.prep-vomiting.pobj-\u001b[34mdiarrhea\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mPigs\u001b[0m that are infected with TGEV usually present symptoms such as vomiting , dehydration , and severe \u001b[34mdiarrhea\u001b[0m\tCOUNT: 1\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 2:\n",
      "\ta arg1:subset of patients $progress to arg2:hemorrhagic fever\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m pediatric \u001b[31mcases\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mdisease\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mdisease\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-failure.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m develop \u001b[34msevere\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-failure.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m can develop \u001b[34msevere\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mdisease\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mdisease\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-failure.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m rapidly develop \u001b[34msevere\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-failure.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m rapidly develop \u001b[34msevere\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-failure.nmod-\u001b[34mrespiratory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m may progress into \u001b[34mrespiratory\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-failure.nmod-\u001b[34mrespiratory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m quickly progresses to \u001b[34mrespiratory\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-failure.nmod-\u001b[34mrespiratory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m quickly progresses to \u001b[34mrespiratory\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-case.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , the \u001b[31mdisease\u001b[0m may progress\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mconj\u001b[0m-\u001b[1mclinic\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-\u001b[34mdisease\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: clinic , COVID-19 \u001b[31mpatients\u001b[0m most commonly present with fever , cough and dyspnea , and from there the \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mconj\u001b[0m-\u001b[1mclinic\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-\u001b[34mdisease\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: clinic , COVID-19 \u001b[31mpatients\u001b[0m most commonly present with fever , cough and dyspnea , and from there the \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-case.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , \u001b[31mit\u001b[0m can progress\tCOUNT: 2\n",
      "PATH: \u001b[31mcondition\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-case.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , the \u001b[31mconditions\u001b[0m may develop\tCOUNT: 2\n",
      "PATH: \u001b[31mcondition\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-case.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , the \u001b[31mconditions\u001b[0m may develop\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-failure.nmod-\u001b[34mrespiratory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m develops with primary infection , occurs rarely in children , and progresses to \u001b[34mrespiratory\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-disease.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m may develop \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1madvcl\u001b[0m-pneumonia.nmod-\u001b[34mviral\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses to \u001b[34mviral\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1madvcl\u001b[0m-pneumonia.nmod-\u001b[34mviral\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses to \u001b[34mviral\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-result.conj-failure.nmod-\u001b[34mcardiac\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses very slowly , but can result in \u001b[34mcardiac\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-result.conj-failure.nmod-\u001b[34mcardiac\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses very slowly , but can result in \u001b[34mcardiac\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mviral\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mviral\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mviral\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mviral\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mDisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-syndrome.nmod-\u001b[34mand\u001b[0m.\u001b[34mcc\u001b[0m\tLINEAR: \u001b[31mDisease\u001b[0m can progress to acute respiratory distress syndrome \u001b[34mand\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mDisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-syndrome.nmod-\u001b[34mand\u001b[0m.\u001b[34mcc\u001b[0m\tLINEAR: \u001b[31mDisease\u001b[0m can progress to acute respiratory distress syndrome \u001b[34mand\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-infection.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-failure.nmod-\u001b[34mrespiratory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m develops rapidly and eventually progresses after 2 to 4 days into \u001b[34mrespiratory\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-infection.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-edema.dobj-\u001b[34mpulmonary\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m often develop refractory \u001b[34mpulmonary\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-edema.dobj-\u001b[34mpulmonary\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m often develop refractory \u001b[34mpulmonary\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mmay\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m \u001b[34mmay\u001b[0m progress\tCOUNT: 2\n",
      "PATH: \u001b[31mcan\u001b[0m.\u001b[31maux\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-complication.nsubj-involvement.nmod-\u001b[34mpulmonary\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mpulmonary\u001b[0m involvement \u001b[31mcan\u001b[0m result\tCOUNT: 2\n",
      "PATH: \u001b[31mcan\u001b[0m.\u001b[31maux\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-complication.nsubj-involvement.nmod-\u001b[34mpulmonary\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mpulmonary\u001b[0m involvement \u001b[31mcan\u001b[0m result\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-failure.dobj-response.conj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m whose condition deteriorates to critical status primarily decompensate from a respiratory standpoint , but may also develop multi-organ failure ( respiratory failure , cardiac failure , renal failure , hypercoagulable state , thrombotic microangiopathy ) , as well as \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-failure.dobj-response.conj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m whose condition deteriorates to critical status primarily decompensate from a respiratory standpoint , but may also develop multi-organ failure ( respiratory failure , cardiac failure , renal failure , hypercoagulable state , thrombotic microangiopathy ) , as well as \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mmay\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m \u001b[34mmay\u001b[0m progress\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-form.dobj-\u001b[1mexperience\u001b[0m.\u001b[1mROOT\u001b[0m-suffer.conj-complication.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: experience a mild form of \u001b[31mdisease\u001b[0m , but those with advanced age or underlying comorbidities may suffer \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-form.dobj-\u001b[1mexperience\u001b[0m.\u001b[1mROOT\u001b[0m-suffer.conj-complication.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: experience a mild form of \u001b[31mdisease\u001b[0m , but those with advanced age or underlying comorbidities may suffer \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-case.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , \u001b[31mit\u001b[0m can progress\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-disease.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m of every age can develop \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-have.advcl-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-lead.advcl-\u001b[34mdeath\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m have mild symptoms such as fever , headache , cough , myalgia and anosmia , some develop acute respiratory distress syndrome , leading to \u001b[34mdeath\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-have.advcl-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-lead.advcl-\u001b[34mdeath\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m have mild symptoms such as fever , headache , cough , myalgia and anosmia , some develop acute respiratory distress syndrome , leading to \u001b[34mdeath\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-case.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , the \u001b[31mdisease\u001b[0m may progress\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdevelop\u001b[0m.\u001b[34mxcomp\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m progress rapidly to \u001b[34mdevelop\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdevelop\u001b[0m.\u001b[34mxcomp\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m progress rapidly to \u001b[34mdevelop\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mprogressive\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mprogressive\u001b[0m local \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mprogressive\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mprogressive\u001b[0m local \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-syndrome.nmod-failure.conj-\u001b[34mrespiratory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mit\u001b[0m may result in adult \u001b[34mrespiratory\u001b[0m distress syndrome and respiratory\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-syndrome.nmod-failure.conj-\u001b[34mrespiratory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mit\u001b[0m may result in adult \u001b[34mrespiratory\u001b[0m distress syndrome and respiratory\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-lymphadenopathy.conj-\u001b[34mgeneralize\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: results in \u001b[31mdisease\u001b[0m that is less severe and commonly presents as nondescript , consisting of fever , myalgia , and \u001b[34mgeneralized\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mresult\u001b[0m.\u001b[1mROOT\u001b[0m-lymphadenopathy.conj-\u001b[34mgeneralize\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: results in \u001b[31mdisease\u001b[0m that is less severe and commonly presents as nondescript , consisting of fever , myalgia , and \u001b[34mgeneralized\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mform\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mthis\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34mthis\u001b[0m form of the \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mform\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mthis\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34mthis\u001b[0m form of the \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-onset.nsubj-\u001b[1mbegin\u001b[0m.\u001b[1mROOT\u001b[0m-case.nmod-\u001b[34msymptomatic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msymptomatic\u001b[0m cases , the onset of \u001b[31mdisease\u001b[0m begins\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-onset.nsubj-\u001b[1mbegin\u001b[0m.\u001b[1mROOT\u001b[0m-case.nmod-\u001b[34msymptomatic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msymptomatic\u001b[0m cases , the onset of \u001b[31mdisease\u001b[0m begins\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-plague.dobj-pneumonic.amod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m may progress to \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-plague.dobj-pneumonic.amod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m may progress to \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-pneumonia.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m may develop \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-pneumonia.dobj-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m may develop \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmay\u001b[0m.\u001b[31maux\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-to.prep-state.pobj-\u001b[34mtoxic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mmay\u001b[0m progress to an increasingly \u001b[34mtoxic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcan\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m in this age group \u001b[34mcan\u001b[0m progress\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcan\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m \u001b[34mcan\u001b[0m progress\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmay\u001b[0m.\u001b[31maux\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-to.prep-state.pobj-\u001b[34mtoxic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mmay\u001b[0m progress to an increasingly \u001b[34mtoxic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-asymptomatic.advcl-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-symptom.dobj-\u001b[34mserious\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m usually asymptomatic , cryptococcosis can cause \u001b[34mserious\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-asymptomatic.advcl-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-symptom.dobj-\u001b[34mserious\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m usually asymptomatic , cryptococcosis can cause \u001b[34mserious\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-presentation.nmod-include.acl:relcl-pharyngitis.dobj-\u001b[34mdisease\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m usually develops within the first 3 months of transplantation , with a presentation that might include pharyngitis , tracheitis , bronchitis , pneumonitis , enteritis , hemorrhagic cystitis , or disseminated \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-presentation.nmod-include.acl:relcl-pharyngitis.dobj-\u001b[34mdisease\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m usually develops within the first 3 months of transplantation , with a presentation that might include pharyngitis , tracheitis , bronchitis , pneumonitis , enteritis , hemorrhagic cystitis , or disseminated \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-lead.advcl-to.prep-dyspnea.pobj-stridor.conj-cyanosis.conj-shock.conj-\u001b[34mseptic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses rapidly , leading to dyspnea , stridor , cyanosis , and \u001b[34mseptic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprogress\u001b[0m.\u001b[1mROOT\u001b[0m-lead.advcl-to.prep-dyspnea.pobj-stridor.conj-cyanosis.conj-shock.conj-\u001b[34mseptic\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses rapidly , leading to dyspnea , stridor , cyanosis , and \u001b[34mseptic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mDisease\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mlimited\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-infection.nmod-bronchiolitis.nmod-\u001b[34mpneumonia\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mDisease\u001b[0m is mostly limited to the upper airways and is self-limiting , but a small percentage can progress to lower respiratory tract infections as bronchiolitis and \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mDisease\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mlimited\u001b[0m.\u001b[1mROOT\u001b[0m-progress.conj-infection.nmod-bronchiolitis.nmod-\u001b[34mpneumonia\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mDisease\u001b[0m is mostly limited to the upper airways and is self-limiting , but a small percentage can progress to lower respiratory tract infections as bronchiolitis and \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-some.nsubj-\u001b[1msevere\u001b[0m.\u001b[1mROOT\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m may be \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-some.nsubj-\u001b[1msevere\u001b[0m.\u001b[1mROOT\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m may be \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mshock\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[34mshock\u001b[0m in approximately 15 % \u001b[31mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcase\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdie\u001b[0m.\u001b[1mROOT\u001b[0m-have.conj-sign.dobj-\u001b[34mclinical\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m may die within 1 to 2 days because of overwhelming viremia and vasculitis of all major organs and yet have minimal \u001b[34mclinical\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 3:\n",
      "\tpeople with arg1:[e]asthma are $susceptible to arg2:[e]asthma\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m.\u001b[31mnmod\u001b[0m-subject.conj-exacerbation.dobj-trigger.xcomp-\u001b[1mknow\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubjpass\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are highly susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are highly susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to the \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more susceptible to \u001b[34minfections\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with iatrogenic or disease related immune suppression are highly susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are generally more susceptible to \u001b[34minfections\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m who are immunocompromised such as due to steroids or organ and hematopoietic stem cell transplantation are highly susceptible to atypical viral \u001b[34minfections\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m may be as susceptible to active Mycobacterium tuberculous \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are also susceptible to nosocomial viral \u001b[34minfections\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with hematologic malignancies , especially in the neutropenic state after aggressive chemotherapy or HSCT and HSCT recipients with GVHD , are particularly susceptible to invasive fungal \u001b[34minfections\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more susceptible to bacterial , fungal , viral , and parasitic \u001b[34minfections\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with DAH are especially susceptible to pulmonary \u001b[34minfections\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mcompound\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients , particularly those under anticancer treatment , are potentially more susceptible for a severe \u001b[34minfection\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mcompound\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients and immunocompromised hosts are particularly susceptible to lung \u001b[34minfection\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mcompound\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients are more susceptible to \u001b[34minfections\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mcompound\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mcompound\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients are potentially more susceptible to Coronavirus \u001b[34minfection\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mcompound\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients are more susceptible to \u001b[34minfections\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with liver cirrhosis or liver cancer are at high risk of SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with defective cell-mediated immunity are at risk of \u001b[34minfections\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with primary adrenal insufficiency including Addison 's disease and congenital adrenal hyperplasia are at an increased risk of \u001b[34minfections\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with prolonged neutropenia who have received intensive cytotoxic chemotherapy are at risk for invasive fungal \u001b[34minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m , especially those with neutropenia , are at increased risk of \u001b[34minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m , including those with HIV/AIDS and patients taking immunosuppressants post-transplant , are at an increased risk for viral and fungal \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprone\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are also more prone to RSV \u001b[34minfections\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with immunodeficiency syndromes are also at risk of \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprone\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with ESLD are prone to \u001b[34minfections\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with associated CD4 + cell depletion not receiving appropriate prophylaxis are at high risk for Pneumocystis jiroveci \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpneumonia\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with a single LT may be at greater risk of \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprone\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m , including not only those with HIV \u001b[34minfection\u001b[0m but also those who undergo small bowel transplantation for short bowel syndrome , are prone to CMV infection\tCOUNT: 4\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mprone\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are also prone to other community acquired and nosocomial \u001b[34minfections\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mds\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-lower.nmod-\u001b[34minfection\u001b[0m.\u001b[34mdep\u001b[0m\tLINEAR: \u001b[31mDS\u001b[0m are highly susceptible to lower and higher respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mds\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-lower.nmod-\u001b[34minfection\u001b[0m.\u001b[34mdep\u001b[0m\tLINEAR: \u001b[31mDS\u001b[0m are highly susceptible to lower and higher respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mds\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-lower.nmod-\u001b[34minfection\u001b[0m.\u001b[34mdep\u001b[0m\tLINEAR: \u001b[31mDS\u001b[0m are highly susceptible to lower and higher respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mcompound\u001b[0m-patient.nmod-status.nsubj-\u001b[1mincrease\u001b[0m.\u001b[1mROOT\u001b[0m-risk.dobj-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients ( whether caused by the disease itself or the treatment ) increases their risk of \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mcompound\u001b[0m-patient.nmod-status.nsubj-\u001b[1mincrease\u001b[0m.\u001b[1mROOT\u001b[0m-risk.dobj-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients ( whether caused by the disease itself or the treatment ) increases their risk of \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mcompound\u001b[0m-patient.nmod-status.nsubj-\u001b[1mincrease\u001b[0m.\u001b[1mROOT\u001b[0m-risk.dobj-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients ( whether caused by the disease itself or the treatment ) increases their risk of \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m undergoing allogeneic stem cell transplantation are at a much higher risk of \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with rheumatic and inflammatory bowel diseases ( IBDs ) may be at higher risk of \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mconj\u001b[0m-dentition.nmod-patient.nsubj-\u001b[1mlikely\u001b[0m.\u001b[1mROOT\u001b[0m-develop.xcomp-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m are more likely to develop aspiration \u001b[34mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mconj\u001b[0m-dentition.nmod-patient.nsubj-\u001b[1mlikely\u001b[0m.\u001b[1mROOT\u001b[0m-develop.xcomp-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m are more likely to develop aspiration \u001b[34mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mconj\u001b[0m-dentition.nmod-patient.nsubj-\u001b[1mlikely\u001b[0m.\u001b[1mROOT\u001b[0m-develop.xcomp-\u001b[34mpneumonia\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m are more likely to develop aspiration \u001b[34mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m without prior exposure to varicella-zoster virus are at increased risk of severe \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31millness\u001b[0m.\u001b[31mdobj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mxcomp\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: develop severe \u001b[31millness\u001b[0m after \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31millness\u001b[0m.\u001b[31mdobj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mxcomp\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: develop severe \u001b[31millness\u001b[0m after \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msepsis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with immunodeficiency due to human immunodeficiency virus ( HIV ) infection are highly susceptible to viral \u001b[34msepsis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mvulnerable\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more vulnerable to \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mvulnerable\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are often vulnerable to opportunistic \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mibd\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mIBD\u001b[0m are at increased risk of \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mibd\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mIBD\u001b[0m are at increased risk of \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-bacterial.nmod-\u001b[34minfection\u001b[0m.\u001b[34mdep\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are particularly susceptible to bacterial and candidal \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1msinusitis\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-cause.acl-\u001b[34mbacteria\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31msinusitis\u001b[0m caused by encapsulated \u001b[34mbacteria\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-severity.dobj-increase.acl:relcl-depletion.nmod-\u001b[1mrelated\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34minfections\u001b[0m are also related to lymphoid depletion and immunosuppression , which likely increase the severity of secondary \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-be.cop-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m who are more heavily immunosuppressed and who are suffering from other immunologic and infectious complications of transplant are at higher risk for \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34msepsis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with iron overload ( hemochromatosis ) are more susceptible to yersinial \u001b[34msepsis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mbacterial\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mbacterial\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mdobj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1macl\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: developing severe \u001b[31mdisease\u001b[0m upon primary HRSV \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1mdevelop\u001b[0m.\u001b[1mdep\u001b[0m-form.dobj-\u001b[34maspergillosis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m or milder forms of immunosuppression develop semi-invasive forms of \u001b[34maspergillosis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-\u001b[1mdevelop\u001b[0m.\u001b[1mdep\u001b[0m-form.dobj-\u001b[34maspergillosis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m or milder forms of immunosuppression develop semi-invasive forms of \u001b[34maspergillosis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1msinusitis\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-cause.acl-\u001b[34mbacteria\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31msinusitis\u001b[0m caused by capsulated \u001b[34mbacteria\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-be.cop-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are at risk of serious \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-bacterial.nmod-\u001b[34minfection\u001b[0m.\u001b[34mdep\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m on high dose corticosteroids and mechanical ventilation are particularly susceptible to superimposed bacterial and opportunistic \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-severity.dobj-increase.acl:relcl-depletion.nmod-\u001b[1mrelated\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34minfections\u001b[0m are also related to lymphoid depletion and immunosuppression , which likely increase the severity of secondary \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mdobj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1macl\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: developing severe \u001b[31mdisease\u001b[0m by \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m KIPyV \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m.\u001b[31mnsubj\u001b[0m-be.cop-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with GI bleeding are at risk of developing bacterial \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mare\u001b[0m more susceptible to \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcancer\u001b[0m.\u001b[31mnmod\u001b[0m-patient.nsubj-be.cop-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are at the risk of SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1msusceptible\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mare\u001b[0m more susceptible to \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mviral\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mviral\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 4:\n",
      "\targ1:[e]paracetamol is $not useful for treating arg2:[e]asthma.\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mincrease\u001b[0m.\u001b[1mROOT\u001b[0m-influenza.nmod-\u001b[34minfection\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m may increase the risk of mortality and morbidity ( e.g. secondary \u001b[34minfections\u001b[0m ) in severe influenza and other viral infections\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mincrease\u001b[0m.\u001b[1mROOT\u001b[0m-influenza.nmod-\u001b[34minfection\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m may increase the risk of mortality and morbidity ( e.g. secondary \u001b[34minfections\u001b[0m ) in severe influenza and other viral infections\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mconsider\u001b[0m.\u001b[1mccomp\u001b[0m-management.nmod-case.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m and IgIV can be considered for the management of \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1meffective\u001b[0m.\u001b[1mROOT\u001b[0m-virus.nmod-\u001b[34msars\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m is only marginally effective against the \u001b[34mSARS\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mantiviral\u001b[0m.\u001b[31mamod\u001b[0m-option.nsubjpass-\u001b[1mlimited\u001b[0m.\u001b[1mROOT\u001b[0m-be.advcl-prove.conj-effective.xcomp-occur.advcl-\u001b[34mdisease\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[31mantiviral\u001b[0m treatment options are limited because no parenteral drug is available and no drug has been proved to be effective once life-threatening \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mantiviral\u001b[0m.\u001b[31mamod\u001b[0m-option.nsubjpass-\u001b[1mlimited\u001b[0m.\u001b[1mROOT\u001b[0m-be.advcl-prove.conj-effective.xcomp-occur.advcl-\u001b[34mdisease\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[31mantiviral\u001b[0m treatment options are limited because no parenteral drug is available and no drug has been proved to be effective once life-threatening \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mconj\u001b[0m-cidofovir.nmod-\u001b[1magent\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[34magents\u001b[0m ( such as cidofovir , foscarnet , and \u001b[31mribavirin\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mconj\u001b[0m-cidofovir.nmod-\u001b[1magent\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[34magents\u001b[0m ( such as cidofovir , foscarnet , and \u001b[31mribavirin\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1meffective\u001b[0m.\u001b[1mROOT\u001b[0m-virus.nmod-\u001b[34msars\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m is only marginally effective against the \u001b[34mSARS\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mof\u001b[0m.\u001b[31mcase\u001b[0m-therapy.nmod-efficacy.conj-effect.nmod-\u001b[1mcompromise\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.nsubjpass-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m after liver transplantation is often compromised by enhanced adverse effects and limited efficacy \u001b[31mof\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mconsider\u001b[0m.\u001b[1mccomp\u001b[0m-management.nmod-case.nmod-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m with or without immunoglobulin can be considered for the management of \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mcompound\u001b[0m-therapy.nsubj-sufficient.ccomp-\u001b[1mthink\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m , it is increasingly thought that \u001b[31mcorticosteroid\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mcompound\u001b[0m-therapy.nsubj-sufficient.ccomp-\u001b[1mthink\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m , it is increasingly thought that \u001b[31mcorticosteroid\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mof\u001b[0m.\u001b[31mcase\u001b[0m-therapy.nmod-efficacy.conj-effect.nmod-\u001b[1mcompromise\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.nsubjpass-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m after LT is compromised by enhanced adverse effects and limited efficacy \u001b[31mof\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mantiviral\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-available.amod-practice.nmod-treatment.nmod-\u001b[34mpneumonia\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mantivirals\u001b[0m available in clinical practice for the treatment of \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mcompound\u001b[0m-therapy.nsubj-\u001b[1meffective\u001b[0m.\u001b[1mROOT\u001b[0m-%.nmod-form.nmod-\u001b[34mttp\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcorticosteroid\u001b[0m therapy is effective in 56 % of purely hematological forms of \u001b[34mTTP\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mcompound\u001b[0m-therapy.nsubj-\u001b[1meffective\u001b[0m.\u001b[1mROOT\u001b[0m-%.nmod-form.nmod-\u001b[34mttp\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcorticosteroid\u001b[0m therapy is effective in 56 % of purely hematological forms of \u001b[34mTTP\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mantiviral\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-induce.conj-rejection.dobj-\u001b[34morgan\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mAntivirals\u001b[0m themselves have significant side effects , and their use may induce \u001b[34morgan\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mantiviral\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-induce.conj-rejection.dobj-\u001b[34morgan\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mAntivirals\u001b[0m themselves have significant side effects , and their use may induce \u001b[34morgan\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mantiviral\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-available.amod-practice.nmod-treatment.nmod-\u001b[34mpneumonia\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mantivirals\u001b[0m available in clinical practice for the treatment of \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-agent.nsubj-patient.nmod-active.nmod-\u001b[34mtuberculosis\u001b[0m.\u001b[34mdep\u001b[0m\tLINEAR: \u001b[31mit\u001b[0m is not an appropriate agent in patients with active or latent \u001b[34mtuberculosis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1msufficient\u001b[0m.\u001b[1macl:relcl\u001b[0m-suppress.advcl-\u001b[34minflammation\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m alone are not sufficient for suppressing \u001b[34minflammation\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1museful\u001b[0m.\u001b[1mROOT\u001b[0m-treat.advcl-infection.dobj-\u001b[34msars\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m may not be useful for treating \u001b[34mSARS\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtherapy\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mrecommend\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.nmod-sars-cov-2.nmod-\u001b[34mof\u001b[0m.\u001b[34mcase\u001b[0m\tLINEAR: \u001b[31mtherapy\u001b[0m is not recommended in the clinical treatment \u001b[34mof\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mrecommend\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m are not recommended in COVID-19 \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnsubj\u001b[0m-fail.conj-\u001b[1mdie\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with PCP typically die due to refractory hypoxemia from severe respiratory failure , and \u001b[31mcorticosteroids\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1meffective\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.nmod-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m are not effective for the treatment of lung injury or shock in adults ' SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnsubjpass\u001b[0m-recommend.ccomp-\u001b[1mdelay\u001b[0m.\u001b[1mROOT\u001b[0m-clearance.dobj-\u001b[34mvirus\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mCorticosteroids\u001b[0m in the treatment of SARS-CoV-2 pneumonia are not usually recommended ; they may delay \u001b[34mvirus\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mavailable\u001b[0m.\u001b[1mconj\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m is available for CVB3 \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mlicense\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.nmod-infection.nmod-\u001b[34mcmv\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mDrugs\u001b[0m currently licensed for the treatment of systemic \u001b[34mCMV\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-Most.nsubj-\u001b[1meffective\u001b[0m.\u001b[1mROOT\u001b[0m-use.conj-progression.nmod-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31magents\u001b[0m are mildly effective and slow-acting , and therefore , should not be used as the only treatment modality due to the rapid progression of \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mantiviral\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-case.nmod-infection.nmod-\u001b[34minfluenza\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mantivirals\u001b[0m such as NA inhibitors and M2 blockers have limited efficacy in severe cases of \u001b[34minfluenza\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m.\u001b[31mnsubj\u001b[0m-ineffective.conj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-low.acomp-in.prep-\u001b[34mchild\u001b[0m.\u001b[34mpobj\u001b[0m\tLINEAR: is also low in \u001b[34mchildren\u001b[0m , and the \u001b[31mtreatment\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnmod\u001b[0m-use.nsubj-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-suppression.dobj-\u001b[34mhost\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m in the treatment of COVID-19 can cause \u001b[34mhost\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minterferon\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mnsubj\u001b[0m-treat.acl-\u001b[34mdengue\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: use of \u001b[31minterferon\u001b[0m to treat \u001b[34mdengue\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mconj\u001b[0m-trial.nmod-\u001b[1mobserve\u001b[0m.\u001b[1mROOT\u001b[0m-consider.conj-be.xcomp-drug.attr-of.prep-choice.pobj-for.prep-\u001b[34minfluenza\u001b[0m.\u001b[34mpobj\u001b[0m\tLINEAR: observed in all clinical trials and \u001b[31mribavirin\u001b[0m is currently not considered to be a drug of choice for \u001b[34minfluenza\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31maciclovir\u001b[0m.\u001b[31mcompound\u001b[0m-monotherapy.nmod-efficacy.nsubjpass-\u001b[1mhamper\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mencephalitis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34mencephalitis\u001b[0m , the efficacy of \u001b[31maciclovir\u001b[0m monotherapy may be hampered\tCOUNT: 1\n",
      "PATH: \u001b[31macyclovir\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1madvcl\u001b[0m-efficacy.dobj-prevent.acl-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31macyclovir\u001b[0m has had certain efficacy for preventing CMV \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mfam\u001b[0m.\u001b[31mnsubj\u001b[0m-therapy.advcl-\u001b[1margue\u001b[0m.\u001b[1mROOT\u001b[0m-use.advcl-prophylaxis.nmod-\u001b[34msurvival\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mFAM\u001b[0m is standard therapy for established BOS , recent data argue strongly against using azithromycin as prophylaxis against BOS due to decreased \u001b[34msurvival\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-available.advcl-infection.nmod-\u001b[34minfluenza\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[34minfluenza\u001b[0m infections ( e.g. , M2 and neuraminidase inhibitors ) , these \u001b[31mdrugs\u001b[0m have\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mlimit\u001b[0m.\u001b[1mROOT\u001b[0m-response.nmod-therapy.nmod-suppression.nmod-\u001b[34mimmune\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mtreatment\u001b[0m is frequently limited by insufficient response to therapy or side effects of \u001b[34mimmune\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubj\u001b[0m-demonstrate.advcl-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.nsubj-\u001b[34mcchf\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: been no specific treatment for \u001b[34mCCHF\u001b[0m , though \u001b[31mribavirin\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mbiologic\u001b[0m.\u001b[31mamod\u001b[0m-therapy.nsubj-\u001b[1mprovide\u001b[0m.\u001b[1madvcl\u001b[0m-option.dobj-\u001b[34mUC\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mbiologic\u001b[0m therapies provide a valuable treatment option in \u001b[34mUC\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mappos\u001b[0m-therapy.nsubjpass-use.conj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-vaccine.nsubj-prevent.acl-\u001b[34mrsv\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: is no vaccine to prevent \u001b[34mRSV\u001b[0m , and the only accepted therapy ( \u001b[31mribavirin\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-resistance.nmod-association.appos-shedding.nmod-\u001b[34mvirus\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mTreatment\u001b[0m with M2 inhibitors , such as amantadine , is generally not used in transplant recipients because of widespread resistance , the association with prolonged shedding of \u001b[34mvirus\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mzanamivir\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minduce\u001b[0m.\u001b[1mROOT\u001b[0m-be.ccomp-benefit.attr-prove.acl-\u001b[34mtreatment\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34mtreatment\u001b[0m outside of these specific circumstances , as it comes at a cost and may be associated with side effects ; for example , \u001b[31mzanamivir\u001b[0m can induce\tCOUNT: 1\n",
      "PATH: \u001b[31mantiviral\u001b[0m.\u001b[31mamod\u001b[0m-\u001b[1mtherapy\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mspecific\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSpecific\u001b[0m \u001b[31mantiviral\u001b[0m therapies\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-choice.attr-patient.nmod-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m may not be a standard choice in patients with influenza A \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mauxpass\u001b[0m-\u001b[1mcontraindicate\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mcirrhosis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m contraindicated in advanced \u001b[34mcirrhosis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minduce\u001b[0m.\u001b[1mROOT\u001b[0m-effective.advcl-c.nmod-\u001b[34mhepatitis\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[34mhepatitis\u001b[0m C , \u001b[31mribavirin\u001b[0m can induce\tCOUNT: 1\n",
      "PATH: \u001b[31mcidofovir\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mremain\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.attr-death.nmod-report.acl-secondary.xcomp-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcidofovir\u001b[0m remains an imperfect treatment , with deaths reported secondary to disseminated adenoviral \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-efficacy.dobj-pneumonia.nmod-\u001b[34mbacterial\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31magents\u001b[0m have limited efficacy in advanced \u001b[34mbacterial\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1meffective\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m and immunosuppressive drugs \u001b[34mare\u001b[0m not universally effective\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m.\u001b[31mcompound\u001b[0m-toxicity.nmod-associate.conj-\u001b[1mcomplicated\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.nsubj-recipient.nmod-develop.acl:relcl-cre.dobj-\u001b[34minfection\u001b[0m.\u001b[34mdep\u001b[0m\tLINEAR: \u001b[34minfections\u001b[0m is quite complicated , often requires combination antimicrobial therapy , and can also be associated with \u001b[31mdrug\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mivig\u001b[0m.\u001b[31mnmod\u001b[0m-treatment.nsubj-\u001b[1mtherapy\u001b[0m.\u001b[1madvcl\u001b[0m-\u001b[34mkd\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mIVIG\u001b[0m is an effective therapy for \u001b[34mKD\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m.\u001b[31mnmod\u001b[0m-use.nsubjpass-\u001b[1mlimit\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mad\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34mAD\u001b[0m , continuous use of systemic immunosuppressive \u001b[31magents\u001b[0m is limited\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mchallenging\u001b[0m.\u001b[1mROOT\u001b[0m-alleviate.advcl-symptom.dobj-\u001b[34minflammatory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mtreatment\u001b[0m is challenging as IL-1 inhibitors can alleviate the \u001b[34minflammatory\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m.\u001b[31mnmod\u001b[0m-interaction.nmod-\u001b[1mpose\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mtreatment\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mTreatment\u001b[0m of MTB after SOT poses special challenges because of potential interactions between anti-MTB \u001b[31mdrugs\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnmod\u001b[0m-use.nsubj-\u001b[1mcontroversial\u001b[0m.\u001b[1mROOT\u001b[0m-impact.nmod-response.nmod-\u001b[34mimmune\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m for the treatment of COVID-19 is controversial due to their negative impact on anti-viral \u001b[34mimmune\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnmod\u001b[0m-switch.nsubjpass-\u001b[1mrecommend\u001b[0m.\u001b[1mROOT\u001b[0m-worsen.conj-\u001b[34mdisease\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m [ 16 ] is not recommended during SARS-CoV-2 infection and may worsen the \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhaart\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-make.xcomp-timing.dobj-controversial.amod-patient.nmod-\u001b[34msepsis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mHAART\u001b[0m is associated with potentially deleterious sequelae , making timing of the therapy very controversial in patients with active \u001b[34msepsis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mantiviral\u001b[0m.\u001b[31mamod\u001b[0m-therapy.nsubjpass-\u001b[1mneed\u001b[0m.\u001b[1mROOT\u001b[0m-absence.conj-intervention.nmod-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mantiviral\u001b[0m therapies are needed due to troubles in maintaining adequate stocks of plasma and the absence of effective interventions for treated \u001b[34mpatients\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31malthough\u001b[0m.\u001b[31mmark\u001b[0m-\u001b[1madopt\u001b[0m.\u001b[1madvcl\u001b[0m-treatment.nmod-\u001b[34msars\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mAlthough\u001b[0m lopinavir/ritonavir have been adopted for the treatment of \u001b[34mSARS\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m.\u001b[31mnmod\u001b[0m-use.dobj-need.advcl-\u001b[1mrespond\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m afflicted with HIV-associated AIDs including inflammatory musculoskeletal involvement respond well to conventional therapy such as NSAIDs , narcotic drugs , and DMARDs , but refractory cases may need the use of biological \u001b[31magents\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mapprove\u001b[0m.\u001b[1madvcl\u001b[0m-treatment.nmod-infection.nmod-\u001b[34mhrsv\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m has been approved for the treatment of \u001b[34mHRSV\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minhibit\u001b[0m.\u001b[1mROOT\u001b[0m-replication.dobj-\u001b[34mviral\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m inhibits \u001b[34mviral\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mantiviral\u001b[0m.\u001b[31mamod\u001b[0m-drug.nmod-benefit.nsubjpass-\u001b[1mestablish\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.nmod-\u001b[34msars\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mantiviral\u001b[0m drugs or glucocorticoids has not been established for treatment of \u001b[34mSARS\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnmod\u001b[0m-use.nsubj-be.cop-\u001b[1mconvenient\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m may not be convenient in \u001b[34mpatients\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m.\u001b[31mnmod\u001b[0m-use.dobj-need.advcl-\u001b[1mrespond\u001b[0m.\u001b[1mROOT\u001b[0m-proportion.nsubj-involvement.nmod-\u001b[34minflammatory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34minflammatory\u001b[0m musculoskeletal involvement respond well to conventional therapy such as NSAIDs , narcotic drugs and DMARDs , but refractory cases may need the use of biological \u001b[31magents\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mvzig\u001b[0m.\u001b[31mnsubj\u001b[0m-efficient.advcl-\u001b[1mbeneficial\u001b[0m.\u001b[1mROOT\u001b[0m-therapy.nmod-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mVZIG\u001b[0m is clearly efficient in post-exposure prophylaxis , it is not beneficial for therapy of already established VZV \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m.\u001b[31mnmod\u001b[0m-class.nmod-efficacy.nsubjpass-\u001b[1mlimit\u001b[0m.\u001b[1mROOT\u001b[0m-development.nmod-resistance.nmod-\u001b[34mantiviral\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mdrugs\u001b[0m is limited due to the rapid development of \u001b[34mantiviral\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mtreatment\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mCRS\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSteroids\u001b[0m are also a used treatment in SARS-CoV-2 \u001b[34mCRS\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mefficacious\u001b[0m.\u001b[1madvcl\u001b[0m-reduce.conj-level.dobj-patient.nmod-infection.nmod-\u001b[34mhbv\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31magents\u001b[0m have been efficacious in experimental animal studies and reduce \u001b[34mHBV\u001b[0m DNA levels in patients with chronic HBV\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnmod\u001b[0m-profile.nsubj-\u001b[1mlimit\u001b[0m.\u001b[1mROOT\u001b[0m-use.dobj-treat.acl-\u001b[34minfection\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m including teratogenicity limits its use to treat ZIKV \u001b[34minfections\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtherapy\u001b[0m.\u001b[31mnmod\u001b[0m-conjunction.nmod-\u001b[1mtoxicity\u001b[0m.\u001b[1mnsubj\u001b[0m-\u001b[34mpulmonary\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mpulmonary\u001b[0m toxicity in conjunction with FOLFOX \u001b[31mtherapy\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m.\u001b[31mnsubj\u001b[0m-mainstay.nsubj-\u001b[1mcontroversial\u001b[0m.\u001b[1mROOT\u001b[0m-use.nsubj-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m are the mainstay of any treatment plan however its use during COVID-19 \u001b[34minfection\u001b[0m is controversial\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1mdrug\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-treatment.nmod-\u001b[34mvhf\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdrugs\u001b[0m for the treatment of \u001b[34mVHF\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mivig\u001b[0m.\u001b[31mcompound\u001b[0m-treatment.nmod-initiation.nsubj-\u001b[1mresult\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mkd\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mIVIg\u001b[0m treatment before Day 5 of fever can sometimes result in refractory \u001b[34mKD\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m.\u001b[31mnmod\u001b[0m-therapy.nsubjpass-\u001b[1mneed\u001b[0m.\u001b[1mROOT\u001b[0m-control.xcomp-\u001b[34mvasculitis\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m , and cyclophosphamide , or rituximab may be needed to control life-threatening \u001b[34mvasculitis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mglucocorticoid\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mefficacy\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mtreatment\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: efficacy of \u001b[31mglucocorticoids\u001b[0m in the \u001b[34mtreatment\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-that.dobj-effective.amod-control.advcl-activity.dobj-\u001b[34mdisease\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31magents\u001b[0m have a downside in that they are not that effective in controlling MS \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m.\u001b[31mcompound\u001b[0m-option.nsubjpass-\u001b[1mlimited\u001b[0m.\u001b[1mROOT\u001b[0m-trial.conj-lopinavir/ritonavir.nmod-medication.appos-\u001b[34mhiv\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mtreatment\u001b[0m options for COVID-19 are limited and may not be effective-a randomized trial of lopinavir/ritonavir , a common \u001b[34mHIV\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mcombination\u001b[0m.\u001b[1mROOT\u001b[0m-treatment.nsubj-patient.nmod-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m is the combination of \u001b[31mribavirin\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m.\u001b[31mdep\u001b[0m-effect.nsubjpass-\u001b[1mcontraindicate\u001b[0m.\u001b[1mROOT\u001b[0m-patient.nmod-\u001b[34mmyocarditis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m may be contraindicated in patients with acute and chronic \u001b[34mmyocarditis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mconj\u001b[0m-bronchodilator.dobj-include.conj-\u001b[1mbenefit\u001b[0m.\u001b[1mROOT\u001b[0m-plan.nsubj-\u001b[34mrsv\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m are of limited benefit and include bronchodilators , \u001b[31mcorticosteroids\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1mdrug\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubjpass\u001b[0m\u001b[0m-treat.acl-\u001b[34minfection\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mdrugs\u001b[0m to treat HCMV \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtherapy\u001b[0m.\u001b[31mnmod\u001b[0m-refractory.xcomp-\u001b[1mremain\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m remain refractory to immunoglobulin \u001b[31mtherapy\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m.\u001b[31mnmod\u001b[0m-therapy.nsubjpass-use.advcl-\u001b[1mrefractory\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m , plasma exchange ( PE ) , IVIG and immunosuppressive drugs are routinely used , many \u001b[34mpatients\u001b[0m are refractory\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1mRibavirin\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubjpass\u001b[0m\u001b[0m-option.appos-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mRibavirin\u001b[0m , the only therapeutic option for LCMV \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31maminoglycoside\u001b[0m.\u001b[31mamod\u001b[0m-\u001b[1mmonotherapy\u001b[0m.\u001b[1mnsubjpass\u001b[0m-treatment.nmod-\u001b[34mpneumonia\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mAminoglycoside\u001b[0m monotherapy for the treatment of \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhydroxychloroquine\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mworsen\u001b[0m.\u001b[1mccomp\u001b[0m-covid-19.nmod-\u001b[34mpatient\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mhydroxychloroquine\u001b[0m may actually substantially worsen outcomes in COVID-19 + \u001b[34mpatients\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mbenefit\u001b[0m.\u001b[1mccomp\u001b[0m-patient.nsubj-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m will benefit from \u001b[31mcorticosteroids\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mrituximab\u001b[0m.\u001b[31mnmod\u001b[0m-experience.nsubj-encourage.advcl-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-%.nmod-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: develops in about 20 % of \u001b[34mpatients\u001b[0m [ 71 ] [ 72 ] [ 73 ] [ 74 ] [ 75 ] [ 76 ] and may respond relatively poorly to ITP therapies , although recent experience with \u001b[31mrituximab\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mglucocorticoid\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mcontraindicate\u001b[0m.\u001b[1madvcl\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mglucocorticoids\u001b[0m are currently contraindicated in SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m.\u001b[31mnsubj\u001b[0m-become.conj-\u001b[1mpersist\u001b[0m.\u001b[1mROOT\u001b[0m-success.nsubj-\u001b[34mtreatment\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[34mtreatment\u001b[0m success specifically for BO often does not persist , and other immunosuppressive \u001b[31mdrugs\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mJakinibs\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mshow\u001b[0m.\u001b[1madvcl\u001b[0m-efficacy.dobj-treatment.nmod-condition.nmod-\u001b[34minflammatory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mJakinibs\u001b[0m including tofacitinib have shown efficacy in the treatment of \u001b[34minflammatory\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdaptomycin\u001b[0m.\u001b[31mconj\u001b[0m-vancomycin.nsubj-\u001b[1mtherapy\u001b[0m.\u001b[1mnsubjpass\u001b[0m-bacteremia.nmod-\u001b[34mmrsa\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mdaptomycin\u001b[0m are the recommended first-line therapies for \u001b[34mMRSA\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnmod\u001b[0m-agent.nmod-\u001b[1msee\u001b[0m.\u001b[1mROOT\u001b[0m-occur.advcl-result.nmod-response.nmod-\u001b[34minflammatory\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34minflammatory\u001b[0m response to lung injury , a good treatment response is seen with broadspectrum anti-inflammatory agents , such as \u001b[31mcorticosteroids\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mapprove\u001b[0m.\u001b[1mROOT\u001b[0m-for.prep-treat.pcomp-covid-19.dobj-\u001b[34mpneumonia\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m are not approved for treating COVID-19 or any viral \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcart\u001b[0m.\u001b[31mdobj\u001b[0m-\u001b[1mtolerate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m do not tolerate \u001b[31mcART\u001b[0m\tCOUNT: 1\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 5:\n",
      "\targ1:[e]stroke is a $complication of :[e]COVID-19 arg2:infection\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a novel respiratory \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a novel respiratory \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a highly contagious \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m an infectious \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m an acute infectious \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m an acute resolved \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a common cardiovascular \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mpatient\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with severe COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m is a common complication in \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is a known complication among critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mpatient\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with invasive GAS \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m ( varicella ) is an uncommon but severe complication in SCT \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is a common complication in ICU \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mpatient\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mpatient\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mpatient\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is the most frequent infectious complication in lung transplant \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1mdeath\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdeath\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mdeath\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdeath\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mdeath\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdeath\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mdeath\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mdeath\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 4\n",
      "PATH: \u001b[31minjury\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-condition.attr-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minjury\u001b[0m is a common condition among the hospitalized \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m a complication in critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m a complication in critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a respiratory \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-complication.attr-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m is the most common infectious complication in multiple trauma \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-complication.attr-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m is the most common infectious complication in multiple trauma \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m a common complication of APSCT in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mpatient\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with COVID-19 \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mpatient\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with COVID-19 \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mpatient\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with communityacquired \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a frequent complication in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a systemic \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-morbidity.nmod-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a major cause of morbidity and mortality in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-morbidity.nmod-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a major cause of morbidity and mortality in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minjury\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-condition.attr-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minjury\u001b[0m is a common condition among the hospitalized \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minjury\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-condition.attr-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minjury\u001b[0m is a common condition among the hospitalized \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mof\u001b[0m.\u001b[34mcase\u001b[0m\tLINEAR: \u001b[34mof\u001b[0m COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-morbidity.nmod-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is an important cause of morbidity and mortality in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-complication.attr-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m is a frequent infectious complication in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a respiratory \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m during pregnancy \u001b[34mis\u001b[0m often associated\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mof\u001b[0m.\u001b[34mcase\u001b[0m\tLINEAR: \u001b[34mof\u001b[0m CPV-2 \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mauxpass\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mof\u001b[0m.\u001b[34mcase\u001b[0m\tLINEAR: \u001b[34mof\u001b[0m COVID‐19 \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a common complication for \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m evolving to ARDS is the major complication in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mAKI\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1moccur\u001b[0m.\u001b[1mROOT\u001b[0m-patient.nmod-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mAKI\u001b[0m occurs frequently among patients with Covid-19 \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mAKI\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1moccur\u001b[0m.\u001b[1mROOT\u001b[0m-patient.nmod-\u001b[34mdisease\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mAKI\u001b[0m occurs frequently among patients with Covid-19 \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-associate.acl-mortality.nmod-cause.nmod-\u001b[1mone\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m one of the major causes of mortality associated with COVID-19 \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnmod\u001b[0m-associate.acl-mortality.nmod-cause.nmod-\u001b[1mone\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m one of the major causes of mortality associated with COVID-19 \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1mcommon\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m common in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1mcommon\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m common in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mchild\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a common complication of VZV septicemia in \u001b[34mchildren\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mchild\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a common complication of VZV septicemia in \u001b[34mchildren\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbacterial\u001b[0m.\u001b[31mamod\u001b[0m-superinfection.nsubj-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mBacterial\u001b[0m superinfection is a common complication of viral lower respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a common complication of respiratory virus \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m a complication\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubjpass\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m COVID-19 \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a complication of S-OIV \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31marf\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[31mARF\u001b[0m \u001b[34mis\u001b[0m a common complication\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m in pediatric \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbacterial\u001b[0m.\u001b[31mamod\u001b[0m-superinfection.nsubj-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mBacterial\u001b[0m superinfection is a potential and serious complication of viral lower respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mfailure\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mfailure\u001b[0m is the most lethal complication of SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcommon\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m common\tCOUNT: 2\n",
      "PATH: \u001b[31minfluenza\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a common and potentially severe complication of \u001b[31minfluenza\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfluenza\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a common and potentially severe complication of \u001b[31minfluenza\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcommon\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m common\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mobserve\u001b[0m.\u001b[1mROOT\u001b[0m-%.nmod-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSepsis\u001b[0m has been observed in up to 59 % of hospitalized COVID-19 \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minjury\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcommon\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31minjury\u001b[0m is common in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m or acute respiratory distress syndrome ( ARDS ) in immunocompromised \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m the most frequent cause\tCOUNT: 2\n",
      "PATH: \u001b[31msevere\u001b[0m.\u001b[31mamod\u001b[0m-covid-19.nsubj-\u001b[1mlead\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcan\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31mSevere\u001b[0m COVID-19 \u001b[34mcan\u001b[0m lead\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mproblem\u001b[0m.\u001b[1mconj\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31msepsis\u001b[0m is a major problem in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mproblem\u001b[0m.\u001b[1mconj\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31msepsis\u001b[0m is a major problem in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mshock\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with ARDS , superinfection is frequently associated with septic \u001b[31mshock\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31marf\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[31mARF\u001b[0m \u001b[34mis\u001b[0m a common complication\tCOUNT: 2\n",
      "PATH: \u001b[31msevere\u001b[0m.\u001b[31mamod\u001b[0m-covid-19.nsubj-\u001b[1mlead\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcan\u001b[0m.\u001b[34maux\u001b[0m\tLINEAR: \u001b[31mSevere\u001b[0m COVID-19 \u001b[34mcan\u001b[0m lead\tCOUNT: 2\n",
      "PATH: \u001b[31mshock\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1massociate\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m , superinfection is often associated with \u001b[31mshock\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcomplication\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m \u001b[34mis\u001b[0m a common complication\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mcomplication\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m.\u001b[34mcop\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a potentially devastating \u001b[31mcomplication\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mILD\u001b[0m.\u001b[31mdobj\u001b[0m-develop.advcl-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-be.cop-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with COVID-19 respiratory illness are at risk for developing \u001b[31mILD\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mILD\u001b[0m.\u001b[31mdobj\u001b[0m-develop.advcl-\u001b[1mrisk\u001b[0m.\u001b[1mROOT\u001b[0m-be.cop-\u001b[34mpatient\u001b[0m.\u001b[34mnsubj\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with COVID-19 respiratory illness are at risk for developing \u001b[31mILD\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcirci\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcommon\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mCIRCI\u001b[0m is most common in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcirci\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mcommon\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mCIRCI\u001b[0m is most common in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mcomplication\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-arise.acl:relcl-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcomplication\u001b[0m that can arise after a MV \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mcomplication\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-arise.acl:relcl-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mcomplication\u001b[0m that can arise after a MV \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mare\u001b[0m among the leading causes of death in critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mcop\u001b[0m-\u001b[1mcause\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mare\u001b[0m among the leading causes of death in critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmeningitis\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mfinding\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mmeningitis\u001b[0m is a common finding in many systemic viral \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmeningitis\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mfinding\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34minfection\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mmeningitis\u001b[0m is a common finding in many systemic viral \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubjpass\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m necrotizing CA-MRSA \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mevent\u001b[0m.\u001b[31mconj\u001b[0m-syndrome.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-among.prep-cause.pobj-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mevents\u001b[0m are among the leading causes of death in critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mevent\u001b[0m.\u001b[31mconj\u001b[0m-syndrome.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-among.prep-cause.pobj-\u001b[34mpatient\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mevents\u001b[0m are among the leading causes of death in critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 6:\n",
      "\tthe recommended arg1:[w]quarantine period is arg2:14 :[w]days\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mxcomp\u001b[0m\u001b[0m-for.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mxcomp\u001b[0m\u001b[0m-for.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mxcomp\u001b[0m\u001b[0m-for.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mvaccination\u001b[0m.\u001b[31mcompound\u001b[0m-protocol.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-administration.attr-\u001b[34msingle\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mvaccination\u001b[0m protocol in this situation would be a \u001b[34msingle\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mvaccination\u001b[0m.\u001b[31mcompound\u001b[0m-protocol.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-administration.attr-\u001b[34msingle\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mvaccination\u001b[0m protocol in this situation would be a \u001b[34msingle\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mvaccination\u001b[0m.\u001b[31mcompound\u001b[0m-protocol.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-administration.attr-\u001b[34msingle\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mvaccination\u001b[0m protocol in this situation would be a \u001b[34msingle\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mvaccination\u001b[0m.\u001b[31mcompound\u001b[0m-protocol.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-administration.attr-\u001b[34msingle\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mvaccination\u001b[0m protocol in this situation would be a \u001b[34msingle\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mxcomp\u001b[0m\u001b[0m-for.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34ma\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 22-day \u001b[31mquarantine\u001b[0m period\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34mA\u001b[0m 14-day \u001b[31mquarantine\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34mA\u001b[0m 14‐day \u001b[31mquarantine\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34ma\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 14-day \u001b[31mquarantine\u001b[0m period\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mauxpass\u001b[0m-\u001b[1mrequire\u001b[0m.\u001b[1mROOT\u001b[0m\tLINEAR: \u001b[31mare\u001b[0m \u001b[34mrequired\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mauxpass\u001b[0m-\u001b[1mrequire\u001b[0m.\u001b[1mROOT\u001b[0m\tLINEAR: \u001b[31mare\u001b[0m \u001b[34mrequired\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mauxpass\u001b[0m-\u001b[1misolate\u001b[0m.\u001b[1mROOT\u001b[0m-week.nmod-\u001b[34m3\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m isolated for at least \u001b[34m3\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mauxpass\u001b[0m-\u001b[1misolate\u001b[0m.\u001b[1mROOT\u001b[0m-week.nmod-\u001b[34m3\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m isolated for at least \u001b[34m3\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mauxpass\u001b[0m-\u001b[1misolate\u001b[0m.\u001b[1mROOT\u001b[0m-week.nmod-\u001b[34m3\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m isolated for at least \u001b[34m3\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34ma\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m week-long \u001b[31mquarantine\u001b[0m period\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mauxpass\u001b[0m-\u001b[1mrequire\u001b[0m.\u001b[1mROOT\u001b[0m\tLINEAR: \u001b[31mare\u001b[0m \u001b[34mrequired\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-for.prep-day.pobj-\u001b[34m30\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for at least \u001b[34m30\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-for.prep-day.pobj-\u001b[34m30\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for at least \u001b[34m30\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-for.prep-day.pobj-\u001b[34m30\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for at least \u001b[34m30\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcontagious\u001b[0m.\u001b[31mamod\u001b[0m-period.nsubj-be.conj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.attr-\u001b[34m12\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: is \u001b[34m12\u001b[0m days , and early rash \u001b[31mcontagious\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcontagious\u001b[0m.\u001b[31mamod\u001b[0m-period.nsubj-be.conj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.attr-\u001b[34m12\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: is \u001b[34m12\u001b[0m days , and early rash \u001b[31mcontagious\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcontagious\u001b[0m.\u001b[31mamod\u001b[0m-period.nsubj-be.conj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.attr-\u001b[34m12\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: is \u001b[34m12\u001b[0m days , and early rash \u001b[31mcontagious\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubj\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 5-day \u001b[31mquarantine\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubjpass-\u001b[1mextend\u001b[0m.\u001b[1mROOT\u001b[0m-week.npadvmod-\u001b[34mthree\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period should be extended up to \u001b[34mthree\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-length.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mccomp\u001b[0m-day.attr-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be at least \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-length.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mccomp\u001b[0m-day.attr-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be at least \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubjpass-\u001b[1mextend\u001b[0m.\u001b[1mROOT\u001b[0m-week.npadvmod-\u001b[34mthree\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period should be extended up to \u001b[34mthree\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.attr-\u001b[34m30\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period is typically \u001b[34m30\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubjpass\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 14-day \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mpobj\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-\u001b[1mday\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days of centralized \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mauxpass\u001b[0m-\u001b[1msuspend\u001b[0m.\u001b[1mROOT\u001b[0m-for.prep-day.pobj-\u001b[34m21\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m suspended for up to \u001b[34m21\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtime\u001b[0m.\u001b[31mattr\u001b[0m-be.acl:relcl-\u001b[1mday\u001b[0m.\u001b[1mnmod\u001b[0m-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days , which is the longest predicted incubation \u001b[31mtime\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.dobj-\u001b[1mprolong\u001b[0m.\u001b[1mxcomp\u001b[0m-to.prep-week.pobj-\u001b[34mthree\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: prolonging the \u001b[31mquarantine\u001b[0m period to \u001b[34mthree\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-for.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.dobj-\u001b[1mprolong\u001b[0m.\u001b[1mxcomp\u001b[0m-to.prep-week.pobj-\u001b[34mthree\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: prolonging the \u001b[31mquarantine\u001b[0m period to \u001b[34mthree\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtime\u001b[0m.\u001b[31mattr\u001b[0m-be.acl:relcl-\u001b[1mday\u001b[0m.\u001b[1mnmod\u001b[0m-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days , which is the longest predicted incubation \u001b[31mtime\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-duration.dobj-\u001b[1mapproximate\u001b[0m.\u001b[1mROOT\u001b[0m-value.nsubj-\u001b[34mthese\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34mThese\u001b[0m values approximate the duration of \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-duration.dobj-\u001b[1mapproximate\u001b[0m.\u001b[1mROOT\u001b[0m-value.nsubj-\u001b[34mthese\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34mThese\u001b[0m values approximate the duration of \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mconj\u001b[0m-day.attr-\u001b[34m4\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m period is \u001b[34m4\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mconj\u001b[0m-day.attr-\u001b[34m4\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m period is \u001b[34m4\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mnumber\u001b[0m.\u001b[31mdobj\u001b[0m-make.acl-order.pobj-in.prep-\u001b[1mfall\u001b[0m.\u001b[1mROOT\u001b[0m-under.prep-hour.pobj-8.nummod-\u001b[34m12\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: fall under \u001b[34m12\u001b[0m - 8 hours in order to make the reproduction \u001b[31mnumber\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mnumber\u001b[0m.\u001b[31mdobj\u001b[0m-make.acl-order.pobj-in.prep-\u001b[1mfall\u001b[0m.\u001b[1mROOT\u001b[0m-under.prep-hour.pobj-8.nummod-\u001b[34m12\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: fall under \u001b[34m12\u001b[0m - 8 hours in order to make the reproduction \u001b[31mnumber\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mextend\u001b[0m.\u001b[1mROOT\u001b[0m-day.nmod-\u001b[34m21\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m may be extended for up to \u001b[34m21\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mamod\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mdobj\u001b[0m-of.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubjpass\u001b[0m\u001b[0m-of.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m of \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mamod\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mdobj\u001b[0m-of.prep-day.pobj-\u001b[34m9\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of \u001b[34m9\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtransmission\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1moccur\u001b[0m.\u001b[1mROOT\u001b[0m-wait.parataxis-day.nsubjpass-\u001b[34m62\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mtransmission\u001b[0m may still occur : if the surveillance sensitivity is only 40 % , then \u001b[34m62\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.attr-\u001b[34m30\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mQuarantine\u001b[0m period for all felid species is typically \u001b[34m30\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mdobj\u001b[0m\u001b[0m-of.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m of \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mdobj\u001b[0m\u001b[0m-of.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m of \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtransmission\u001b[0m.\u001b[31mdobj\u001b[0m-\u001b[1mreduce\u001b[0m.\u001b[1mxcomp\u001b[0m-in.prep-order.pobj-have.acl-after.prep-day.pobj-\u001b[34m60\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: reduce \u001b[31mtransmission\u001b[0m to zero in order to have about 100 cases after \u001b[34m60\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtransmission\u001b[0m.\u001b[31mdobj\u001b[0m-\u001b[1mreduce\u001b[0m.\u001b[1mxcomp\u001b[0m-in.prep-order.pobj-have.acl-after.prep-day.pobj-\u001b[34m60\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: reduce \u001b[31mtransmission\u001b[0m to zero in order to have about 100 cases after \u001b[34m60\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mamod\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mdobj\u001b[0m-of.prep-day.pobj-\u001b[34m9\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of \u001b[34m9\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubjpass\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m.\u001b[34mdet\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 2-week \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnsubjpass\u001b[0m\u001b[0m-of.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m of \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mincubation\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubjpass-\u001b[1mestimate\u001b[0m.\u001b[1mROOT\u001b[0m-be.xcomp-day.npadvmod-2.nummod-\u001b[34m10\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mincubation\u001b[0m period was estimated to be between 2 and \u001b[34m10\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtransmission\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1moccur\u001b[0m.\u001b[1mROOT\u001b[0m-wait.parataxis-day.nsubjpass-\u001b[34m62\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mtransmission\u001b[0m may still occur : if the surveillance sensitivity is only 40 % , then \u001b[34m62\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-\u001b[1mday\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days of \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtime\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.attr-\u001b[34m4\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mtime\u001b[0m before becoming contagious , or the latent period L , is around \u001b[34m4\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtime\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.attr-\u001b[34m4\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mtime\u001b[0m before becoming contagious , or the latent period L , is around \u001b[34m4\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mextend\u001b[0m.\u001b[1mROOT\u001b[0m-day.nmod-\u001b[34m21\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m may be extended for up to \u001b[34m21\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mnsubj\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m.\u001b[31m\u001b[1mROOT\u001b[0m\u001b[0m-for.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mincubation\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubjpass-\u001b[1mestimate\u001b[0m.\u001b[1mROOT\u001b[0m-be.xcomp-day.npadvmod-2.nummod-\u001b[34m10\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: \u001b[31mincubation\u001b[0m period is estimated to be between 2 and \u001b[34m10\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mamod\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mdobj\u001b[0m-of.prep-day.pobj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mpobj\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m.\u001b[31mauxpass\u001b[0m-\u001b[1msuspend\u001b[0m.\u001b[1mROOT\u001b[0m-for.prep-day.pobj-\u001b[34m21\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m suspended for \u001b[34m21\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mchloroquine\u001b[0m.\u001b[31mnmod\u001b[0m-mg.nmod-\u001b[1mtreatment\u001b[0m.\u001b[1mnsubj\u001b[0m-for.prep-day.pobj-\u001b[34mten\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: treatment of 500 mg of \u001b[31mchloroquine\u001b[0m per day for \u001b[34mten\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mchloroquine\u001b[0m.\u001b[31mnmod\u001b[0m-mg.nmod-\u001b[1mtreatment\u001b[0m.\u001b[1mnsubj\u001b[0m-for.prep-day.pobj-\u001b[34mten\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: treatment of 500 mg of \u001b[31mchloroquine\u001b[0m per day for \u001b[34mten\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mrisk\u001b[0m.\u001b[31mcompound\u001b[0m-level.nsubj-reach.advcl-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-after.prep-day.pobj-\u001b[34m90\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mrisk\u001b[0m level reach 20 % , the peak will be above 1000 active cases after \u001b[34m90\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mrisk\u001b[0m.\u001b[31mcompound\u001b[0m-level.nsubj-reach.advcl-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-after.prep-day.pobj-\u001b[34m90\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mrisk\u001b[0m level reach 20 % , the peak will be above 1000 active cases after \u001b[34m90\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mepidemic\u001b[0m.\u001b[31mpobj\u001b[0m-to.prep-delay.nsubjpass-\u001b[1mestimate\u001b[0m.\u001b[1mROOT\u001b[0m-maximum.nmod-of.prep-\u001b[34mday\u001b[0m.\u001b[34mpobj\u001b[0m\tLINEAR: \u001b[31mepidemic\u001b[0m was estimated at a maximum of 2 \u001b[34mdays\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mepidemic\u001b[0m.\u001b[31mpobj\u001b[0m-to.prep-delay.nsubjpass-\u001b[1mestimate\u001b[0m.\u001b[1mROOT\u001b[0m-maximum.nmod-of.prep-\u001b[34mday\u001b[0m.\u001b[34mpobj\u001b[0m\tLINEAR: \u001b[31mepidemic\u001b[0m was estimated at a maximum of 2 \u001b[34mdays\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mconj\u001b[0m-bip.pobj-between.prep-transport.relcl-distance.nsubjpass-\u001b[1mreduce\u001b[0m.\u001b[1mccomp\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be \u001b[34mreduced\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mconj\u001b[0m-bip.pobj-between.prep-transport.relcl-distance.nsubjpass-\u001b[1mreduce\u001b[0m.\u001b[1mccomp\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be \u001b[34mreduced\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-take.conj-=.parataxis-day.dobj-\u001b[34m11\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m develops after an average of six days of incubation , and it takes an average of five days from morbidity to diagnosis ( according to NHCC ) , that is , 5 + 6 = \u001b[34m11\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mdevelop\u001b[0m.\u001b[1mROOT\u001b[0m-take.conj-=.parataxis-day.dobj-\u001b[34m11\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m develops after an average of six days of incubation , and it takes an average of five days from morbidity to diagnosis ( according to NHCC ) , that is , 5 + 6 = \u001b[34m11\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.attr-\u001b[34m22\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period must be at least \u001b[34m22\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.pobj-of.prep-duration.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.attr-\u001b[34m30\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period should be 21 to \u001b[34m30\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-for.prep-\u001b[1mday\u001b[0m.\u001b[1mpobj\u001b[0m-\u001b[34m22\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[34m22\u001b[0m days for \u001b[31mquarantine\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mneed\u001b[0m.\u001b[1mROOT\u001b[0m-implement.xcomp-\u001b[34mwithin\u001b[0m.\u001b[34mprep\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m from symptom onset needs to be implemented \u001b[34mwithin\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-after.prep-week.npadvmod-\u001b[34m2\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period should be around \u001b[34m2\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-period.attr-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-day.nsubj-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days should be the period of \u001b[31mquarantine\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-duration.nsubjpass-\u001b[1mextend\u001b[0m.\u001b[1mROOT\u001b[0m-to.prep-week.pobj-\u001b[34m3\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be extended to \u001b[34m3\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mnsubj\u001b[0m-last.ccomp-be.conj-\u001b[1mvary\u001b[0m.\u001b[1mROOT\u001b[0m-day.nmod-7.nummod-\u001b[34m14\u001b[0m.\u001b[34mconj\u001b[0m\tLINEAR: varies between 7 and \u001b[34m14\u001b[0m days for moderate cases according to [ 3 ] , and this is why \u001b[31mquarantine\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-duration.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mccomp\u001b[0m-day.attr-\u001b[34m4\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m is \u001b[34m4\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mnsubj\u001b[0m-of.prep-day.pobj-\u001b[34m15\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of at least \u001b[34m15\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-base.prep-day.npadvmod-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period is \u001b[34m14\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtime\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mexceed\u001b[0m.\u001b[1mROOT\u001b[0m-hour.npadvmod-\u001b[34m24\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mtime\u001b[0m for COVID-19 related medical waste in the hospital should not exceed \u001b[34m24\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-duration.nsubj-\u001b[1mdepend\u001b[0m.\u001b[1mROOT\u001b[0m-be.conj-minimum.attr-of.prep-day.pobj-\u001b[34m30\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mQuarantine\u001b[0m duration depends on national regulations but should be a minimum of \u001b[34m30\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-duration.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mccomp\u001b[0m-day.attr-\u001b[34m14\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be at least \u001b[34m14\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mperiod\u001b[0m.\u001b[1mnsubjpass\u001b[0m-of.prep-day.pobj-\u001b[34m90\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of 60 to \u001b[34m90\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mcompound\u001b[0m-period.nsubj-\u001b[1mbe\u001b[0m.\u001b[1mROOT\u001b[0m-less.acomp-than.prep-week.pobj-\u001b[34mseveral\u001b[0m.\u001b[34mamod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period , which starts when the most recently received animals are placed into a quarantine , should not be less than \u001b[34mseveral\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mamod\u001b[0m-officer.nsubj-detain.ccomp-mean.advcl-\u001b[1mdescribe\u001b[0m.\u001b[1mROOT\u001b[0m-day.nmod-\u001b[34m20\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: described as \u001b[34m20\u001b[0m days , meaning a \u001b[31mquarantine\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m.\u001b[31mpobj\u001b[0m-of.prep-duration.nsubjpass-\u001b[1mextend\u001b[0m.\u001b[1mROOT\u001b[0m-to.prep-week.pobj-\u001b[34mthree\u001b[0m.\u001b[34mnummod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be extended to \u001b[34mthree\u001b[0m\tCOUNT: 1\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 7:\n",
      "\targ1:[e]COVID-19 $infects arg2:cells\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects lung alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects ACE2positive \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects human epithelial \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m can infect \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters respiratory epithelial \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects endothelial \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters the \u001b[34mcell\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcell\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-COV-2\u001b[0m infects human \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly infects type II alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m primarily infects \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-Cov-2\u001b[0m enters the \u001b[34mcell\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-Cov-2\u001b[0m enters the \u001b[34mcell\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects human lung alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m may infect circulating immune \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters the pulmonary \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects mammalian \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters target \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human target \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human target \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minvade\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m invades target \u001b[34mcells\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minvade\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m invades \u001b[34mcells\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minvade\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly invades alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minvade\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly invades alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minvade\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly invades alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minvade\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly invades alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minvade\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m invades host \u001b[34mcells\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31mmers-cov\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m infects \u001b[34mcells\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mmers-cov\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m infects unciliated bronchial epithelial \u001b[34mcells\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mmers-cov\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m and SARS-CoV infect human primary T \u001b[34mcells\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mmers-cov\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m , but not SARS-CoV , can infect both CD4 and CD8 T \u001b[34mcells\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mmers-cov\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m infects unciliated bronchial epithelial \u001b[34mcells\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m enters host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mappos\u001b[0m-coronavirus.nsubj-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m ) infects host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mappos\u001b[0m-coronavirus.nsubj-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m ) infects host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mappos\u001b[0m-coronavirus.nsubj-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m ) infects host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mappos\u001b[0m-coronavirus.nsubj-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m ) infects host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m enters the host \u001b[34mcell\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m enters the host \u001b[34mcell\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enter.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( ACE2 ) as the receptor to enter host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV\u001b[0m infects human host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects immune \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV\u001b[0m infects epithelial \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mhuman\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mhumans\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV\u001b[0m primarily infects epithelial \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-infect.conj-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enter and infect target host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov2\u001b[0m.\u001b[31mnsubj\u001b[0m-protein.nsubjpass-\u001b[1mreport\u001b[0m.\u001b[1mROOT\u001b[0m-form.xcomp-channel.dobj-associate.acl:relcl-\u001b[34mpathogenesis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSARS-CoV2\u001b[0m is an enveloped virus and E proteins present in them are reported to form ion channels , which is mainly associated with \u001b[34mpathogenesis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov2\u001b[0m.\u001b[31mnsubj\u001b[0m-protein.nsubjpass-\u001b[1mreport\u001b[0m.\u001b[1mROOT\u001b[0m-form.xcomp-channel.dobj-associate.acl:relcl-\u001b[34mpathogenesis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSARS-CoV2\u001b[0m is an enveloped virus and E proteins present in them are reported to form ion channels , which is mainly associated with \u001b[34mpathogenesis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov2\u001b[0m.\u001b[31mnsubj\u001b[0m-protein.nsubjpass-\u001b[1mreport\u001b[0m.\u001b[1mROOT\u001b[0m-form.xcomp-channel.dobj-associate.acl:relcl-\u001b[34mpathogenesis\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSARS-CoV2\u001b[0m is an enveloped virus and E proteins present in them are reported to form ion channels , which is mainly associated with \u001b[34mpathogenesis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1mcoronavirus\u001b[0m.\u001b[1mnmod\u001b[0m-invade.acl:relcl-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: coronavirus \u001b[31m2\u001b[0m , which invades a \u001b[34mcell\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-infect.conj-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters into and infects host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-infect.conj-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters into and infects host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enter.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses Angiotensin converting enzyme)-2 ( ACE2 ) as a viral receptor to enter host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mhuman\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mhumans\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mhuman\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mhumans\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1mcoronavirus\u001b[0m.\u001b[1mnmod\u001b[0m-invade.acl:relcl-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: coronavirus \u001b[31m2\u001b[0m , which invades \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1mcoronavirus\u001b[0m.\u001b[1mnmod\u001b[0m-invade.acl:relcl-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: coronavirus \u001b[31m2\u001b[0m , which invades \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enter.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m and SARS-CoV use the angiotensin converting enzyme 2 ( ACE2 ) to enter 65 target \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbind\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-\u001b[34mcell\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the ACE2 receptor on ciliated bronchial epithelial \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mairway\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-Cov-2\u001b[0m first predominantly infects lower \u001b[34mairways\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mtract\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects the GI \u001b[34mtract\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mtract\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects the GI \u001b[34mtract\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrecognize\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-allow.acl:relcl-infect.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m recognizes the human Angiotensin Converting Enzyme 2 ( hACE2 ) as a cellular receptor that allows it to infect different host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrecognize\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-allow.acl:relcl-infect.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m recognizes the human Angiotensin Converting Enzyme 2 ( hACE2 ) as a cellular receptor that allows it to infect different host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbind\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-\u001b[34mcell\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the ACE2 receptor on ciliated bronchial epithelial \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1msars-cov-2\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-enter.acl:relcl-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , which enters host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mappos\u001b[0m-\u001b[1mcoronavirus\u001b[0m.\u001b[1mROOT\u001b[0m-infect.acl:relcl-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: coronavirus 2 ( \u001b[31mSARS-CoV-2\u001b[0m ) ( 6 ) , which infects the \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mappos\u001b[0m-\u001b[1mcoronavirus\u001b[0m.\u001b[1mROOT\u001b[0m-infect.acl:relcl-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: coronavirus 2 ( \u001b[31mSARS-CoV-2\u001b[0m ) ( 6 ) , which infects the \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mairway\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-Cov-2\u001b[0m first predominantly infects lower \u001b[34mairways\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters the host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1minfect\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV2\u001b[0m infects lung alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mvirus\u001b[0m.\u001b[1mROOT\u001b[0m-be.conj-evidence.attr-associate.acl-surface-exposed.advcl-mediate.conj-entry.dobj-\u001b[34mcell\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m is an enveloped virus and there are ample evidences that its Spike protein ( S-protein ) is mainly associated with pathogenesis as it is surface-exposed and mediates entry into host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mvirus\u001b[0m.\u001b[1mROOT\u001b[0m-be.conj-evidence.attr-associate.acl-surface-exposed.advcl-mediate.conj-entry.dobj-\u001b[34mcell\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m is an enveloped virus and there are ample evidences that its Spike protein ( S-protein ) is mainly associated with pathogenesis as it is surface-exposed and mediates entry into host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-invade.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , which is the virus causing coronavirus disease 2019 ( COVID-19 ) , uses the angiotensin-converting enzyme 2 ( ACE2 ) as a cell receptor to invade human \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-invade.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , which is the virus causing coronavirus disease 2019 ( COVID-19 ) , uses the angiotensin-converting enzyme 2 ( ACE2 ) as a cell receptor to invade human \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnmod\u001b[0m-\u001b[1mentry\u001b[0m.\u001b[1mnsubjpass\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: entry of \u001b[31mSARS-CoV-2\u001b[0m into host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1msars-cov-2\u001b[0m\u001b[0m.\u001b[31m\u001b[1mnmod\u001b[0m\u001b[0m-enter.acl:relcl-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , which enters human target \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-enter.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme 2 ( ACE2 ) as a viral receptor to enter the target \u001b[34mcell\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters the \u001b[34mcell\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-potential.dobj-replicate.acl-\u001b[34mcardiomyocyte\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m has the potential to directly replicate within \u001b[34mcardiomyocytes\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mhave\u001b[0m.\u001b[1mROOT\u001b[0m-potential.dobj-replicate.acl-\u001b[34mcardiomyocyte\u001b[0m.\u001b[34mnmod\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m has the potential to directly replicate within \u001b[34mcardiomyocytes\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mconj\u001b[0m-sars-cov.nsubj-\u001b[1minteract\u001b[0m.\u001b[1mROOT\u001b[0m-enter.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m interact directly with angiotensin-converting enzyme 2 ( ACE2 ) to enter host target \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mconj\u001b[0m-sars-cov.nsubj-\u001b[1minteract\u001b[0m.\u001b[1mROOT\u001b[0m-enter.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m interact directly with angiotensin-converting enzyme 2 ( ACE2 ) to enter host target \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enter.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses a spike protein binding the angiotensin converting enzyme ( ACE2 ) to enter the \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-enter.xcomp-\u001b[34mcell\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m may use host receptor angiotensin-converting enzyme 2 ( ACE2 ) to enter the \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 8:\n",
      "\targ1:[e]COVID-19 activates the arg2:ATP $receptor\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: Enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m and SARS-CoV use angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses human angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m and SARS-CoV use the angiotensin converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme II ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 11\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses \u001b[34mACE2\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses \u001b[34mACE2\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m might also use \u001b[34mACE2\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses \u001b[34mACE2\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses \u001b[34mACE2\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses both \u001b[34mACE2\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m can use \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbind\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.dobj-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbind\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.dobj-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mace2\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mreceptor\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mace2\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mreceptor\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses receptor \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mace2\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mreceptor\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mace2\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mnmod\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mreceptor\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mappos\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mappos\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mappos\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbind\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.dobj-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the Angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbind\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.dobj-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the angiotensin I converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mappos\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , like SARS-CoV , uses the same receptor angiotensin converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , like SARS-CoV ( Li et al. , 2003 ) , uses the angiotensin converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m(ace)-2\u001b[0m.\u001b[31mdep\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mdobj\u001b[0m\tLINEAR: \u001b[34mreceptor\u001b[0m , angiotensin converting enzyme \u001b[31m(ACE)-2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.dobj-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.dobj-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m use the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m may use angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m ) receptor\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbind\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m(ace)-2\u001b[0m.\u001b[31mdep\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mdobj\u001b[0m\tLINEAR: \u001b[34mreceptor\u001b[0m , angiotensin converting enzyme \u001b[31m(ACE)-2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-\u001b[34mcell\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , which is the virus causing coronavirus disease 2019 ( COVID-19 ) , uses the angiotensin-converting enzyme 2 ( ACE2 ) as a \u001b[34mcell\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-\u001b[34mcell\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , which is the virus causing coronavirus disease 2019 ( COVID-19 ) , uses the angiotensin-converting enzyme 2 ( ACE2 ) as a \u001b[34mcell\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m ) receptor\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1memploy\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m employs the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1memploy\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m employs \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.dobj-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1memploy\u001b[0m.\u001b[1mccomp\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m employs the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the receptor angiotensinconverting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mdobj\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m ) receptor\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbind\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds with the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-\u001b[34mcell\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the membrane protein Angiotensin I converting enzyme 2(ACE2 ) as a \u001b[34mcell\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mbind\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.nmod-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m(ace)-2\u001b[0m.\u001b[31mdep\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mdobj\u001b[0m\tLINEAR: \u001b[34mreceptor\u001b[0m , angiotensin converting enzyme \u001b[31m(ACE)-2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-bind.advcl-domain.nmod-enzyme.nmod-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.dobj-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , much like the structurally similar and precedent SARS-CoV , uses the \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mutilize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m utilizes \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mshow\u001b[0m.\u001b[1mROOT\u001b[0m-use.xcomp-receptor.dobj-\u001b[34mcell\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m has been shown to use the same \u001b[34mcell\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubjpass\u001b[0m-\u001b[1mshow\u001b[0m.\u001b[1mROOT\u001b[0m-use.xcomp-receptor.dobj-\u001b[34mcell\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m has been shown to use the same \u001b[34mcell\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1menter\u001b[0m.\u001b[1mROOT\u001b[0m-bind.advcl-domain.nmod-enzyme.nmod-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrequire\u001b[0m.\u001b[1mccomp\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , as well as other corona viruses , requires the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mace2\u001b[0m.\u001b[31mcompound\u001b[0m-\u001b[1mreceptor\u001b[0m.\u001b[1mnmod\u001b[0m-\u001b[34mcell\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[34mcell\u001b[0m \u001b[31mACE2\u001b[0m receptors\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34menzyme\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin converting \u001b[34menzyme\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34menzyme\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin converting \u001b[34menzyme\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcovid-19\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mccomp\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mCOVID-19\u001b[0m uses the angiotensin converting enzyme II ( \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m2\u001b[0m.\u001b[31mnummod\u001b[0m-\u001b[1menzyme\u001b[0m.\u001b[1mnmod\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1muse\u001b[0m.\u001b[1mROOT\u001b[0m-receptor.dobj-\u001b[34mace2\u001b[0m.\u001b[34mcompound\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mconj\u001b[0m-sars-cov.nsubj-\u001b[1minteract\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.nmod-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m interact directly with angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mconj\u001b[0m-sars-cov.nsubj-\u001b[1minteract\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.nmod-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m interact directly with angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrequire\u001b[0m.\u001b[1mccomp\u001b[0m-enzyme.dobj-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , just like SARS-CoV , requires the angiotensinconverting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnsubj\u001b[0m-\u001b[1mrecognize\u001b[0m.\u001b[1mROOT\u001b[0m-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also recognizes human \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mace2\u001b[0m.\u001b[31mnsubjpass\u001b[0m-identify.advcl-\u001b[1msurprising\u001b[0m.\u001b[1mROOT\u001b[0m-adapt.ccomp-bind.xcomp-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m was identified as the receptor for SARS-CoV , it is not surprising that SARS-CoV has adapted itself to bind human \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mace2\u001b[0m.\u001b[31mnsubjpass\u001b[0m-identify.advcl-\u001b[1msurprising\u001b[0m.\u001b[1mROOT\u001b[0m-adapt.ccomp-bind.xcomp-\u001b[34mace2\u001b[0m.\u001b[34mdobj\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m was identified as the receptor for SARS-CoV , it is not surprising that SARS-CoV has adapted itself to bind human \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnmod\u001b[0m-receptor.xcomp-\u001b[1mshow\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.nsubjpass-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[34mACE2\u001b[0m ) has been shown to be a functional receptor for \u001b[31mSARS-CoV-2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m.\u001b[31mnmod\u001b[0m-receptor.xcomp-\u001b[1mshow\u001b[0m.\u001b[1mROOT\u001b[0m-enzyme.nsubjpass-\u001b[34mace2\u001b[0m.\u001b[34mappos\u001b[0m\tLINEAR: \u001b[34mACE2\u001b[0m ) has been shown to be a functional receptor for \u001b[31mSARS-CoV-2\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mace2\u001b[0m.\u001b[31mnmod\u001b[0m-invade.conj-\u001b[1mbelong\u001b[0m.\u001b[1mROOT\u001b[0m-covid-19.nsubj-\u001b[34mboth\u001b[0m.\u001b[34mcc:preconj\u001b[0m\tLINEAR: \u001b[34mBoth\u001b[0m COVID-19 and SARS-CoV belong to the coronavirus family and both invade target cells through \u001b[31mACE2\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    }
   ],
   "source": [
    "collect(500, \"lemmas-deps\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Pattern: lemmas along dep path"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 0:\n",
      "\t<>arg1:virus $infection $causes a <>arg2:condition .\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m cause a debilitating \u001b[34mdisease\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes respiratory tract \u001b[34mdisease\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in humans can cause a wide range of clinical manifestations , from mild febrile \u001b[34mdisease\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m of JEV can cause nervous system \u001b[34mdisease\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with LIV in humans can cause a neurological \u001b[34mdisease\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with SARS-CoV causes lower respiratory tract \u001b[34mdisease\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with MAdV-1 causes multisystemic \u001b[34mdisease\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can cause severe lung \u001b[34mdisease\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can result in severe respiratory \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m results in an acute , self-limiting and icteric \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in humans often results in a severe , life-threatening \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m with encephalitic alphaviruses may result in severe neurologic \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m by LCMV can result in acute central nervous system \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m of cattle with BoHV-1 generally results in inflammatory \u001b[34mdisease\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m also characterized\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in humans \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with hMPV \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34minflammation\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in humans is characterized by extensive pulmonary \u001b[34minflammation\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mcan\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m of humans \u001b[34mcan\u001b[0m result\tCOUNT: 3\n",
      "PATH: \u001b[31mibv\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[31mIBV\u001b[0m \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mcan\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mcan\u001b[0m result\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31mibv\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[31mIBV\u001b[0m \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mibv\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[31mIBV\u001b[0m \u001b[34mInfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mcan\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mcan\u001b[0m results\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34minflammation\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m are characterized by \u001b[34minflammation\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34minflammation\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m are characterized by \u001b[34minflammation\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34msyndrome\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m , in domestic cats , causes a variable immunodeficiency \u001b[34msyndrome\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mvirus\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mvirus\u001b[0m causes a lower respiratory tract \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mmyocarditis\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes \u001b[34mmyocarditis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpedv\u001b[0m-infection-\u001b[1mcause\u001b[0m-\u001b[34menteritis\u001b[0m\tLINEAR: \u001b[31mPEDV\u001b[0m infections cause acute , severe atrophic \u001b[34menteritis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34millness\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes undifferentiated febrile \u001b[34millness\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-spectrum-symptom-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with DENV can cause a spectrum of \u001b[34mclinical\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpedv\u001b[0m-infection-\u001b[1mcause\u001b[0m-\u001b[34menteritis\u001b[0m\tLINEAR: \u001b[31mPEDV\u001b[0m infections cause acute , severe atrophic \u001b[34menteritis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34millness\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes \u001b[34millness\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-result-\u001b[34mdamage\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m characterized by severe clinical manifestations of the lower respiratory tract , resulting in diffuse alveolar \u001b[34mdamage\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-result-\u001b[34mdamage\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m characterized by severe clinical manifestations of the lower respiratory tract , resulting in diffuse alveolar \u001b[34mdamage\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbkv\u001b[0m-\u001b[1mestablish\u001b[0m-cause-number-\u001b[34mdisorder\u001b[0m\tLINEAR: \u001b[31mBKV\u001b[0m establishes infection in the kidney and the urinary tract , and its activation causes a number of \u001b[34mdisorders\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbkv\u001b[0m-\u001b[1mestablish\u001b[0m-cause-number-\u001b[34mdisorder\u001b[0m\tLINEAR: \u001b[31mBKV\u001b[0m establishes infection in the kidney and the urinary tract , and its activation causes a number of \u001b[34mdisorders\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34msyndrome\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of humans with SARS-CoV typically causes an influenza-like \u001b[34msyndrome\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a systemic \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1minduce\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of both susceptible and resistant mouse strains induces an early acute \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-spectrum-symptom-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes a broad spectrum of \u001b[34mclinical\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpedv\u001b[0m-infection-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mPEDV\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1massociate\u001b[0m-onset-\u001b[34menteritis\u001b[0m\tLINEAR: \u001b[34menteritis\u001b[0m is associated with \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1massociate\u001b[0m-onset-\u001b[34menteritis\u001b[0m\tLINEAR: \u001b[34menteritis\u001b[0m is associated with \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m an important systemic parvoviral \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-spectrum-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes a wide spectrum of \u001b[34mdiseases\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-spectrum-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes a wide spectrum of \u001b[34mdiseases\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mcan\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m by SFTSV \u001b[34mcan\u001b[0m cause\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mhowever\u001b[0m\tLINEAR: \u001b[34mHowever\u001b[0m , SARS-CoV-2 causes \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mhowever\u001b[0m\tLINEAR: \u001b[34mHowever\u001b[0m , SARS-CoV-2 causes \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpedv\u001b[0m-infection-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mPEDV\u001b[0m infections \u001b[34mare\u001b[0m characterized\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-loss-\u001b[34mfocal\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of the brain with the JHM strain of MHV ( JHMV ) results in \u001b[34mfocal\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-loss-\u001b[34mfocal\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of the brain with the JHM strain of MHV ( JHMV ) results in \u001b[34mfocal\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34millness\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with CHIKV often results in acute \u001b[34millness\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mmyocarditis\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m of mice can cause \u001b[34mmyocarditis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mcan\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mcan\u001b[0m cause\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34millness\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of ZV results in a self-limiting mild \u001b[34millness\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mvirus\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mvirus\u001b[0m causes \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1minduce\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in dogs generally induces a multisystemic \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-manifestation-\u001b[34mneurologic\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can also cause \u001b[34mneurologic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-manifestation-\u001b[34mneurologic\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can also cause \u001b[34mneurologic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mcause\u001b[0m-characterize-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m the major cause of lower respiratory tract infections in infants and \u001b[34mis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mcause\u001b[0m-characterize-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m the major cause of lower respiratory tract infections in infants and \u001b[34mis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mvirus\u001b[0m-\u001b[1minduce\u001b[0m-\u001b[34minflammation\u001b[0m\tLINEAR: \u001b[31mvirus\u001b[0m , like MHV-3 infection in mice , can induce exaggerated \u001b[34minflammation\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m-\u001b[1minduce\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m induces acute \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-immunosuppression-\u001b[34mprogressive\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes \u001b[34mprogressive\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-encephalitis-disorder-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m can cause Japanese encephalitis ( JE ) with \u001b[34msevere\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mproduce\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m with HHV-6 can produce a mononucleosis-like illness and , more rarely , severe \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-illness-\u001b[34mfebrile\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with MV typically results in an acute \u001b[34mfebrile\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mbrv\u001b[0m-infection-\u001b[1mcomponent\u001b[0m-pathogenesis-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mBRV\u001b[0m is a lytic infection and destruction of infected mucosal epithelial cells is an important component of \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mbegin\u001b[0m-progress-stage-infection-characterize-fever-\u001b[34mshock\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m begins with flu-like symptoms and progresses rapidly to the final stages of viral hemorrhagic fever infection , which are characterized by fever , hemorrhage , and hypotensive \u001b[34mshock\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpedv\u001b[0m-\u001b[1minfect\u001b[0m-cause-atrophy-villi-result-\u001b[34mdiarrhea\u001b[0m\tLINEAR: \u001b[31mPEDV\u001b[0m infects the epithelium of the small intestine , an environment rich in proteases , and causes atrophy of the villi resulting in \u001b[34mdiarrhea\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-associate-\u001b[34mgastroenteritis\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m results in respiratory tract complications with varying degree of severity and has been associated with \u001b[34mgastroenteritis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfect\u001b[0m-human-\u001b[1mdevelop\u001b[0m-\u001b[34msyndrome\u001b[0m\tLINEAR: \u001b[31minfected\u001b[0m with RVFV usually develop an acute febrile myalgic \u001b[34msyndrome\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mprrsv\u001b[0m-\u001b[1mincrease\u001b[0m-result-\u001b[34mseverity\u001b[0m\tLINEAR: \u001b[31mPRRSV\u001b[0m increases the susceptibility of the host to a wide range of viral and bacterial respiratory pathogens , resulting in increased \u001b[34mseverity\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m causes severe \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msars-cov\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mSARS-CoV\u001b[0m causes interstitial \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mvirus\u001b[0m-spread-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m characterized by a rapid and extensive spread of the \u001b[31mvirus\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mrepresent\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m mostly represented\tCOUNT: 1\n",
      "PATH: \u001b[31mvirus\u001b[0m-ability-\u001b[1mresult\u001b[0m-\u001b[34mdamage\u001b[0m\tLINEAR: results from overwhelming cytopathic \u001b[34mdamage\u001b[0m due to the ability of Ebola \u001b[31mvirus\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mmers-cov\u001b[0m-infect-human-\u001b[1mreport\u001b[0m-develop-\u001b[34millness\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m have been reported to develop a severe acute respiratory \u001b[34millness\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mJEV\u001b[0m-\u001b[1minvade\u001b[0m-trigger-response-\u001b[34minflammatory\u001b[0m\tLINEAR: \u001b[31mJEV\u001b[0m invades the central nervous system , wherein virus replication triggers a massive \u001b[34minflammatory\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mmcmv\u001b[0m-\u001b[1mcause\u001b[0m-cause-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mMCMV\u001b[0m causes asymptomatic infection in adult immunocompetent mice , but experimental inoculation of neonates has caused lethal \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mlead\u001b[0m-viremia-\u001b[34mto\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m leads \u001b[34mto\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mfiv\u001b[0m-pathogen-\u001b[1mcause\u001b[0m-degeneration-function-lead-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mFIV\u001b[0m is an important viral pathogen worldwide in the domestic cat ( Felis catus ) , causes a slow progressive degeneration of immune functions that eventually leads to a \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34monset\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m causes a sudden \u001b[34monset\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-immunosuppression-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m in young chickens results in \u001b[34msevere\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mprrsv\u001b[0m-\u001b[1mreplicate\u001b[0m-lead-infection-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mPRRSV\u001b[0m replicates mainly in porcine alveolar macrophages ( PAMs ) and dendritic cells ( DCs ) and leads to persistent infection , interstitial \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-characterize-cascade-event-lead-inflammation-\u001b[34mpulmonary\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m of SARS-CoV causes severe acute respiratory syndrome ( SARS ) , which is an emerging infectious disease and characterized by a cascade of immunological events leading to \u001b[34mpulmonary\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mmhv\u001b[0m-infection-\u001b[1mcause\u001b[0m-\u001b[34mencephalitis\u001b[0m\tLINEAR: \u001b[31mMHV\u001b[0m infection causes \u001b[34mencephalitis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31malphavirus\u001b[0m-infection-\u001b[1minduce\u001b[0m-\u001b[34marthritis\u001b[0m\tLINEAR: \u001b[31malphavirus\u001b[0m infections , such as those involving CHIKV , Ross River virus ( RRV ) , and Sindbis virus ( SINV ) , induce debilitating \u001b[34marthritis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-atrophy-intestine-result-\u001b[34mdiarrhea\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is characterized by severe villous atrophy in the small intestine that results in watery \u001b[34mdiarrhea\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mvirus\u001b[0m-\u001b[1mable\u001b[0m-cross-stimulate-\u001b[34minflammation\u001b[0m\tLINEAR: \u001b[31mvirus\u001b[0m is able to cross the blood-brain barrier and stimulate \u001b[34minflammation\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mmnv\u001b[0m-infection-\u001b[1mresult\u001b[0m-replication-associate-\u001b[34mdiarrhea\u001b[0m\tLINEAR: \u001b[31mMNV\u001b[0m infection in immunocompromised mice lacking innate immunity factors such as STAT1 or interferon receptors can result in persistent or acute virus replication associated with severe \u001b[34mdiarrhea\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-severe-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m results in severe and even fatal lung \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 1:\n",
      "\tinfected arg1:patients $usually $develop <>arg2:[entity]respiratory illness.\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m with PEDV \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m clinically characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m \u001b[34mare\u001b[0m characterized\tCOUNT: 9\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1msign\u001b[0m-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[34mClinical\u001b[0m signs of CPV-2 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1msign\u001b[0m-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[34mClinical\u001b[0m signs in human \u001b[31minfections\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1msign\u001b[0m-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of respiratory \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1msign\u001b[0m-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of BDV \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1msign\u001b[0m-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of FPV \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m who have pneumonic plague typically develop fulminant \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m rapidly develop \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m caused by these human coronaviruses , SARS \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with severe cases usually develop \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with BCC develop a life-threatening , sometimes necrotizing , \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m in neonatal kids \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mcharacterize\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m \u001b[34mis\u001b[0m characterized\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mpresent\u001b[0m-\u001b[34msymptom\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m infected with SARS-CoV often present with \u001b[34msymptoms\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mrabbit\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34msepsis\u001b[0m\tLINEAR: \u001b[31mrabbits\u001b[0m usually develop \u001b[34msepsis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mrabbit\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34msepsis\u001b[0m\tLINEAR: \u001b[31mrabbits\u001b[0m usually develop \u001b[34msepsis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mrabbit\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34msepsis\u001b[0m\tLINEAR: \u001b[31mrabbits\u001b[0m usually develop \u001b[34msepsis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34mfever\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m develop rapid onset \u001b[34mfever\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mpresent\u001b[0m-\u001b[34msymptom\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with severe MERS often present with pneumonic \u001b[34msymptoms\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mhuman\u001b[0m-\u001b[1mdisease\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mhuman\u001b[0m-\u001b[1mdisease\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34mfever\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m develop \u001b[34mfever\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mhuman\u001b[0m-\u001b[1mdisease\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mpresent\u001b[0m-\u001b[34msymptom\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m generally present with mild upper respiratory infection \u001b[34msymptoms\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34mfever\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m usually develop \u001b[34mfever\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mhuman\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1msymptom\u001b[0m-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m symptoms of MERS-CoV \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34msymptom\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m initially causes non-specific \u001b[34msymptoms\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m \u001b[31mis\u001b[0m associated\tCOUNT: 2\n",
      "PATH: \u001b[31manimal\u001b[0m-\u001b[1mdie\u001b[0m\tLINEAR: \u001b[31manimals\u001b[0m usually \u001b[34mdie\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m of COVID-19 \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-lead-\u001b[34mfever\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m , immature schistosomula pass through the lung and can lead to \u001b[34mfever\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m of human \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31manimal\u001b[0m-\u001b[1mdevelop\u001b[0m-range-sign-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[31manimals\u001b[0m may develop a wide range of \u001b[34mclinical\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mclinical\u001b[0m-manifestation-\u001b[1mevolve\u001b[0m-picture-\u001b[34mseptic\u001b[0m\tLINEAR: \u001b[31mclinical\u001b[0m manifestations of inhalational anthrax generally evolve to a fulminant \u001b[34mseptic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mclinical\u001b[0m-manifestation-\u001b[1mevolve\u001b[0m-picture-\u001b[34mseptic\u001b[0m\tLINEAR: \u001b[31mclinical\u001b[0m manifestations of inhalational anthrax generally evolve to a fulminant \u001b[34mseptic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfant\u001b[0m-\u001b[1mhave\u001b[0m-\u001b[34msymptom\u001b[0m\tLINEAR: \u001b[31mInfants\u001b[0m with myocarditis usually have \u001b[34msymptoms\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfant\u001b[0m-\u001b[1mhave\u001b[0m-\u001b[34msymptom\u001b[0m\tLINEAR: \u001b[31mInfants\u001b[0m with myocarditis usually have \u001b[34msymptoms\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31manimal\u001b[0m-\u001b[1mdie\u001b[0m\tLINEAR: \u001b[31manimals\u001b[0m usually \u001b[34mdie\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhost\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34mdiarrhea\u001b[0m\tLINEAR: \u001b[31mhosts\u001b[0m usually develop self-limiting \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhost\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34mdiarrhea\u001b[0m\tLINEAR: \u001b[31mhosts\u001b[0m usually develop self-limiting \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m-\u001b[1msign\u001b[0m-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of \u001b[31msepsis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m-\u001b[1msign\u001b[0m-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m signs of \u001b[31msepsis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m-infection-\u001b[1mcause\u001b[0m-\u001b[34msyndrome\u001b[0m\tLINEAR: \u001b[31mhumans\u001b[0m typically causes an influenza-like \u001b[34msyndrome\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m-infection-\u001b[1mcause\u001b[0m-\u001b[34msyndrome\u001b[0m\tLINEAR: \u001b[31mhumans\u001b[0m with SARS-CoV typically causes an influenza-like \u001b[34msyndrome\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with symptomatic EPEC \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1msymptom\u001b[0m\tLINEAR: \u001b[34msymptoms\u001b[0m of rapidly-lethal \u001b[31minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcase\u001b[0m-\u001b[1moccur\u001b[0m-\u001b[34mdyspnea\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , \u001b[34mdyspnea\u001b[0m and hypoxemia usually occur\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with symptomatic EPEC \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1msevere\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m \u001b[31mis\u001b[0m usually more severe\tCOUNT: 2\n",
      "PATH: \u001b[31mmouse\u001b[0m-suckle-growth-\u001b[1mcharacterize\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m is characterized by retarded growth , ruffled fur , soft feces or diarrhea , rectal prolapse , and moderate mortality in older suckling or recently weaned \u001b[31mmice\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmouse\u001b[0m-suckle-growth-\u001b[1mcharacterize\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m is characterized by retarded growth , ruffled fur , soft feces or diarrhea , rectal prolapse , and moderate mortality in older suckling or recently weaned \u001b[31mmice\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mclinic\u001b[0m-progress-\u001b[34mdisease\u001b[0m\tLINEAR: clinic , COVID-19 \u001b[31mpatients\u001b[0m most commonly present with fever , cough and dyspnea , and from there the \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mclinic\u001b[0m-progress-\u001b[34mdisease\u001b[0m\tLINEAR: clinic , COVID-19 \u001b[31mpatients\u001b[0m most commonly present with fever , cough and dyspnea , and from there the \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34msymptom\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m usually causes mild \u001b[34msymptoms\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-lead-\u001b[34mfever\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m , immature schistosomula pass through the lung , and can lead to \u001b[34mfever\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1msevere\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m \u001b[31mis\u001b[0m usually more severe\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mbe\u001b[0m\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m usually a self-limited \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mbe\u001b[0m\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m usually a self-limited \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmouse\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m in immunocompetent adult \u001b[31mmice\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31manimal\u001b[0m-\u001b[1mdevelop\u001b[0m-range-sign-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[31manimals\u001b[0m may develop a wide range of \u001b[34mclinical\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m infected with COVID-19 typically present with fever , cough , dyspnea , and myalgia , and the infection may cause severe \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m infected with COVID-19 typically present with fever , cough , dyspnea , and myalgia , and the infection may cause severe \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mdiarrhea\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m usually result in \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m typically associated with acute cholestatic hepatic \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mmanifest\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m caused by the virus manifests in most cases as a lower respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mmanifest\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m caused by the virus manifests in most cases as a lower respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1msymptom\u001b[0m-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[34mclinical\u001b[0m symptoms of norovirus \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1msymptom\u001b[0m\tLINEAR: \u001b[34msymptoms\u001b[0m of calicivirus \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcase\u001b[0m-\u001b[1moccur\u001b[0m-\u001b[34mdyspnea\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , \u001b[34mdyspnea\u001b[0m occurs\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m-\u001b[1msymptom\u001b[0m\tLINEAR: \u001b[34mSymptoms\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mresult\u001b[0m-\u001b[34mdiarrhea\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m results in profuse greenish , mucoid \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mhuman\u001b[0m-\u001b[1msymptom\u001b[0m\tLINEAR: \u001b[34mSymptoms\u001b[0m in \u001b[31mhumans\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmouse\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m in immunocompetent \u001b[31mmice\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcat\u001b[0m-young-have-\u001b[1mprofuse\u001b[0m-\u001b[34mdiarrhea\u001b[0m\tLINEAR: \u001b[31mcats\u001b[0m with cryptosporidiosis will have profuse , watery \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcat\u001b[0m-young-have-\u001b[1mprofuse\u001b[0m-\u001b[34mdiarrhea\u001b[0m\tLINEAR: \u001b[31mcats\u001b[0m with cryptosporidiosis will have profuse , watery \u001b[34mdiarrhea\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpeople\u001b[0m-\u001b[1mmanifest\u001b[0m-feature-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mpeople\u001b[0m commonly manifest features of \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mexhibit\u001b[0m-encephalopathy-\u001b[34mencephalitis\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m suffering from severe DENV infection often exhibit encephalopathy and \u001b[34mencephalitis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcat\u001b[0m-\u001b[1mshow\u001b[0m-sign-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[31mCats\u001b[0m with FIP show nonspecific \u001b[34mclinical\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcat\u001b[0m-\u001b[1mhave\u001b[0m\tLINEAR: \u001b[31mCats\u001b[0m with signs from FIV often \u001b[34mhave\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34menteric\u001b[0m\tLINEAR: \u001b[34mEnteric\u001b[0m FCoV \u001b[31minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-illness-\u001b[34mrespiratory\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with MERS develop severe acute \u001b[34mrespiratory\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-stage-\u001b[1minclude\u001b[0m-\u001b[34mbleeding\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m usually include diffuse \u001b[34mbleeding\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1masymptomatic\u001b[0m-occur-sign-\u001b[34mclinical\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is usually asymptomatic , although nonspecific \u001b[34mclinical\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mpresent\u001b[0m-headache-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m can present with \u001b[34msevere\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdeteriorate\u001b[0m-present-\u001b[34msymptom\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m infected with EVD rapidly deteriorate and commonly present with gastrointestinal \u001b[34msymptoms\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mrabbit\u001b[0m-\u001b[1mdevelop\u001b[0m-course-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mrabbits\u001b[0m usually develop a chronic \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcat\u001b[0m-\u001b[1minfect\u001b[0m-manifest-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mCats\u001b[0m are primarily infected subclinically , but gastrointestinal \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1mmarmoset\u001b[0m\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mmarmosets\u001b[0m with measles \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhuman\u001b[0m-\u001b[1mcause\u001b[0m-onset-\u001b[34msudden\u001b[0m\tLINEAR: \u001b[31mhumans\u001b[0m , VEEV infection causes a \u001b[34msudden\u001b[0m\tCOUNT: 1\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 2:\n",
      "\ta arg1:subset of patients $progress to arg2:hemorrhagic fever\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m pediatric \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mcase\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mcases\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpatients\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31mcase\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mcase\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mcase\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mcase\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mdisease\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mdisease\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mdisease\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mcase\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m , infection can cause \u001b[34mpneumonia\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mdisease\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31mdisease\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-failure-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m develop \u001b[34msevere\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-failure-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m can develop \u001b[34msevere\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-failure-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m rapidly develop \u001b[34msevere\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-failure-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m rapidly develop \u001b[34msevere\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-failure-\u001b[34mrespiratory\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m may progress into \u001b[34mrespiratory\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-failure-\u001b[34mrespiratory\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m quickly progresses to \u001b[34mrespiratory\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-failure-\u001b[34mrespiratory\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m quickly progresses to \u001b[34mrespiratory\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mviral\u001b[0m\tLINEAR: \u001b[34mviral\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mviral\u001b[0m\tLINEAR: \u001b[34mviral\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mviral\u001b[0m\tLINEAR: \u001b[34mViral\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-case-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , the \u001b[31mdisease\u001b[0m may progress\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mclinic\u001b[0m-progress-\u001b[34mdisease\u001b[0m\tLINEAR: clinic , COVID-19 \u001b[31mpatients\u001b[0m most commonly present with fever , cough and dyspnea , and from there the \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mclinic\u001b[0m-progress-\u001b[34mdisease\u001b[0m\tLINEAR: clinic , COVID-19 \u001b[31mpatients\u001b[0m most commonly present with fever , cough and dyspnea , and from there the \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m-\u001b[1mprogress\u001b[0m-case-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , \u001b[31mit\u001b[0m can progress\tCOUNT: 2\n",
      "PATH: \u001b[31mcondition\u001b[0m-\u001b[1mdevelop\u001b[0m-case-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , the \u001b[31mconditions\u001b[0m may develop\tCOUNT: 2\n",
      "PATH: \u001b[31mcondition\u001b[0m-\u001b[1mdevelop\u001b[0m-case-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , the \u001b[31mconditions\u001b[0m may develop\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1millness\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m \u001b[31millness\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mdevelop\u001b[0m-progress-failure-\u001b[34mrespiratory\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m develops with primary infection , occurs rarely in children , and progresses to \u001b[34mrespiratory\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-disease-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m may develop \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-pneumonia-\u001b[34mviral\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses to \u001b[34mviral\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-pneumonia-\u001b[34mviral\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses to \u001b[34mviral\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-result-failure-\u001b[34mcardiac\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses very slowly , but can result in \u001b[34mcardiac\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-result-failure-\u001b[34mcardiac\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m progresses very slowly , but can result in \u001b[34mcardiac\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mDisease\u001b[0m-\u001b[1mprogress\u001b[0m-syndrome-\u001b[34mand\u001b[0m\tLINEAR: \u001b[31mDisease\u001b[0m can progress to acute respiratory distress syndrome \u001b[34mand\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mDisease\u001b[0m-\u001b[1mprogress\u001b[0m-syndrome-\u001b[34mand\u001b[0m\tLINEAR: \u001b[31mDisease\u001b[0m can progress to acute respiratory distress syndrome \u001b[34mand\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-infection-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mdevelop\u001b[0m-progress-failure-\u001b[34mrespiratory\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m develops rapidly and eventually progresses after 2 to 4 days into \u001b[34mrespiratory\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpatient\u001b[0m\u001b[0m-infection-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcase\u001b[0m-\u001b[1mdevelop\u001b[0m-edema-\u001b[34mpulmonary\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m often develop refractory \u001b[34mpulmonary\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcase\u001b[0m-\u001b[1mdevelop\u001b[0m-edema-\u001b[34mpulmonary\u001b[0m\tLINEAR: \u001b[31mcases\u001b[0m often develop refractory \u001b[34mpulmonary\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1millness\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31millnesses\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mprogress\u001b[0m-\u001b[34mmay\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m \u001b[34mmay\u001b[0m progress\tCOUNT: 2\n",
      "PATH: \u001b[31mcan\u001b[0m-\u001b[1mresult\u001b[0m-complication-involvement-\u001b[34mpulmonary\u001b[0m\tLINEAR: \u001b[34mpulmonary\u001b[0m involvement \u001b[31mcan\u001b[0m result\tCOUNT: 2\n",
      "PATH: \u001b[31mcan\u001b[0m-\u001b[1mresult\u001b[0m-complication-involvement-\u001b[34mpulmonary\u001b[0m\tLINEAR: \u001b[34mpulmonary\u001b[0m involvement \u001b[31mcan\u001b[0m result\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-failure-response-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m whose condition deteriorates to critical status primarily decompensate from a respiratory standpoint , but may also develop multi-organ failure ( respiratory failure , cardiac failure , renal failure , hypercoagulable state , thrombotic microangiopathy ) , as well as \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-failure-response-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m whose condition deteriorates to critical status primarily decompensate from a respiratory standpoint , but may also develop multi-organ failure ( respiratory failure , cardiac failure , renal failure , hypercoagulable state , thrombotic microangiopathy ) , as well as \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mprogress\u001b[0m-\u001b[34mmay\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m \u001b[34mmay\u001b[0m progress\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-form-\u001b[1mexperience\u001b[0m-suffer-complication-\u001b[34msevere\u001b[0m\tLINEAR: experience a mild form of \u001b[31mdisease\u001b[0m , but those with advanced age or underlying comorbidities may suffer \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-form-\u001b[1mexperience\u001b[0m-suffer-complication-\u001b[34msevere\u001b[0m\tLINEAR: experience a mild form of \u001b[31mdisease\u001b[0m , but those with advanced age or underlying comorbidities may suffer \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m-\u001b[1mprogress\u001b[0m-case-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , \u001b[31mit\u001b[0m can progress\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-disease-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m of every age can develop \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-have-\u001b[1mdevelop\u001b[0m-lead-\u001b[34mdeath\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m have mild symptoms such as fever , headache , cough , myalgia and anosmia , some develop acute respiratory distress syndrome , leading to \u001b[34mdeath\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-have-\u001b[1mdevelop\u001b[0m-lead-\u001b[34mdeath\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m have mild symptoms such as fever , headache , cough , myalgia and anosmia , some develop acute respiratory distress syndrome , leading to \u001b[34mdeath\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-case-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m cases , the \u001b[31mdisease\u001b[0m may progress\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mprogress\u001b[0m-\u001b[34mdevelop\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m progress rapidly to \u001b[34mdevelop\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mprogress\u001b[0m-\u001b[34mdevelop\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m progress rapidly to \u001b[34mdevelop\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34mprogressive\u001b[0m\tLINEAR: \u001b[34mprogressive\u001b[0m local \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34mprogressive\u001b[0m\tLINEAR: \u001b[34mprogressive\u001b[0m local \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m-\u001b[1mresult\u001b[0m-syndrome-failure-\u001b[34mrespiratory\u001b[0m\tLINEAR: \u001b[31mit\u001b[0m may result in adult \u001b[34mrespiratory\u001b[0m distress syndrome and respiratory\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m-\u001b[1mresult\u001b[0m-syndrome-failure-\u001b[34mrespiratory\u001b[0m\tLINEAR: \u001b[31mit\u001b[0m may result in adult \u001b[34mrespiratory\u001b[0m distress syndrome and respiratory\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mresult\u001b[0m-lymphadenopathy-\u001b[34mgeneralize\u001b[0m\tLINEAR: results in \u001b[31mdisease\u001b[0m that is less severe and commonly presents as nondescript , consisting of fever , myalgia , and \u001b[34mgeneralized\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mresult\u001b[0m-lymphadenopathy-\u001b[34mgeneralize\u001b[0m\tLINEAR: results in \u001b[31mdisease\u001b[0m that is less severe and commonly presents as nondescript , consisting of fever , myalgia , and \u001b[34mgeneralized\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m may \u001b[34mdevelop\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mform\u001b[0m-\u001b[34mthis\u001b[0m\tLINEAR: \u001b[34mthis\u001b[0m form of the \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mform\u001b[0m-\u001b[34mthis\u001b[0m\tLINEAR: \u001b[34mthis\u001b[0m form of the \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-onset-\u001b[1mbegin\u001b[0m-case-\u001b[34msymptomatic\u001b[0m\tLINEAR: \u001b[34msymptomatic\u001b[0m cases , the onset of \u001b[31mdisease\u001b[0m begins\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-onset-\u001b[1mbegin\u001b[0m-case-\u001b[34msymptomatic\u001b[0m\tLINEAR: \u001b[34msymptomatic\u001b[0m cases , the onset of \u001b[31mdisease\u001b[0m begins\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-plague-pneumonic-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m may progress to \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-plague-pneumonic-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m may progress to \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-pneumonia-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m may develop \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m-pneumonia-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m may develop \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmay\u001b[0m-\u001b[1mprogress\u001b[0m-to-state-\u001b[34mtoxic\u001b[0m\tLINEAR: \u001b[31mmay\u001b[0m progress to an increasingly \u001b[34mtoxic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-\u001b[34mcan\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m in this age group \u001b[34mcan\u001b[0m progress\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mdevelop\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m \u001b[34mdevelop\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mprogress\u001b[0m-\u001b[34mcan\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m \u001b[34mcan\u001b[0m progress\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mmay\u001b[0m-\u001b[1mprogress\u001b[0m-to-state-\u001b[34mtoxic\u001b[0m\tLINEAR: \u001b[31mmay\u001b[0m progress to an increasingly \u001b[34mtoxic\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-asymptomatic-\u001b[1mcause\u001b[0m-symptom-\u001b[34mserious\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m usually asymptomatic , cryptococcosis can cause \u001b[34mserious\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-asymptomatic-\u001b[1mcause\u001b[0m-symptom-\u001b[34mserious\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m usually asymptomatic , cryptococcosis can cause \u001b[34mserious\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mdevelop\u001b[0m-presentation-include-pharyngitis-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m usually develops within the first 3 months of transplantation , with a presentation that might include pharyngitis , tracheitis , bronchitis , pneumonitis , enteritis , hemorrhagic cystitis , or disseminated \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 3:\n",
      "\tpeople with arg1:[e]asthma are $susceptible to arg2:[e]asthma\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are highly susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are highly susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients , particularly those under anticancer treatment , are potentially more susceptible for a severe \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to the \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients and immunocompromised hosts are particularly susceptible to lung \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are generally more susceptible to \u001b[34minfections\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients are more susceptible to \u001b[34minfections\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients are potentially more susceptible to Coronavirus \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients are more susceptible to \u001b[34minfections\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m may be as susceptible to active Mycobacterium tuberculous \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients are more susceptible to \u001b[34minfections\u001b[0m\tCOUNT: 20\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mcopd\u001b[0m-subject-exacerbation-trigger-\u001b[1mknow\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34mInfection\u001b[0m with RV is known to trigger acute exacerbations and subjects with \u001b[31mCOPD\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more susceptible to \u001b[34minfections\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with iatrogenic or disease related immune suppression are highly susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m who are immunocompromised such as due to steroids or organ and hematopoietic stem cell transplantation are highly susceptible to atypical viral \u001b[34minfections\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with compromised immune systems are more susceptible to viral \u001b[34minfections\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more susceptible to \u001b[34minfection\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are also susceptible to nosocomial viral \u001b[34minfections\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with hematologic malignancies , especially in the neutropenic state after aggressive chemotherapy or HSCT and HSCT recipients with GVHD , are particularly susceptible to invasive fungal \u001b[34minfections\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more susceptible to bacterial , fungal , viral , and parasitic \u001b[34minfections\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with DAH are especially susceptible to pulmonary \u001b[34minfections\u001b[0m\tCOUNT: 10\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with liver cirrhosis or liver cancer are at high risk of SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with defective cell-mediated immunity are at risk of \u001b[34minfections\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with primary adrenal insufficiency including Addison 's disease and congenital adrenal hyperplasia are at an increased risk of \u001b[34minfections\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with prolonged neutropenia who have received intensive cytotoxic chemotherapy are at risk for invasive fungal \u001b[34minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m , especially those with neutropenia , are at increased risk of \u001b[34minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mrsv\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m , including those with HIV/AIDS and patients taking immunosuppressants post-transplant , are at an increased risk for viral and fungal \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mprone\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are also more prone to RSV \u001b[34minfections\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with immunodeficiency syndromes are also at risk of \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mprone\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with ESLD are prone to \u001b[34minfections\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with associated CD4 + cell depletion not receiving appropriate prophylaxis are at high risk for Pneumocystis jiroveci \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m with a single LT may be at greater risk of \u001b[34mpneumonia\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mprone\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m , including not only those with HIV \u001b[34minfection\u001b[0m but also those who undergo small bowel transplantation for short bowel syndrome , are prone to CMV infection\tCOUNT: 4\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mprone\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are also prone to other community acquired and nosocomial \u001b[34minfections\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mds\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-lower-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mDS\u001b[0m are highly susceptible to lower and higher respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mds\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-lower-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mDS\u001b[0m are highly susceptible to lower and higher respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mds\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-lower-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mDS\u001b[0m are highly susceptible to lower and higher respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-status-\u001b[1mincrease\u001b[0m-risk-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients ( whether caused by the disease itself or the treatment ) increases their risk of \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-status-\u001b[1mincrease\u001b[0m-risk-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients ( whether caused by the disease itself or the treatment ) increases their risk of \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-status-\u001b[1mincrease\u001b[0m-risk-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients ( whether caused by the disease itself or the treatment ) increases their risk of \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m undergoing allogeneic stem cell transplantation are at a much higher risk of \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mbacterial\u001b[0m\tLINEAR: \u001b[34mbacterial\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m-patient-\u001b[1mdevelop\u001b[0m-form-\u001b[34maspergillosis\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m or milder forms of immunosuppression develop semi-invasive forms of \u001b[34maspergillosis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m-patient-\u001b[1mdevelop\u001b[0m-form-\u001b[34maspergillosis\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m or milder forms of immunosuppression develop semi-invasive forms of \u001b[34maspergillosis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-be-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are at risk of serious \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with rheumatic and inflammatory bowel diseases ( IBDs ) may be at higher risk of \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mbacterial\u001b[0m\tLINEAR: \u001b[34mbacterial\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m-dentition-patient-\u001b[1mlikely\u001b[0m-develop-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m are more likely to develop aspiration \u001b[34mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m-dentition-patient-\u001b[1mlikely\u001b[0m-develop-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m are more likely to develop aspiration \u001b[34mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m-dentition-patient-\u001b[1mlikely\u001b[0m-develop-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m are more likely to develop aspiration \u001b[34mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mdisease\u001b[0m-patient-\u001b[1mdevelop\u001b[0m-form-\u001b[34maspergillosis\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m or milder forms of immunosuppression can develop semi-invasive forms of \u001b[34maspergillosis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mrisk\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m without prior exposure to varicella-zoster virus are at increased risk of severe \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-be-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m patients who require surgery may be at risk of coronavirus \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-be-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcancer\u001b[0m are at the risk of SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mbacterial\u001b[0m\tLINEAR: \u001b[34mbacterial\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31millness\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: develop severe \u001b[31millness\u001b[0m after \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31millness\u001b[0m-\u001b[1mdevelop\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: develop severe \u001b[31millness\u001b[0m after \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34msepsis\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with immunodeficiency due to human immunodeficiency virus ( HIV ) infection are highly susceptible to viral \u001b[34msepsis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mvulnerable\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are more vulnerable to \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-develop-\u001b[34mhepatitis\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are at higher risk for developing fulminant acute \u001b[34mhepatitis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mvulnerable\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are often vulnerable to opportunistic \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcancer\u001b[0m-patient-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mCancer\u001b[0m patients are at an increased risk for these \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mibd\u001b[0m-patient-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mIBD\u001b[0m are at increased risk of \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mibd\u001b[0m-patient-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mIBD\u001b[0m are at increased risk of \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1mrisk\u001b[0m-develop-\u001b[34mhepatitis\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are at risk for developing acute fulminant \u001b[34mhepatitis\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-bacterial-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m are particularly susceptible to bacterial and candidal \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mfibrosis\u001b[0m-patient-\u001b[1msusceptible\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mfibrosis\u001b[0m are particularly susceptible to chronic \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1msinusitis\u001b[0m\u001b[0m-cause-\u001b[34mbacteria\u001b[0m\tLINEAR: \u001b[31msinusitis\u001b[0m caused by encapsulated \u001b[34mbacteria\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-severity-increase-depletion-\u001b[1mrelated\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfections\u001b[0m are also related to lymphoid depletion and immunosuppression , which likely increase the severity of secondary \u001b[31minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-be-\u001b[1mrisk\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpatients\u001b[0m who are more heavily immunosuppressed and who are suffering from other immunologic and infectious complications of transplant are at higher risk for \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31minfections\u001b[0m frequently cause persistent \u001b[34minfections\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpatient\u001b[0m-\u001b[1msusceptible\u001b[0m-\u001b[34msepsis\u001b[0m\tLINEAR: \u001b[31mPatients\u001b[0m with iron overload ( hemochromatosis ) are more susceptible to yersinial \u001b[34msepsis\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 4:\n",
      "\targ1:[e]paracetamol is $not useful for treating arg2:[e]asthma.\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-\u001b[1mincrease\u001b[0m-influenza-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m may increase the risk of mortality and morbidity ( e.g. secondary \u001b[34minfections\u001b[0m ) in severe influenza and other viral infections\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-\u001b[1mincrease\u001b[0m-influenza-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m may increase the risk of mortality and morbidity ( e.g. secondary \u001b[34minfections\u001b[0m ) in severe influenza and other viral infections\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1mconsider\u001b[0m-management-case-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m and IgIV can be considered for the management of \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1meffective\u001b[0m-virus-\u001b[34msars\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m is only marginally effective against the \u001b[34mSARS\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mantiviral\u001b[0m-option-\u001b[1mlimited\u001b[0m-be-prove-effective-occur-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mantiviral\u001b[0m treatment options are limited because no parenteral drug is available and no drug has been proved to be effective once life-threatening \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mantiviral\u001b[0m-option-\u001b[1mlimited\u001b[0m-be-prove-effective-occur-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mantiviral\u001b[0m treatment options are limited because no parenteral drug is available and no drug has been proved to be effective once life-threatening \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m-cidofovir-\u001b[1magent\u001b[0m\tLINEAR: \u001b[34magents\u001b[0m ( such as cidofovir , foscarnet , and \u001b[31mribavirin\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m-cidofovir-\u001b[1magent\u001b[0m\tLINEAR: \u001b[34magents\u001b[0m ( such as cidofovir , foscarnet , and \u001b[31mribavirin\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1meffective\u001b[0m-virus-\u001b[34msars\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m is only marginally effective against the \u001b[34mSARS\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mof\u001b[0m-therapy-efficacy-effect-\u001b[1mcompromise\u001b[0m-treatment-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m after liver transplantation is often compromised by enhanced adverse effects and limited efficacy \u001b[31mof\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1mconsider\u001b[0m-management-case-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m with or without immunoglobulin can be considered for the management of \u001b[34msevere\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-therapy-sufficient-\u001b[1mthink\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m , it is increasingly thought that \u001b[31mcorticosteroid\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-therapy-sufficient-\u001b[1mthink\u001b[0m-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[34mdisease\u001b[0m , it is increasingly thought that \u001b[31mcorticosteroid\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mof\u001b[0m-therapy-efficacy-effect-\u001b[1mcompromise\u001b[0m-treatment-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m after LT is compromised by enhanced adverse effects and limited efficacy \u001b[31mof\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mantiviral\u001b[0m\u001b[0m-available-practice-treatment-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mantivirals\u001b[0m available in clinical practice for the treatment of \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-therapy-\u001b[1meffective\u001b[0m-%-form-\u001b[34mttp\u001b[0m\tLINEAR: \u001b[31mcorticosteroid\u001b[0m therapy is effective in 56 % of purely hematological forms of \u001b[34mTTP\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-therapy-\u001b[1meffective\u001b[0m-%-form-\u001b[34mttp\u001b[0m\tLINEAR: \u001b[31mcorticosteroid\u001b[0m therapy is effective in 56 % of purely hematological forms of \u001b[34mTTP\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mantiviral\u001b[0m-\u001b[1mhave\u001b[0m-induce-rejection-\u001b[34morgan\u001b[0m\tLINEAR: \u001b[31mAntivirals\u001b[0m themselves have significant side effects , and their use may induce \u001b[34morgan\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mantiviral\u001b[0m-\u001b[1mhave\u001b[0m-induce-rejection-\u001b[34morgan\u001b[0m\tLINEAR: \u001b[31mAntivirals\u001b[0m themselves have significant side effects , and their use may induce \u001b[34morgan\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mantiviral\u001b[0m\u001b[0m-available-practice-treatment-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mantivirals\u001b[0m available in clinical practice for the treatment of \u001b[34mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m-PRON-\u001b[0m-\u001b[1mbe\u001b[0m-agent-patient-active-\u001b[34mtuberculosis\u001b[0m\tLINEAR: \u001b[31mit\u001b[0m is not an appropriate agent in patients with active or latent \u001b[34mtuberculosis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m-\u001b[1msufficient\u001b[0m-suppress-\u001b[34minflammation\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m alone are not sufficient for suppressing \u001b[34minflammation\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1museful\u001b[0m-treat-infection-\u001b[34msars\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m may not be useful for treating \u001b[34mSARS\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtherapy\u001b[0m-\u001b[1mrecommend\u001b[0m-treatment-sars-cov-2-\u001b[34mof\u001b[0m\tLINEAR: \u001b[31mtherapy\u001b[0m is not recommended in the clinical treatment \u001b[34mof\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m-\u001b[1mrecommend\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m are not recommended in COVID-19 \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-fail-\u001b[1mdie\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with PCP typically die due to refractory hypoxemia from severe respiratory failure , and \u001b[31mcorticosteroids\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m-\u001b[1meffective\u001b[0m-treatment-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m are not effective for the treatment of lung injury or shock in adults ' SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-recommend-\u001b[1mdelay\u001b[0m-clearance-\u001b[34mvirus\u001b[0m\tLINEAR: \u001b[31mCorticosteroids\u001b[0m in the treatment of SARS-CoV-2 pneumonia are not usually recommended ; they may delay \u001b[34mvirus\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1mavailable\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m is available for CVB3 \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m-\u001b[1mlicense\u001b[0m-treatment-infection-\u001b[34mcmv\u001b[0m\tLINEAR: \u001b[31mDrugs\u001b[0m currently licensed for the treatment of systemic \u001b[34mCMV\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m-of-Most-\u001b[1meffective\u001b[0m-use-progression-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31magents\u001b[0m are mildly effective and slow-acting , and therefore , should not be used as the only treatment modality due to the rapid progression of \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mantiviral\u001b[0m-\u001b[1mhave\u001b[0m-case-infection-\u001b[34minfluenza\u001b[0m\tLINEAR: \u001b[31mantivirals\u001b[0m such as NA inhibitors and M2 blockers have limited efficacy in severe cases of \u001b[34minfluenza\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m-ineffective-\u001b[1mbe\u001b[0m-low-in-\u001b[34mchild\u001b[0m\tLINEAR: is also low in \u001b[34mchildren\u001b[0m , and the \u001b[31mtreatment\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-use-\u001b[1mcause\u001b[0m-suppression-\u001b[34mhost\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m in the treatment of COVID-19 can cause \u001b[34mhost\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31minterferon\u001b[0m-\u001b[1muse\u001b[0m-treat-\u001b[34mdengue\u001b[0m\tLINEAR: use of \u001b[31minterferon\u001b[0m to treat \u001b[34mdengue\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-trial-\u001b[1mobserve\u001b[0m-consider-be-drug-of-choice-for-\u001b[34minfluenza\u001b[0m\tLINEAR: observed in all clinical trials and \u001b[31mribavirin\u001b[0m is currently not considered to be a drug of choice for \u001b[34minfluenza\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31maciclovir\u001b[0m-monotherapy-efficacy-\u001b[1mhamper\u001b[0m-\u001b[34mencephalitis\u001b[0m\tLINEAR: \u001b[34mencephalitis\u001b[0m , the efficacy of \u001b[31maciclovir\u001b[0m monotherapy may be hampered\tCOUNT: 1\n",
      "PATH: \u001b[31macyclovir\u001b[0m-\u001b[1mhave\u001b[0m-efficacy-prevent-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31macyclovir\u001b[0m has had certain efficacy for preventing CMV \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mfam\u001b[0m-therapy-\u001b[1margue\u001b[0m-use-prophylaxis-\u001b[34msurvival\u001b[0m\tLINEAR: \u001b[31mFAM\u001b[0m is standard therapy for established BOS , recent data argue strongly against using azithromycin as prophylaxis against BOS due to decreased \u001b[34msurvival\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m-\u001b[1mhave\u001b[0m-available-infection-\u001b[34minfluenza\u001b[0m\tLINEAR: \u001b[34minfluenza\u001b[0m infections ( e.g. , M2 and neuraminidase inhibitors ) , these \u001b[31mdrugs\u001b[0m have\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m-\u001b[1mlimit\u001b[0m-response-therapy-suppression-\u001b[34mimmune\u001b[0m\tLINEAR: \u001b[31mtreatment\u001b[0m is frequently limited by insufficient response to therapy or side effects of \u001b[34mimmune\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-demonstrate-\u001b[1mbe\u001b[0m-treatment-\u001b[34mcchf\u001b[0m\tLINEAR: been no specific treatment for \u001b[34mCCHF\u001b[0m , though \u001b[31mribavirin\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mbiologic\u001b[0m-therapy-\u001b[1mprovide\u001b[0m-option-\u001b[34mUC\u001b[0m\tLINEAR: \u001b[31mbiologic\u001b[0m therapies provide a valuable treatment option in \u001b[34mUC\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-therapy-use-\u001b[1mbe\u001b[0m-vaccine-prevent-\u001b[34mrsv\u001b[0m\tLINEAR: is no vaccine to prevent \u001b[34mRSV\u001b[0m , and the only accepted therapy ( \u001b[31mribavirin\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m-\u001b[1muse\u001b[0m-resistance-association-shedding-\u001b[34mvirus\u001b[0m\tLINEAR: \u001b[31mTreatment\u001b[0m with M2 inhibitors , such as amantadine , is generally not used in transplant recipients because of widespread resistance , the association with prolonged shedding of \u001b[34mvirus\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mzanamivir\u001b[0m-\u001b[1minduce\u001b[0m-be-benefit-prove-\u001b[34mtreatment\u001b[0m\tLINEAR: \u001b[34mtreatment\u001b[0m outside of these specific circumstances , as it comes at a cost and may be associated with side effects ; for example , \u001b[31mzanamivir\u001b[0m can induce\tCOUNT: 1\n",
      "PATH: \u001b[31mantiviral\u001b[0m-\u001b[1mtherapy\u001b[0m-\u001b[34mspecific\u001b[0m\tLINEAR: \u001b[34mSpecific\u001b[0m \u001b[31mantiviral\u001b[0m therapies\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-\u001b[1mbe\u001b[0m-choice-patient-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m may not be a standard choice in patients with influenza A \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mcontraindicate\u001b[0m-\u001b[34mcirrhosis\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m contraindicated in advanced \u001b[34mcirrhosis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1minduce\u001b[0m-effective-c-\u001b[34mhepatitis\u001b[0m\tLINEAR: \u001b[34mhepatitis\u001b[0m C , \u001b[31mribavirin\u001b[0m can induce\tCOUNT: 1\n",
      "PATH: \u001b[31mcidofovir\u001b[0m-\u001b[1mremain\u001b[0m-treatment-death-report-secondary-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mcidofovir\u001b[0m remains an imperfect treatment , with deaths reported secondary to disseminated adenoviral \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m-\u001b[1mhave\u001b[0m-efficacy-pneumonia-\u001b[34mbacterial\u001b[0m\tLINEAR: \u001b[31magents\u001b[0m have limited efficacy in advanced \u001b[34mbacterial\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m-\u001b[1meffective\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m and immunosuppressive drugs \u001b[34mare\u001b[0m not universally effective\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m-toxicity-associate-\u001b[1mcomplicated\u001b[0m-treatment-recipient-develop-cre-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfections\u001b[0m is quite complicated , often requires combination antimicrobial therapy , and can also be associated with \u001b[31mdrug\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mivig\u001b[0m-treatment-\u001b[1mtherapy\u001b[0m-\u001b[34mkd\u001b[0m\tLINEAR: \u001b[31mIVIG\u001b[0m is an effective therapy for \u001b[34mKD\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m-use-\u001b[1mlimit\u001b[0m-\u001b[34mad\u001b[0m\tLINEAR: \u001b[34mAD\u001b[0m , continuous use of systemic immunosuppressive \u001b[31magents\u001b[0m is limited\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m-\u001b[1mchallenging\u001b[0m-alleviate-symptom-\u001b[34minflammatory\u001b[0m\tLINEAR: \u001b[31mtreatment\u001b[0m is challenging as IL-1 inhibitors can alleviate the \u001b[34minflammatory\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m-interaction-\u001b[1mpose\u001b[0m-\u001b[34mtreatment\u001b[0m\tLINEAR: \u001b[34mTreatment\u001b[0m of MTB after SOT poses special challenges because of potential interactions between anti-MTB \u001b[31mdrugs\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-use-\u001b[1mcontroversial\u001b[0m-impact-response-\u001b[34mimmune\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m for the treatment of COVID-19 is controversial due to their negative impact on anti-viral \u001b[34mimmune\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-switch-\u001b[1mrecommend\u001b[0m-worsen-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m [ 16 ] is not recommended during SARS-CoV-2 infection and may worsen the \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhaart\u001b[0m-\u001b[1massociate\u001b[0m-make-timing-controversial-patient-\u001b[34msepsis\u001b[0m\tLINEAR: \u001b[31mHAART\u001b[0m is associated with potentially deleterious sequelae , making timing of the therapy very controversial in patients with active \u001b[34msepsis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mantiviral\u001b[0m-therapy-\u001b[1mneed\u001b[0m-absence-intervention-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mantiviral\u001b[0m therapies are needed due to troubles in maintaining adequate stocks of plasma and the absence of effective interventions for treated \u001b[34mpatients\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31malthough\u001b[0m-\u001b[1madopt\u001b[0m-treatment-\u001b[34msars\u001b[0m\tLINEAR: \u001b[31mAlthough\u001b[0m lopinavir/ritonavir have been adopted for the treatment of \u001b[34mSARS\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m-use-need-\u001b[1mrespond\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m afflicted with HIV-associated AIDs including inflammatory musculoskeletal involvement respond well to conventional therapy such as NSAIDs , narcotic drugs , and DMARDs , but refractory cases may need the use of biological \u001b[31magents\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1mapprove\u001b[0m-treatment-infection-\u001b[34mhrsv\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m has been approved for the treatment of \u001b[34mHRSV\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1minhibit\u001b[0m-replication-\u001b[34mviral\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m inhibits \u001b[34mviral\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mantiviral\u001b[0m-drug-benefit-\u001b[1mestablish\u001b[0m-treatment-\u001b[34msars\u001b[0m\tLINEAR: \u001b[31mantiviral\u001b[0m drugs or glucocorticoids has not been established for treatment of \u001b[34mSARS\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-use-be-\u001b[1mconvenient\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m may not be convenient in \u001b[34mpatients\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m-use-need-\u001b[1mrespond\u001b[0m-proportion-involvement-\u001b[34minflammatory\u001b[0m\tLINEAR: \u001b[34minflammatory\u001b[0m musculoskeletal involvement respond well to conventional therapy such as NSAIDs , narcotic drugs and DMARDs , but refractory cases may need the use of biological \u001b[31magents\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mvzig\u001b[0m-efficient-\u001b[1mbeneficial\u001b[0m-therapy-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mVZIG\u001b[0m is clearly efficient in post-exposure prophylaxis , it is not beneficial for therapy of already established VZV \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m-class-efficacy-\u001b[1mlimit\u001b[0m-development-resistance-\u001b[34mantiviral\u001b[0m\tLINEAR: \u001b[31mdrugs\u001b[0m is limited due to the rapid development of \u001b[34mantiviral\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m-\u001b[1mtreatment\u001b[0m-\u001b[34mCRS\u001b[0m\tLINEAR: \u001b[31mSteroids\u001b[0m are also a used treatment in SARS-CoV-2 \u001b[34mCRS\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m-\u001b[1mefficacious\u001b[0m-reduce-level-patient-infection-\u001b[34mhbv\u001b[0m\tLINEAR: \u001b[31magents\u001b[0m have been efficacious in experimental animal studies and reduce \u001b[34mHBV\u001b[0m DNA levels in patients with chronic HBV\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-profile-\u001b[1mlimit\u001b[0m-use-treat-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m including teratogenicity limits its use to treat ZIKV \u001b[34minfections\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtherapy\u001b[0m-conjunction-\u001b[1mtoxicity\u001b[0m-\u001b[34mpulmonary\u001b[0m\tLINEAR: \u001b[34mpulmonary\u001b[0m toxicity in conjunction with FOLFOX \u001b[31mtherapy\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m-mainstay-\u001b[1mcontroversial\u001b[0m-use-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m are the mainstay of any treatment plan however its use during COVID-19 \u001b[34minfection\u001b[0m is controversial\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1mdrug\u001b[0m\u001b[0m-treatment-\u001b[34mvhf\u001b[0m\tLINEAR: \u001b[31mdrugs\u001b[0m for the treatment of \u001b[34mVHF\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mivig\u001b[0m-treatment-initiation-\u001b[1mresult\u001b[0m-\u001b[34mkd\u001b[0m\tLINEAR: \u001b[31mIVIg\u001b[0m treatment before Day 5 of fever can sometimes result in refractory \u001b[34mKD\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m-therapy-\u001b[1mneed\u001b[0m-control-\u001b[34mvasculitis\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m , and cyclophosphamide , or rituximab may be needed to control life-threatening \u001b[34mvasculitis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mglucocorticoid\u001b[0m-\u001b[1mefficacy\u001b[0m-\u001b[34mtreatment\u001b[0m\tLINEAR: efficacy of \u001b[31mglucocorticoids\u001b[0m in the \u001b[34mtreatment\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31magent\u001b[0m-\u001b[1mhave\u001b[0m-that-effective-control-activity-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31magents\u001b[0m have a downside in that they are not that effective in controlling MS \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtreatment\u001b[0m-option-\u001b[1mlimited\u001b[0m-trial-lopinavir/ritonavir-medication-\u001b[34mhiv\u001b[0m\tLINEAR: \u001b[31mtreatment\u001b[0m options for COVID-19 are limited and may not be effective-a randomized trial of lopinavir/ritonavir , a common \u001b[34mHIV\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-\u001b[1mcombination\u001b[0m-treatment-patient-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m is the combination of \u001b[31mribavirin\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mribavirin\u001b[0m-effect-\u001b[1mcontraindicate\u001b[0m-patient-\u001b[34mmyocarditis\u001b[0m\tLINEAR: \u001b[31mribavirin\u001b[0m may be contraindicated in patients with acute and chronic \u001b[34mmyocarditis\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-bronchodilator-include-\u001b[1mbenefit\u001b[0m-plan-\u001b[34mrsv\u001b[0m\tLINEAR: \u001b[34mRSV\u001b[0m are of limited benefit and include bronchodilators , \u001b[31mcorticosteroids\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1mdrug\u001b[0m\u001b[0m-treat-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mdrugs\u001b[0m to treat HCMV \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mtherapy\u001b[0m-refractory-\u001b[1mremain\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m remain refractory to immunoglobulin \u001b[31mtherapy\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31msteroid\u001b[0m-therapy-use-\u001b[1mrefractory\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31msteroids\u001b[0m , plasma exchange ( PE ) , IVIG and immunosuppressive drugs are routinely used , many \u001b[34mpatients\u001b[0m are refractory\tCOUNT: 1\n",
      "PATH: \u001b[31m\u001b[1mRibavirin\u001b[0m\u001b[0m-option-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mRibavirin\u001b[0m , the only therapeutic option for LCMV \u001b[34mdisease\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31maminoglycoside\u001b[0m-\u001b[1mmonotherapy\u001b[0m-treatment-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mAminoglycoside\u001b[0m monotherapy for the treatment of \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mhydroxychloroquine\u001b[0m-\u001b[1mworsen\u001b[0m-covid-19-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mhydroxychloroquine\u001b[0m may actually substantially worsen outcomes in COVID-19 + \u001b[34mpatients\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-\u001b[1mbenefit\u001b[0m-patient-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m will benefit from \u001b[31mcorticosteroids\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mrituximab\u001b[0m-experience-encourage-\u001b[1mdevelop\u001b[0m-%-\u001b[34mpatient\u001b[0m\tLINEAR: develops in about 20 % of \u001b[34mpatients\u001b[0m [ 71 ] [ 72 ] [ 73 ] [ 74 ] [ 75 ] [ 76 ] and may respond relatively poorly to ITP therapies , although recent experience with \u001b[31mrituximab\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mglucocorticoid\u001b[0m-\u001b[1mcontraindicate\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mglucocorticoids\u001b[0m are currently contraindicated in SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdrug\u001b[0m-become-\u001b[1mpersist\u001b[0m-success-\u001b[34mtreatment\u001b[0m\tLINEAR: \u001b[34mtreatment\u001b[0m success specifically for BO often does not persist , and other immunosuppressive \u001b[31mdrugs\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mJakinibs\u001b[0m-\u001b[1mshow\u001b[0m-efficacy-treatment-condition-\u001b[34minflammatory\u001b[0m\tLINEAR: \u001b[31mJakinibs\u001b[0m including tofacitinib have shown efficacy in the treatment of \u001b[34minflammatory\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mdaptomycin\u001b[0m-vancomycin-\u001b[1mtherapy\u001b[0m-bacteremia-\u001b[34mmrsa\u001b[0m\tLINEAR: \u001b[31mdaptomycin\u001b[0m are the recommended first-line therapies for \u001b[34mMRSA\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-agent-\u001b[1msee\u001b[0m-occur-result-response-\u001b[34minflammatory\u001b[0m\tLINEAR: \u001b[34minflammatory\u001b[0m response to lung injury , a good treatment response is seen with broadspectrum anti-inflammatory agents , such as \u001b[31mcorticosteroids\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcorticosteroid\u001b[0m-\u001b[1mapprove\u001b[0m-for-treat-covid-19-\u001b[34mpneumonia\u001b[0m\tLINEAR: \u001b[31mcorticosteroids\u001b[0m are not approved for treating COVID-19 or any viral \u001b[34mpneumonia\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mcart\u001b[0m-\u001b[1mtolerate\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m do not tolerate \u001b[31mcART\u001b[0m\tCOUNT: 1\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 5:\n",
      "\targ1:[e]stroke is a $complication of :[e]COVID-19 arg2:infection\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a novel respiratory \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a novel respiratory \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a highly contagious \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m an infectious \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m an acute infectious \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m an acute resolved \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mdisease\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a common cardiovascular \u001b[31mdisease\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mpatient\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with severe COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m is a common complication in \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is a known complication among critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mpatient\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with invasive GAS \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m ( varicella ) is an uncommon but severe complication in SCT \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is a common complication in ICU \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mpatient\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mpatient\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m is the most frequent infectious complication in lung transplant \u001b[34mpatients\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m\u001b[1mdeath\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mdeath\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m in pediatric \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: complications of viral \u001b[31mpneumonia\u001b[0m , especially in critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m or acute respiratory distress syndrome ( ARDS ) in immunocompromised \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mdeath\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mdeath\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mdeath\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mdeath\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a frequent complication in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mrsv\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[31mRSV\u001b[0m \u001b[34minfection\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mrsv\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[31mRSV\u001b[0m \u001b[34minfection\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mdeath\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mdeath\u001b[0m in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mrsv\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[31mRSV\u001b[0m \u001b[34minfection\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 4\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a common complication for \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m in infected \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mrsv\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[31mRSV\u001b[0m \u001b[34minfection\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m evolving to ARDS is the major complication in \u001b[34mpatients\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31minjury\u001b[0m-\u001b[1mbe\u001b[0m-condition-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31minjury\u001b[0m is a common condition among the hospitalized \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m a complication in critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m a complication in critically ill \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m a complication\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m COVID-19 \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a respiratory \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34msevere\u001b[0m COVID-19 \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mbe\u001b[0m-complication-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m is the most common infectious complication in multiple trauma \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mbe\u001b[0m-complication-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m is the most common infectious complication in multiple trauma \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m a common complication of APSCT in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with COVID-19 \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with COVID-19 \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with communityacquired \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a systemic \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcause\u001b[0m-morbidity-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a major cause of morbidity and mortality in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcause\u001b[0m-morbidity-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a major cause of morbidity and mortality in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minjury\u001b[0m-\u001b[1mbe\u001b[0m-condition-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31minjury\u001b[0m is a common condition among the hospitalized \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31minjury\u001b[0m-\u001b[1mbe\u001b[0m-condition-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31minjury\u001b[0m is a common condition among the hospitalized \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mof\u001b[0m\tLINEAR: \u001b[34mof\u001b[0m COVID-19 \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mare\u001b[0m uncommon complications of SARS-CoV-2 \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34msevere\u001b[0m\tLINEAR: \u001b[34mSevere\u001b[0m necrotizing CA-MRSA \u001b[31mpneumonia\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcause\u001b[0m-morbidity-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is an important cause of morbidity and mortality in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mbe\u001b[0m-complication-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mPneumonia\u001b[0m is a frequent infectious complication in \u001b[34mpatients\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a respiratory \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m during pregnancy \u001b[34mis\u001b[0m often associated\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mof\u001b[0m\tLINEAR: \u001b[34mof\u001b[0m CPV-2 \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m associated\tCOUNT: 3\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m ( caused by S. aureus , Streptococcus pneumoniae , and H. influenzae ) \u001b[34mis\u001b[0m a feared complication\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1minfection\u001b[0m\u001b[0m-\u001b[34mof\u001b[0m\tLINEAR: \u001b[34mof\u001b[0m COVID‐19 \u001b[31minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mAKI\u001b[0m-\u001b[1moccur\u001b[0m-patient-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mAKI\u001b[0m occurs frequently among patients with Covid-19 \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mAKI\u001b[0m-\u001b[1moccur\u001b[0m-patient-\u001b[34mdisease\u001b[0m\tLINEAR: \u001b[31mAKI\u001b[0m occurs frequently among patients with Covid-19 \u001b[34mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-associate-mortality-cause-\u001b[1mone\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m one of the major causes of mortality associated with COVID-19 \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-associate-mortality-cause-\u001b[1mone\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m one of the major causes of mortality associated with COVID-19 \u001b[31mdisease\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mcommon\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m common in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mcommon\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mis\u001b[0m common in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mchild\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a common complication of VZV septicemia in \u001b[34mchildren\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mchild\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a common complication of VZV septicemia in \u001b[34mchildren\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbacterial\u001b[0m-superinfection-\u001b[1mcomplication\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mBacterial\u001b[0m superinfection is a common complication of viral lower respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a common complication of respiratory virus \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mpneumonia\u001b[0m\u001b[0m-\u001b[34mviral\u001b[0m\tLINEAR: \u001b[34mviral\u001b[0m \u001b[31mpneumonia\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m is a complication of S-OIV \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31marf\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mARF\u001b[0m \u001b[34mis\u001b[0m a common complication\tCOUNT: 2\n",
      "PATH: \u001b[31mbacterial\u001b[0m-superinfection-\u001b[1mcomplication\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mBacterial\u001b[0m superinfection is a potential and serious complication of viral lower respiratory tract \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mfailure\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34minfection\u001b[0m\tLINEAR: \u001b[31mfailure\u001b[0m is the most lethal complication of SARS-CoV-2 \u001b[34minfection\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcommon\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m common\tCOUNT: 2\n",
      "PATH: \u001b[31minfluenza\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a common and potentially severe complication of \u001b[31minfluenza\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfluenza\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a common and potentially severe complication of \u001b[31minfluenza\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcommon\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m common\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m-\u001b[1mobserve\u001b[0m-%-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mSepsis\u001b[0m has been observed in up to 59 % of hospitalized COVID-19 \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minjury\u001b[0m-\u001b[1mcommon\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31minjury\u001b[0m is common in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mcomplication\u001b[0m\u001b[0m-affect-%-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31mcomplication\u001b[0m affecting 1.5 to 7 % of KD \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mpneumonia\u001b[0m-\u001b[1mcause\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mpneumonia\u001b[0m \u001b[34mis\u001b[0m the most frequent cause\tCOUNT: 2\n",
      "PATH: \u001b[31msevere\u001b[0m-covid-19-\u001b[1mlead\u001b[0m-\u001b[34mcan\u001b[0m\tLINEAR: \u001b[31mSevere\u001b[0m COVID-19 \u001b[34mcan\u001b[0m lead\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m-\u001b[1mproblem\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31msepsis\u001b[0m is a major problem in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msepsis\u001b[0m-\u001b[1mproblem\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[31msepsis\u001b[0m is a major problem in \u001b[34mpatients\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mshock\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m with ARDS , superinfection is frequently associated with septic \u001b[31mshock\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31marf\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mARF\u001b[0m \u001b[34mis\u001b[0m a common complication\tCOUNT: 2\n",
      "PATH: \u001b[31msevere\u001b[0m-covid-19-\u001b[1mlead\u001b[0m-\u001b[34mcan\u001b[0m\tLINEAR: \u001b[31mSevere\u001b[0m COVID-19 \u001b[34mcan\u001b[0m lead\tCOUNT: 2\n",
      "PATH: \u001b[31mshock\u001b[0m-\u001b[1massociate\u001b[0m-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mpatients\u001b[0m , superinfection is often associated with \u001b[31mshock\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-\u001b[1mcomplication\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[31mInfection\u001b[0m \u001b[34mis\u001b[0m a common complication\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1mcomplication\u001b[0m\u001b[0m-\u001b[34mbe\u001b[0m\tLINEAR: \u001b[34mis\u001b[0m a potentially devastating \u001b[31mcomplication\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mILD\u001b[0m-develop-\u001b[1mrisk\u001b[0m-be-\u001b[34mpatient\u001b[0m\tLINEAR: \u001b[34mPatients\u001b[0m with COVID-19 respiratory illness are at risk for developing \u001b[31mILD\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 6:\n",
      "\tthe recommended arg1:[w]quarantine period is arg2:14 :[w]days\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m for \u001b[34m14\u001b[0m\tCOUNT: 7\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 14-day \u001b[31mquarantine\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34mA\u001b[0m 14-day \u001b[31mquarantine\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34mA\u001b[0m 14‐day \u001b[31mquarantine\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 2-week \u001b[31mquarantine\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 14-day \u001b[31mquarantine\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m \u001b[34mperiod\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 5-day \u001b[31mquarantine\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 22-day \u001b[31mquarantine\u001b[0m period\tCOUNT: 4\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 14-day \u001b[31mquarantine\u001b[0m period\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-of-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m of \u001b[34m14\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-of-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m of \u001b[34m14\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-of-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m of \u001b[34m14\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-of-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m of \u001b[34m14\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mvaccination\u001b[0m-protocol-\u001b[1mbe\u001b[0m-administration-\u001b[34msingle\u001b[0m\tLINEAR: \u001b[31mvaccination\u001b[0m protocol in this situation would be a \u001b[34msingle\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mvaccination\u001b[0m-protocol-\u001b[1mbe\u001b[0m-administration-\u001b[34msingle\u001b[0m\tLINEAR: \u001b[31mvaccination\u001b[0m protocol in this situation would be a \u001b[34msingle\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mvaccination\u001b[0m-protocol-\u001b[1mbe\u001b[0m-administration-\u001b[34msingle\u001b[0m\tLINEAR: \u001b[31mvaccination\u001b[0m protocol in this situation would be a \u001b[34msingle\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mvaccination\u001b[0m-protocol-\u001b[1mbe\u001b[0m-administration-\u001b[34msingle\u001b[0m\tLINEAR: \u001b[31mvaccination\u001b[0m protocol in this situation would be a \u001b[34msingle\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m week-long \u001b[31mquarantine\u001b[0m period\tCOUNT: 4\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-\u001b[34ma\u001b[0m\tLINEAR: \u001b[34ma\u001b[0m 10-day \u001b[31mquarantine\u001b[0m period\tCOUNT: 4\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-of-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of \u001b[34m14\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-of-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of \u001b[34m14\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mincubation\u001b[0m-period-\u001b[1mestimate\u001b[0m-be-day-2-\u001b[34m10\u001b[0m\tLINEAR: \u001b[31mincubation\u001b[0m period was estimated to be between 2 and \u001b[34m10\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mrequire\u001b[0m\tLINEAR: \u001b[31mare\u001b[0m \u001b[34mrequired\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mrequire\u001b[0m\tLINEAR: \u001b[31mare\u001b[0m \u001b[34mrequired\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1misolate\u001b[0m-week-\u001b[34m3\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m isolated for at least \u001b[34m3\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1misolate\u001b[0m-week-\u001b[34m3\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m isolated for at least \u001b[34m3\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1misolate\u001b[0m-week-\u001b[34m3\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m isolated for at least \u001b[34m3\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mincubation\u001b[0m-period-\u001b[1mestimate\u001b[0m-be-day-2-\u001b[34m10\u001b[0m\tLINEAR: \u001b[31mincubation\u001b[0m period is estimated to be between 2 and \u001b[34m10\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-of-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of \u001b[34m14\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1mrequire\u001b[0m\tLINEAR: \u001b[31mare\u001b[0m \u001b[34mrequired\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mincubation\u001b[0m-period-\u001b[1mestimate\u001b[0m-be-day-2-\u001b[34m10\u001b[0m\tLINEAR: \u001b[31mincubation\u001b[0m period is estimated to be between 2 and \u001b[34m10\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m30\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for at least \u001b[34m30\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m30\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for at least \u001b[34m30\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m\u001b[1mquarantine\u001b[0m\u001b[0m-for-day-\u001b[34m30\u001b[0m\tLINEAR: \u001b[31mquarantined\u001b[0m for at least \u001b[34m30\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcontagious\u001b[0m-period-be-\u001b[1mbe\u001b[0m-day-\u001b[34m12\u001b[0m\tLINEAR: is \u001b[34m12\u001b[0m days , and early rash \u001b[31mcontagious\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcontagious\u001b[0m-period-be-\u001b[1mbe\u001b[0m-day-\u001b[34m12\u001b[0m\tLINEAR: is \u001b[34m12\u001b[0m days , and early rash \u001b[31mcontagious\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mcontagious\u001b[0m-period-be-\u001b[1mbe\u001b[0m-day-\u001b[34m12\u001b[0m\tLINEAR: is \u001b[34m12\u001b[0m days , and early rash \u001b[31mcontagious\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mquarantine\u001b[0m-period-\u001b[1mextend\u001b[0m-week-\u001b[34mthree\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period should be extended up to \u001b[34mthree\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-length-\u001b[1mbe\u001b[0m-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be at least \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-length-\u001b[1mbe\u001b[0m-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be at least \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-period-\u001b[1mextend\u001b[0m-week-\u001b[34mthree\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period should be extended up to \u001b[34mthree\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-period-\u001b[1mbe\u001b[0m-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days should be the period of \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-period-\u001b[1mbe\u001b[0m-day-\u001b[34m30\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period is typically \u001b[34m30\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-duration-\u001b[1mbe\u001b[0m-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be at least \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-duration-\u001b[1mbe\u001b[0m-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m was \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-\u001b[1mday\u001b[0m-\u001b[34m14\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days of centralized \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-\u001b[34mlong\u001b[0m\tLINEAR: \u001b[34mLonger\u001b[0m \u001b[31mquarantine\u001b[0m periods\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1msuspend\u001b[0m-for-day-\u001b[34m21\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m suspended for up to \u001b[34m21\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m day \u001b[31mquarantine\u001b[0m period\tCOUNT: 2\n",
      "PATH: \u001b[31mtime\u001b[0m-be-\u001b[1mday\u001b[0m-\u001b[34m14\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days , which is the longest predicted incubation \u001b[31mtime\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-period-\u001b[1mprolong\u001b[0m-to-week-\u001b[34mthree\u001b[0m\tLINEAR: prolonging the \u001b[31mquarantine\u001b[0m period to \u001b[34mthree\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-period-\u001b[1mprolong\u001b[0m-to-week-\u001b[34mthree\u001b[0m\tLINEAR: prolonging the \u001b[31mquarantine\u001b[0m period to \u001b[34mthree\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-period-\u001b[1mbe\u001b[0m-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m is \u001b[34m14\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtime\u001b[0m-be-\u001b[1mday\u001b[0m-\u001b[34m14\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days , which is the longest predicted incubation \u001b[31mtime\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-day-\u001b[34m14\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days minimum \u001b[31mquarantine\u001b[0m period\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-duration-\u001b[1mapproximate\u001b[0m-value-\u001b[34mthese\u001b[0m\tLINEAR: \u001b[34mThese\u001b[0m values approximate the duration of \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-duration-\u001b[1mapproximate\u001b[0m-value-\u001b[34mthese\u001b[0m\tLINEAR: \u001b[34mThese\u001b[0m values approximate the duration of \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-\u001b[34mlong\u001b[0m\tLINEAR: \u001b[34mlong\u001b[0m \u001b[31mquarantine\u001b[0m period\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-period-\u001b[1mbe\u001b[0m-day-\u001b[34m4\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m period is \u001b[34m4\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31minfection\u001b[0m-period-\u001b[1mbe\u001b[0m-day-\u001b[34m4\u001b[0m\tLINEAR: \u001b[31minfection\u001b[0m period is \u001b[34m4\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mnumber\u001b[0m-make-order-in-\u001b[1mfall\u001b[0m-under-hour-8-\u001b[34m12\u001b[0m\tLINEAR: fall under \u001b[34m12\u001b[0m - 8 hours in order to make the reproduction \u001b[31mnumber\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mnumber\u001b[0m-make-order-in-\u001b[1mfall\u001b[0m-under-hour-8-\u001b[34m12\u001b[0m\tLINEAR: fall under \u001b[34m12\u001b[0m - 8 hours in order to make the reproduction \u001b[31mnumber\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mextend\u001b[0m-day-\u001b[34m21\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m may be extended for up to \u001b[34m21\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-of-day-\u001b[34m9\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of \u001b[34m9\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtransmission\u001b[0m-\u001b[1moccur\u001b[0m-wait-day-\u001b[34m62\u001b[0m\tLINEAR: \u001b[31mtransmission\u001b[0m may still occur : if the surveillance sensitivity is only 40 % , then \u001b[34m62\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-period-\u001b[1mbe\u001b[0m-day-\u001b[34m30\u001b[0m\tLINEAR: \u001b[31mQuarantine\u001b[0m period for all felid species is typically \u001b[34m30\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtransmission\u001b[0m-\u001b[1mreduce\u001b[0m-in-order-have-after-day-\u001b[34m60\u001b[0m\tLINEAR: reduce \u001b[31mtransmission\u001b[0m to zero in order to have about 100 cases after \u001b[34m60\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtransmission\u001b[0m-\u001b[1mreduce\u001b[0m-in-order-have-after-day-\u001b[34m60\u001b[0m\tLINEAR: reduce \u001b[31mtransmission\u001b[0m to zero in order to have about 100 cases after \u001b[34m60\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mperiod\u001b[0m-of-day-\u001b[34m9\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period of \u001b[34m9\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtransmission\u001b[0m-\u001b[1moccur\u001b[0m-wait-day-\u001b[34m62\u001b[0m\tLINEAR: \u001b[31mtransmission\u001b[0m may still occur : if the surveillance sensitivity is only 40 % , then \u001b[34m62\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-of-\u001b[1mday\u001b[0m-\u001b[34m14\u001b[0m\tLINEAR: \u001b[34m14\u001b[0m days of \u001b[31mquarantine\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtime\u001b[0m-\u001b[1mbe\u001b[0m-day-\u001b[34m4\u001b[0m\tLINEAR: \u001b[31mtime\u001b[0m before becoming contagious , or the latent period L , is around \u001b[34m4\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mtime\u001b[0m-\u001b[1mbe\u001b[0m-day-\u001b[34m4\u001b[0m\tLINEAR: \u001b[31mtime\u001b[0m before becoming contagious , or the latent period L , is around \u001b[34m4\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-\u001b[1mextend\u001b[0m-day-\u001b[34m21\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m may be extended for up to \u001b[34m21\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mbe\u001b[0m-\u001b[1msuspend\u001b[0m-for-day-\u001b[34m21\u001b[0m\tLINEAR: \u001b[31mbe\u001b[0m suspended for \u001b[34m21\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mchloroquine\u001b[0m-mg-\u001b[1mtreatment\u001b[0m-for-day-\u001b[34mten\u001b[0m\tLINEAR: treatment of 500 mg of \u001b[31mchloroquine\u001b[0m per day for \u001b[34mten\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mchloroquine\u001b[0m-mg-\u001b[1mtreatment\u001b[0m-for-day-\u001b[34mten\u001b[0m\tLINEAR: treatment of 500 mg of \u001b[31mchloroquine\u001b[0m per day for \u001b[34mten\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mrisk\u001b[0m-level-reach-\u001b[1mbe\u001b[0m-after-day-\u001b[34m90\u001b[0m\tLINEAR: \u001b[31mrisk\u001b[0m level reach 20 % , the peak will be above 1000 active cases after \u001b[34m90\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mrisk\u001b[0m-level-reach-\u001b[1mbe\u001b[0m-after-day-\u001b[34m90\u001b[0m\tLINEAR: \u001b[31mrisk\u001b[0m level reach 20 % , the peak will be above 1000 active cases after \u001b[34m90\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mepidemic\u001b[0m-to-delay-\u001b[1mestimate\u001b[0m-maximum-of-\u001b[34mday\u001b[0m\tLINEAR: \u001b[31mepidemic\u001b[0m was estimated at a maximum of 2 \u001b[34mdays\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mepidemic\u001b[0m-to-delay-\u001b[1mestimate\u001b[0m-maximum-of-\u001b[34mday\u001b[0m\tLINEAR: \u001b[31mepidemic\u001b[0m was estimated at a maximum of 2 \u001b[34mdays\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-bip-between-transport-distance-\u001b[1mreduce\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be \u001b[34mreduced\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-bip-between-transport-distance-\u001b[1mreduce\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m should be \u001b[34mreduced\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mdevelop\u001b[0m-take-=-day-\u001b[34m11\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m develops after an average of six days of incubation , and it takes an average of five days from morbidity to diagnosis ( according to NHCC ) , that is , 5 + 6 = \u001b[34m11\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mdisease\u001b[0m-\u001b[1mdevelop\u001b[0m-take-=-day-\u001b[34m11\u001b[0m\tLINEAR: \u001b[31mdisease\u001b[0m develops after an average of six days of incubation , and it takes an average of five days from morbidity to diagnosis ( according to NHCC ) , that is , 5 + 6 = \u001b[34m11\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31mquarantine\u001b[0m-period-\u001b[1mbe\u001b[0m-day-\u001b[34m22\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period must be at least \u001b[34m22\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m-period-of-duration-\u001b[1mbe\u001b[0m-day-\u001b[34m30\u001b[0m\tLINEAR: \u001b[31mquarantine\u001b[0m period should be 21 to \u001b[34m30\u001b[0m\tCOUNT: 1\n",
      "PATH: \u001b[31mquarantine\u001b[0m-for-\u001b[1mday\u001b[0m-\u001b[34m22\u001b[0m\tLINEAR: \u001b[34m22\u001b[0m days for \u001b[31mquarantine\u001b[0m\tCOUNT: 1\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 7:\n",
      "\targ1:[e]COVID-19 $infects arg2:cells\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects lung alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects ACE2positive \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects human epithelial \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m can infect \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects endothelial \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcell\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-COV-2\u001b[0m infects human \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly infects type II alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects immune \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m primarily infects \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects human lung alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m may infect circulating immune \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects mammalian \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[34mcells\u001b[0m are infected by \u001b[31mSARS-CoV-2\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects host \u001b[34mcells\u001b[0m\tCOUNT: 21\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters respiratory epithelial \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters the \u001b[34mcell\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-Cov-2\u001b[0m enters the \u001b[34mcell\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-Cov-2\u001b[0m enters the \u001b[34mcell\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters the pulmonary \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters target \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human target \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters human target \u001b[34mcells\u001b[0m\tCOUNT: 16\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minvade\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m invades target \u001b[34mcells\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minvade\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m invades \u001b[34mcells\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minvade\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly invades alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minvade\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly invades alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minvade\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly invades alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minvade\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m mainly invades alveolar epithelial \u001b[34mcells\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minvade\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m invades host \u001b[34mcells\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minvade\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m invades host \u001b[34mcells\u001b[0m\tCOUNT: 8\n",
      "PATH: \u001b[31mmers-cov\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m preferentially infects respiratory epithelial \u001b[34mcells\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mmers-cov\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m infects \u001b[34mcells\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mmers-cov\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m infects unciliated bronchial epithelial \u001b[34mcells\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mmers-cov\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m and SARS-CoV infect human primary T \u001b[34mcells\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mmers-cov\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m , but not SARS-CoV , can infect both CD4 and CD8 T \u001b[34mcells\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mmers-cov\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m infects unciliated bronchial epithelial \u001b[34mcells\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enter-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( ACE2 ) as the receptor to enter host \u001b[34mcells\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enter-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme 2 ( ACE2 ) as a viral receptor to enter the target \u001b[34mcell\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enter-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m may use host receptor angiotensin-converting enzyme 2 ( ACE2 ) to enter the \u001b[34mcells\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enter-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses Angiotensin converting enzyme)-2 ( ACE2 ) as a viral receptor to enter host \u001b[34mcells\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enter-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m and SARS-CoV use the angiotensin converting enzyme 2 ( ACE2 ) to enter 65 target \u001b[34mcells\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m enters \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mentry\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: entry of \u001b[31mSARS-CoV-2\u001b[0m into host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m enters host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-coronavirus-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m ) infects host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-coronavirus-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m ) infects host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mentry\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: Entry of \u001b[31mSARS-CoV-2\u001b[0m into a host \u001b[34mcell\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-coronavirus-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m ) infects host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mentry\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: entry into target \u001b[34mcells\u001b[0m by \u001b[31mSARS-CoV-2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mentry\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m entry into the host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-coronavirus-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m ) infects host \u001b[34mcells\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m enters the host \u001b[34mcell\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mMERS-CoV\u001b[0m-\u001b[1menter\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mMERS-CoV\u001b[0m enters the host \u001b[34mcell\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mtract\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects the GI \u001b[34mtract\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mtract\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects the GI \u001b[34mtract\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV\u001b[0m infects human host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV\u001b[0m infects epithelial \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mhuman\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mhumans\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[34minfection\u001b[0m , SARS-CoV and \u001b[31mSARS-CoV-2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV\u001b[0m primarily infects epithelial \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-infect-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enter and infect target host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov2\u001b[0m-protein-\u001b[1mreport\u001b[0m-form-channel-associate-\u001b[34mpathogenesis\u001b[0m\tLINEAR: \u001b[31mSARS-CoV2\u001b[0m is an enveloped virus and E proteins present in them are reported to form ion channels , which is mainly associated with \u001b[34mpathogenesis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov2\u001b[0m-protein-\u001b[1mreport\u001b[0m-form-channel-associate-\u001b[34mpathogenesis\u001b[0m\tLINEAR: \u001b[31mSARS-CoV2\u001b[0m is an enveloped virus and E proteins present in them are reported to form ion channels , which is mainly associated with \u001b[34mpathogenesis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov2\u001b[0m-protein-\u001b[1mreport\u001b[0m-form-channel-associate-\u001b[34mpathogenesis\u001b[0m\tLINEAR: \u001b[31mSARS-CoV2\u001b[0m is an enveloped virus and E proteins present in them are reported to form ion channels , which is mainly associated with \u001b[34mpathogenesis\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1mcoronavirus\u001b[0m-invade-\u001b[34mcell\u001b[0m\tLINEAR: coronavirus \u001b[31m2\u001b[0m , which invades a \u001b[34mcell\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-infect-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters into and infects host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1menter\u001b[0m-infect-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m enters into and infects host \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfection\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m \u001b[34minfection\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mhuman\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mhumans\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mhuman\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m infects \u001b[34mhumans\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1mcoronavirus\u001b[0m-invade-\u001b[34mcell\u001b[0m\tLINEAR: coronavirus \u001b[31m2\u001b[0m , which invades \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1mcoronavirus\u001b[0m-invade-\u001b[34mcell\u001b[0m\tLINEAR: coronavirus \u001b[31m2\u001b[0m , which invades \u001b[34mcells\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mtract\u001b[0m\tLINEAR: \u001b[31mSars-CoV-2\u001b[0m infects the respiratory \u001b[34mtract\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the ACE2 receptor on ciliated bronchial epithelial \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mairway\u001b[0m\tLINEAR: \u001b[31mSARS-Cov-2\u001b[0m first predominantly infects lower \u001b[34mairways\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mrecognize\u001b[0m-receptor-allow-infect-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m recognizes the human Angiotensin Converting Enzyme 2 ( hACE2 ) as a cellular receptor that allows it to infect different host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mrecognize\u001b[0m-receptor-allow-infect-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m recognizes the human Angiotensin Converting Enzyme 2 ( hACE2 ) as a cellular receptor that allows it to infect different host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the ACE2 receptor on ciliated bronchial epithelial \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m2\u001b[0m-enzyme-\u001b[1muse\u001b[0m-infect-\u001b[34mcell\u001b[0m\tLINEAR: use angiotensin-converting enzyme \u001b[31m2\u001b[0m as the cellular receptor to infect host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31m\u001b[1msars-cov-2\u001b[0m\u001b[0m-enter-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , which enters host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mcoronavirus\u001b[0m-infect-\u001b[34mcell\u001b[0m\tLINEAR: coronavirus 2 ( \u001b[31mSARS-CoV-2\u001b[0m ) ( 6 ) , which infects the \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mcoronavirus\u001b[0m-infect-\u001b[34mcell\u001b[0m\tLINEAR: coronavirus 2 ( \u001b[31mSARS-CoV-2\u001b[0m ) ( 6 ) , which infects the \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1minfect\u001b[0m-\u001b[34mairway\u001b[0m\tLINEAR: \u001b[31mSARS-Cov-2\u001b[0m first predominantly infects lower \u001b[34mairways\u001b[0m\tCOUNT: 2\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-entry-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( ACE2 ) as the receptor for entry into host \u001b[34mcells\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY 8:\n",
      "\targ1:[e]COVID-19 activates the arg2:ATP $receptor\u001b[0m\n",
      "\u001b[1m\n",
      "MOST FREQUENT PATTERNS:\n",
      "\u001b[0m\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: Enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1menzyme\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: enzyme \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m\tCOUNT: 24\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m and SARS-CoV use angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses human angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m may use angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m and SARS-CoV use the angiotensin converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme II ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses angiotensin converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 14\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m can use \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses receptor \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m might also use \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses both \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses \u001b[34mACE2\u001b[0m\tCOUNT: 12\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the \u001b[34mACE2\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds with the \u001b[34mACE2\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the Angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m can bind to human angiotensin converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the angiotensin I converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the \u001b[34mACE2\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mbind\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m binds to the \u001b[34mACE2\u001b[0m\tCOUNT: 9\n",
      "PATH: \u001b[31mace2\u001b[0m-\u001b[1mreceptor\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mreceptor\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mace2\u001b[0m-\u001b[1mreceptor\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mreceptor\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mace2\u001b[0m-\u001b[1mreceptor\u001b[0m\tLINEAR: \u001b[34mreceptor\u001b[0m , \u001b[31mACE2\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mace2\u001b[0m-\u001b[1mreceptor\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mreceptor\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mace2\u001b[0m-\u001b[1mreceptor\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mreceptor\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31mace2\u001b[0m-\u001b[1mreceptor\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mreceptor\u001b[0m\tCOUNT: 6\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m also uses the \u001b[34mACE2\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m use the \u001b[34mACE2\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the \u001b[34mACE2\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m and SARS-CoV use the same receptor , \u001b[34mACE2\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the \u001b[34mACE2\u001b[0m\tCOUNT: 5\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1mreceptor\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m ) receptor\tCOUNT: 4\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1mreceptor\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m ) receptor\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1memploy\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m employs the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1memploy\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m employs \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1memploy\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m employs the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1mreceptor\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m ) receptor\tCOUNT: 4\n",
      "PATH: \u001b[31m2\u001b[0m-\u001b[1mreceptor\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31m2\u001b[0m ( \u001b[34mACE2\u001b[0m ) receptor\tCOUNT: 4\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1memploy\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m and SARS-CoV employ \u001b[34mACE2\u001b[0m\tCOUNT: 4\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , much like the structurally similar and precedent SARS-CoV , uses the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mrequire\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , as well as other corona viruses , requires the angiotensin-converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , like SARS-CoV , uses the same receptor angiotensin converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , like SARS-CoV ( Li et al. , 2003 ) , uses the angiotensin converting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m(ace)-2\u001b[0m-\u001b[1mreceptor\u001b[0m\tLINEAR: \u001b[34mreceptor\u001b[0m , angiotensin converting enzyme \u001b[31m(ACE)-2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m(ace)-2\u001b[0m-\u001b[1mreceptor\u001b[0m\tLINEAR: \u001b[34mreceptor\u001b[0m , angiotensin converting enzyme \u001b[31m(ACE)-2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mrequire\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , just like SARS-CoV , requires the angiotensinconverting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , which is the virus causing coronavirus disease 2019 ( COVID-19 ) , uses the angiotensin-converting enzyme 2 ( ACE2 ) as a \u001b[34mcell\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m , which is the virus causing coronavirus disease 2019 ( COVID-19 ) , uses the angiotensin-converting enzyme 2 ( ACE2 ) as a \u001b[34mcell\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mrequire\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m similarly to SARS-CoV requires angiotensin-converting enzyme 2 ( \u001b[34mAcE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mace2\u001b[0m-\u001b[1mprotein\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mprotein\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mace2\u001b[0m-\u001b[1mprotein\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mprotein\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the receptor angiotensinconverting enzyme 2 ( \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the SARS-CoV receptor \u001b[34mACE2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mSARS-CoV-2\u001b[0m-\u001b[1muse\u001b[0m-receptor-\u001b[34mcell\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m uses the membrane protein Angiotensin I converting enzyme 2(ACE2 ) as a \u001b[34mcell\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31m(ace)-2\u001b[0m-\u001b[1mreceptor\u001b[0m\tLINEAR: \u001b[34mreceptor\u001b[0m , angiotensin converting enzyme \u001b[31m(ACE)-2\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31mace2\u001b[0m-\u001b[1mprotein\u001b[0m\tLINEAR: \u001b[31mACE2\u001b[0m \u001b[34mprotein\u001b[0m\tCOUNT: 3\n",
      "PATH: \u001b[31msars-cov-2\u001b[0m-\u001b[1mutilize\u001b[0m-receptor-enzyme-\u001b[34mace2\u001b[0m\tLINEAR: \u001b[31mSARS-CoV-2\u001b[0m utilizes the same receptor of SARS-CoV , which is angiotensin converting enzyme II ( \u001b[34mACE2\u001b[0m\tCOUNT: 2\n",
      "\n",
      "\n",
      "\n",
      "=================================================================\n",
      "=================================================================\n"
     ]
    }
   ],
   "source": [
    "collect(500, \"lemmas\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
